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Regulation of programmed cell death in the developing thalamus
Programmed cell death (PCD) plays a fundamental role during development of the
vertebrate nervous system. At the time of target innervation, many neurons within
specific neuronal populations die (most, if not all, by apoptosis) and neuronal
survival appears to be controlled by target-derived survival promoting (trophic)
support. In many cases, the trophic factors are members of the neurotrophin family.
In thalamus, the occurrence and the regulation of PCD are still unclear. In this thesis,
I examined PCD in the thalamus during the period of innervation of the cortex (late
embryonic to early postnatal ages in mice). I found that apoptosis (revealed by
TUNEL and pyknotic morphology) is a common mode of thalamic PCD both in vivo
and in vitro. In vivo studies showed the highest rate of cell death is in early postnatal
life, at postnatal day 1 (PI). In vivo analysis of animals lacking functional
neurotrophin tyrosine kinase receptors, TrkB and TrkC, and in vitro work in
collaboration with Dr R.B. Lotto showed that brain-derived neurotrophic factor
(BDNF), acting via TrkB, regulates thalamic survival in the perinatal period. My in
vitro studies showed that thalamic cells cultured from El5 for up to 5 days showed a
loss of viability after 2-3 days, which precedes the in vivo increase in thalamic PCD.
Cortical factors in addition to BDNF are able to maintain thalamic viability for
longer periods in culture. Later studies showed that these control factors are not
unique to the cerebral cortex but can be found in other neuronal tissues. Amongst
other tissues, the late-gestation thalamus is able to produce them provided it is
stimulated with elevated levels of K+. Elevated K+ is known to promote thalamic
survival by increasing depolarisation but I found evidence that elevated K+ did not
require TrkB or TrkC signaling to produce a trophic effect since K+had normal
trophic effects on the thalamic explants of either trkB-/- or trkC-/- animals.
Moreover, I observed an increased cell death in the El9 thalamus in mice
homozygous for a mutation of the transcription factor pax-6. This mutant is known to
lack thalamocortical innervation and my in vivo and in vitro analyses of this mutant
suggested that thalamocortical innervation is essential for developing thalamic cells
3
to obtain sufficient trophic factors. Finally, I observed that the neurotrophins might
play not only a survival role but also a proliferative role, as Bromodeoxyuridine
(BrdU) studies of mice lacking TrkC signaling showed proliferative defects in the
occipital cortex.
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Chapter 1: General Introduction
The development of the vertebrate nervous system, like the development of
all other biological systems, consists of both progressive and regressive phenomena.
The progressive phenomena include induction, proliferation, migration,
differentiation, and the development of functional contacts and cellular
communication. Because of their essentially additive character, the progressive
phenomena had dominated scientists' concepts of the nervous system's development
and often overshadowed the significance of the regressive events during
development.
The regressive features had not been regarded as playing a prominent role in
ontogeny (or some researchers even had totally denied their existence) until the late
1940's. That decade was when Levi-Montalcini and Hamburger found evidence of
naturally occurring cell death and cell death following target ablation (limb bud
removal) in developing sensory ganglia and motor nuclei (Levi-Montalcini and
Hamburger, 1949). Not long after, other forms of regressive events were also
discovered. These include axon retraction and synaptic elimination (reviewed by
Oppenheim, 1991).
Increasing evidence from subsequent studies in morphology, biochemistry,
and genetics confirmed the occurrence of these natural regressive phenomena
(Oppenheim, 1999; Clarke, 1990; Clarke, 1994; Pettman and Henderson, 1998). A
substantial amount of cell death is found particularly in the vertebrate nervous
system. As much as 50% or more of cells in many neuronal populations die during
development (Raff et ah, 1993). In terms of evolutionary processes, it was thought
that such massive death should offer some advantages to the organism. This death
must have some specific purpose or serve critical functions for appropriate
development, possibly in cell selection, control of cell number, or biological
sculpturing in embryogenesis. Thus, the study of naturally occurring cell death
becomes a critical and fundamental issue in development.
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Terms and Types of Cell Death during Development
Although it was first discovered and extensively studied in the nervous
system, cell death during ontogeny also takes place in many different types of
tissues. Several terms that are used to classify cell death in general can apply to cell
death in the nervous system. But some of these classifications may involve other
types of cell death in addition to the death that occurs in development.
Generally, cell death can be classified into two broad categories -
pathological cell death and physiological cell death (Kerr et al., 1972; Duvall and
Wyllie, 1986). Pathological cell death results from accidents, injuries, and all
disease-related conditions. In contrast, physiological cell death occurs in normal
conditions, and includes cell turnover in homeostasis and normal cell death during
development. Various terms are used to describe the latter, such as normal cell death,
spontaneous cell death (Oppenheim and Chu-wang, 1977), naturally occurring cell
death (Ferrer et al., 1992), developmental cell death (Henderson, 1997), or
programmed cell death (PCD) (Oppenheim, 1991). The meanings of these terms are
very similar and sometimes interchangeable. The specificity of the terms used might
vary slightly. For instance, developmental cell death can mean any kind of cell death
occurring in development, which includes cell death by normal homeostatic
mechanisms taking place in ontogeny.
Only the term 'programmed cell death' or PCD has the clearest definition for
the specific death that occurs during development. It is described as "a
spcitiotemporcilly-reproducible and specific loss of large numbers of individual cells
which occurs only in time ofdevelopment" (Oppenheim, 1999). This excludes a
proportion of cells that might also die during development but that does not serve
any distinct functions related to embryogenesis, or that dies due to normal
homeostasis. By this original definition PCD itself does not imply any particular
mode of cell death, classified by morphology and/or biochemical processes, although
later studies might find that a certain mode of morphologically classified death is
more characteristic to PCD than others (Oppenheim, 1999).
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Based on morphology alone, cell death during development can be classified
into at least three types: apoptotic (type I), autophagic (type II), and cytoplasmic
(type III) (Clarke, 1990). However this 'threefold' classification is not popular for
several reasons. 1) There may be overlapping features among these three types in
some dying cells. For instance, type II cell death (which is characterised by
autophagic vacuoles) may exhibit pyknosis (resembling type I), and cytoplasmic
dilation (as type III). This classification is thus difficult to interpret. 2) The
classification lacks supporting biochemical evidence to distinguish each type from
others (Clarke, 1990).
A similar but more general cell death classification has been used in both
pathology and physiology. This is based on both biochemical processes and
morphological appearance. Two broad terms are used to describe cell death in this
classification - necrosis and apoptosis (Wyllie, 1998).
Necrosis is morphologically similar to the type III cytoplasmic cell death that
occurs during development. However, necrosis is involved primarily in pathological
conditions and can be regarded as 'cell murder'. It is death caused by external
damage, usually involving destruction of cell integrity (Schwartz et al., 1995;
Schwartz and Osborne, 1995). The necrotic cell exhibits a swollen cytoplasm, its
plasma membrane lyses and releases debris which often induces inflammation. In
essence, this event happens as a passive response to injury. Biochemically, the cell
loses its regulation of ionic homeostasis. Many lysosomal enzymes are released and
activated. DNA is degraded with non-specific patterns. Necrosis can occur in a
matter of seconds (Collins et ah, 1997) but the subsequent repair and scarring might
take a much longer time or even be permanent throughout the life of an organism.
Unlike necrosis, apoptosis is characterised by nuclear and cytoplasmic
condensation and the disintegration of the cell into a number of well preserved,
membrane-bound fragments (Kerr et ah, 1972). These appearances result from the
activation of many reactions of the cell - intrinsic 'cell suicide' machinery. This does
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Figure 1.1
Apoptosis and necrosis: (I) A healthy cell is depicted undergoing stages of apoptosis
(1-5) or necrosis (1'- swelling, and 2'- lysis). In apoptosis, cell-membrane-bound
apoptotic bodies (2) are engulfed and degraded by a macrophage (3-5). (II) Apoptotic
and (III) necrotic motoneurons as seen in the electron microscope. (IV) DNA extracts
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FIGURE 20.8 Schematic illustration of DNA isolated from
control cells (A), apoptotic cells (B), and necrotic cells (C) and
run on agarose gels. Only the DNA from apoptotic cells in which
double-stranded DNA breaks occur between nucleosomes (left
side) appears in a ladder pattern in multiples of ~200 bp on the
gels.
(Taken from Oppenheim et al 1999).
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not appear to involve lysosomal enzymes. Biochemical detail is discussed in the next
section. The processes take a much longer time from the induction step than those of
necrosis. However, once the cellular machinery is committed to death, the
degenerative process (including elimination) is rapid with cells dying and being
removed in minutes or a few hours. The prepackaged membrane-bound components
are engulfed by macrophages, microglia, or even by their neighboring cells (Kerr et
al., 1972).
Apoptosis is not a mechanism restricted only to development, and it is not a
synonym of physiological cell death as it was originally thought. It can be found in
many pathological conditions. In non-developmental physiological states, apoptosis
controls the rate of cellular turnover in adults (a homeostatic mechanism to balance
cell proliferation). Certain hormones, such as glucocorticoids, also induce apoptosis
in both physiological (normal) and pathological (neoplastic) cytotoxic T-
lymphocytes (Wyllie, 1980). Other examples of apoptosis in pathology include
apoptosis following cellular repair, following injury, and in certain
neurodegenerative diseases (Kerr et al., 1972; Isacson, 1993)
Some of the cell death that occurs during normal development may not
involve the mechanisms of apoptosis (reviewed by Sanders, 1997) and, by definition,
apoptosis is not synonymous with PCD. Nevertheless, in many cases the observation
of developmental apoptosis implies that PCD is occurring. They both appear to serve
certain distinct functions related to embryogenesis. PCD exhibits specific
morphology (such as pyknosis) and has the cytochemical properties of apoptosis. At
least one apoptosis-regulating gene, bcl-2, also controls PCD (Oppenheim, 1999).
The highest level of bcl-2 expression is found in neurons during the period of PCD,
which is also the time of target innervation (Holm and Isacson, 1999). Most studies
of PCD rely on detection of apoptosis. Furthermore, the underlying mechanisms in
apoptosis are relatively well understood. For these reasons, in practical use, apoptosis
during development can represent PCD. In development, we can refer to apoptosis as
PCD.
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Molecular Mechanism of Apoptosis
Apoptosis consumes energy. At the DNA level, a key feature of apoptosis is
chromosomal DNA fragmentation, which uses energy. DNA digestion produces
small, double-stranded fragments of approximately 185 base pairs that migrate along
electrophoretic agarose gels in multiples and generate a characteristic 'DNA ladder'
pattern (Arends et al., 1990). DNA fragmentation in apoptosis, unlike that in other
non-apoptotic processes, selectively creates 3' overhang DNA fragments in a much
higher proportion than the other two types of fragments (5'overhang and blunt end
DNA) (Didenko and Hornsby, 1996). The 3'overhangs are also preferred substrates
for terminal deoxynucleotidyl transferase (TdT) which is used widely for an
apoptosis detection method, the in situ DNA fragment labeling technique named
TUNEL (TdT-mediated <iDTP-biotin mck end /abeling) (Gavrieli et al., 1992).
Apoptosis can be genetically predetermined, or regulated by epigenetic
control (see review in Cowan et al., 1984). It is triggered via either intrinsic or
extrinsic factors (Figure 1.2). Intrinsically, certain transcription factor genes such as
ces-1 (C. elegans cell death specification) and ces-2 determine cell fate. Activation
of these genes in specific groups of cells leads to cell death. Some metabolic
perturbation such as an altered cellular oxidation-reduction process may result in
release of many apoptotic mediators (Green and Reed, 1998). Failures to repair
damaged DNA (e.g. following UV irradiation, Wyllie, 1980) also directly triggers
apoptosis without acting via membrane receptors.
Extracellular signaling can induce cell death in two ways: 1) by triggering
death receptors and 2) by trophic deprivation or down-regulation of survival (trophic)
receptors. The first was initially discovered in the immune system. Apoptosis is
triggered by transmembrane death receptors of the tumor necrosis factor receptor
(TNFR, or Fas/TNFR) family. The detail of the pathway is not well understood, but
it has been thought to involve the sphingomyelinase pathway and Ca++ release. The
analogous death receptor in the nervous system is the p75 neurotrophic receptor,
which is also a member of Fas/TNFR family (Pettman and Henderson, 1998).
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Figure 1.2
Summary of the events occurring in apoptosis: Triggering of apoptosis by external or
internal factors proceeds in 4 steps; activation, propagation, commitment, and death.
The first two processes are presented in more detail on neurotrophin signaling in















Neurotrophins, binding receptors and their signal transduction
A) Neurotrophin receptor binding: NGF binds TrkA (sometimes called Trk),
BDNF and NT-4 bind to full-length (functional tyrosine kinase) and truncated (non-
catalytic) TrkB. NT-3 binds to all receptors with a preference for TrkCs.
B) Neurotrophin signal transduction: Signals through Trk receptor are divided
into 2 major pathways. Ras dependent pathway induces the activation of Raf protein
and the phospholipase C (PLC-y) pathway. Both can increase cellular metabolism,
via the action of MAPKK (mitogen activation protein kinase-kinase) and protein
kinase C (PKC, in association with calcium). 2) Ras independent pathway regulates
cell differentiation (the function prominently found for NT-3) via SNT protein, and
prevents cell death by PI-3 kinase (PI3-K).
P75 receptor, on the other hand, acts via IkB and sphingomyelinase to
promote apoptosis. The detailed mechanism is still unclear. Flowever, at the same
time, it is the same p75 receptor that helps increase Trk affinity binding to
neurotrophins. The contradictory functions are not fully understood.
Abbreviations: TRK = tyrosine kinase receptor (including all neurotrophin
receptors), TNFR = tumor necrosis factor receptor, Ras (in)dep. P'w = Ras
(in)dependent pathway, -K = kinase, MAPK = Mitogen activating protein kinase,
TFs = transcription factors, ieg = immediate early genes, drg = delayed responsive
genes, PLC-y = phospholipase C gamma, DG = Diacylglecerol, PIP2 = Phosphatidyl
inositol 4,5 bisphosphate, IP3 = Inositol 1,4,5 triphosphate. PKB = Protein kinase B,
PKC = Protein kinase C, Ca++ = Calcium ion, CREB = cAMP responsive element
binding protein. Other molecules are known by their full names.
Neurotrophin Signaling, (modified from Segal and Greenberg, 1996)
(a) Neurotrophin receptors
NGF BONF NT-4 NT-3
NT-3 M 99 NT-3 #•








































































Survival and death receptors in caspase dependent apoptosis
The Bcl-2 family plays a major role in the caspase dependent pathway for the
induction of apoptosis. One member of this family, Bax protein, which normally is in
dimer form, would heterodimerise with Bcl-xL if Bad is dephosphorylated. Once
heterodimerised, Apoptosis protease-activating factor (Apaf-1) and Cytochrome C
(©) will be released from the mitochondria form a complex with dATP and
procaspase-9 which then activates itself and then activates a key enzyme for
apoptotic degradation, caspase-3. This results in DNA fragmentation, cytoskeletal
disruption, and membrane blebbling.
The mechanism of apoptosis signaling through the Death receptor is not clear
but is thought to involve the Sphingomyelinase pathway, which can i) inhibit Bcl-2
(see below) and ii) activate NFkB transcription factor. The latter can increase several
caspases, endonucleases, and also polyadenosine dinucleotide-ribose polymerase
(PARP) (the enzyme known to involve in DNA fragmentation).
Activation of the survival receptors can keep the cell alive by keeping Bad
phosphorylated via I) PI3 K/Akt kinase, and ii) Increasing Raf products which,
together with Bcl-2, increases the phosphorylated Bad and inhibit apoptosis.
Prevention and inhibition of apoptosis can mediate via Bcl-2 or the Inhibitors of
Apoptosis (IAP) family of protein. The former helps increasing the availability of
phosphorylated Bad, inhibits Bax/Bcl-xL dimerisation, and directly inhibits caspase-
3. But when the trophic factors are deprived, these functions (dotted lines) are
stopped. IAPs inhibit apoptosis by preventing proteolytic processing of procaspases.
Dotted lines/boxes show mechanisms which normally inhibits of apoptosis,
but they will be inactivated if the trophic factors are deprived. Lines with arrows
show activation mechanisms whereas the lines with red-line ends represent the
inhibition processes. Curved arrows mean the release of mitochondrial molecules to
cytosol.
Caspase dependent pathway induced by death receptor or trophic deprivation


























The induction of apoptosis by deprivation of target-derived trophic factor was
originally described as a regulator of PCD in the nervous system. Certain populations
of neurons require some essential molecules for their survival during the period of
their dependency on other cells to which they project (their targets). Neurotrophic
factors and the neurotrophin family in particular are such molecules, being essential
for the activation of survival receptors to keep cells in a number of neuronal classes
alive. Deprivation of trophic factors leads to molecular consequences causing
apoptosis. This process might directly involve protease cascade pathways. Details of
the signaling pathways of the neurotrophins are discussed later on in this chapter.
Much understanding of the molecular mechanisms of apoptosis came initially
from studies in the invertebrate, Caenorhabditis elegans. The cell death pathway in
this animal is in many ways a miniature version of the vertebrate apoptosis pathway.
Several genes responsible for cell death in this nematode have been characterised and
are called ced genes (C. elegans death genes) (Hengartner, 1998). Key genes
regulating apoptosis include a negative regulator (ced-9) and two positive regulators
(ced-4 and ced-3). Proteins encoded from each of these genes have their functional
equivalent in mammals: the negative regulator CED-9 is a member of the Bcl-2
family of apoptosis regulators, CED-4 has a functional equivalent in apoptosis
protease-activating factor-1 (Apaf-1), and CED-3 is the prototypical caspase (see
review in Hengartner, 1998; Pettman and Henderson, 1998).
A major biochemical pathway for the execution of cell death programmes is
cascade activation of the cystein protease family. These cystein proteases are called
caspases (caspase 1-13 have been identified in mammal) (Pettman and Henderson,
1998). Not all caspases are thought to be involved in apoptosis but there are at least
two key enzymes, caspase-3 and caspase-9, known for their roles in regulating
neuronal apoptosis. In particular, caspase-3 activation plays a central role in
apoptosis of many neuronal classes (Kuida et ah, 1996; Du et ah, 1997). This process
requires four components; activation of pro-caspase-9, Apaf-1, cytochrome C
(cytosolic), and dATP.
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When the level of Bcl-2 (an anti-apoptotic gene; see below) is high, Apaf-1
and cytochrome C normally reside in the mitochondria. But when the level of Bcl-2
is low or there is an increase in free cytosolic Bax (a pro-apoptotic gene; see below),
Apaf-1 and cytochrome C are released from mitochondria and form a complex with
cytosolic pro-caspase-9 and dATP. When the complex is formed, the active caspase-
9 activates caspase-3 which leads to morphological changes in the cell including
DNA fragmentation, membrane and cytoskeletal alterations. DNA fragmentation is
the result of one key endonuclease activated by caspase-3, caspase-activated DNase
(CAD) (Enari et al., 1998). However, it should be emphasised here that, this DNA
cleavage alone does not necessarily determine cell death; instead, the death of a cell
is the loss of the ability to maintain its intracellular homeostasis. Inhibition of DNA
cleavage by mutation of CAD does not prevent cell death (Sakahira et ah, 1998).
Another consequence of cell death is also destabilisation of membrane, exposing
phosphatidyl serine to the extracellular side of the membrane. Phosphatidyl serine
can bind to annexinV and can be used for another apoptosis detection technique. The
activation of these caspases is strictly regulated by a family of protein called
Inhibitors of Apoptosis (IAPs). These proteins contain a BIR (baculovirus IAP
repreat) domain near the amino-terminus that can bind several caspases. Many of the
proteins block proteolytic activation of caspase-3, caspase-7 and/or block
cytochrome c-induced activation oof caspase-9, thereby preventing initiation of the
caspase cascade (Deveraux and Reed, 1999) (Figure 1.4).
Other important apoptotic regulators include the Bcl-2 family members, Bcl-
2, Bcl-x, Bax, and Bad. All play a critical role in the regulation of apoptosis (Pinon et
al., 1997). Bcl-2 has an anti-apoptotic activity via many active mechanisms. 1) With
Raf protein (Figurel.3), it inhibits the release of cytochrome C from mitochondria to
cytosol. 2) It prevents the generation of reactive oxygen species in the mitochondria.
3) It can also directly inhibit caspase-3. 4) Lastly, it inhibits ceranride formation, the
product of p75 neurotrophin receptor (Greenlund et al., 1995).
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Bcl-xL is normally bound to the Apaf-1. In living cells, Bax is normally a
dimer. A nonphosphorylated Bad cleaves Bax dimers to Bax monomers. The Bax
monomers heterodimerise with Bcl-xL monomers and cause a release of Apaf-1
when apoptosis is triggered. The released Apaf-1 and cytosolic cytochrome C, with
ATP, activates caspase-9. In brief, Bcl-2, Bcl-xL, and phosphorylated Bad have anti-
apoptotic activity while free Bax, phophorylated Bad, and heterodimer Bax/Bcl-xL
are proapoptotic. Summarised events are shown in Figure 1.4.
In the nervous system, many of these apoptosis regulating proteins (Apaf-1,
caspases, IAPs and Bcl-2 families) have been shown to regulate the neuronal PCD by
genetic manipulation studies. Overexpression of bcl-2 caused an enlarged brain,
increases neurite outgrowth, protects PCD in both CNS and PNS (Holm and Isacson,
1999). However, in Bcl-2 deficient mice, the number of most of subpopulations of
neuron appeared to be normal (Michealidis et ah, 1996). Targeted disruption of apaf-
1, caspase-9, or casepase-3 lead to decreased neuronal apoptosis in the embryonic
nervous system and severe gross structural abnonnalities (Roth et ah, 2000; Yoshida
et ah, 1998; Cecconi et ah, 1998; Kuida et ah, 1996; 1998; Hakem et ah, 1998).
It was thought that the caspase cascade is a universal and central pathway in
apoptosis in all systems. However, there is increasing evidence that a caspase-
independent pathway does exist. Even in the classical model of neuronal death,
induction of motoneuron death by limb-bud removal is founded to be caspase
independent, whereas naturally occurring motoneuron death has been shown to
depend on caspase-3 (Milligan et ah, 1999). However, the novel caspase independent
pathway(s) is/are not fully understood and remain(s) to be characterised.
Cellular Regulation of the PCD and the Neurotrophic Hypothesis
The biological roles of PCD in neuronal populations are still not clear. Many
possibilities have been proposed. Some examples of these are:
1) Neuronal death may eliminate defective cells.
2) Cells die to shape the gross morphology of regions of the nervous system.
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3) Cells die to create space and permissive pathways for axon outgrowth.
4) The early neurons might serve or mediate transient functions in development (e.g.
as temporary targets for early afferents) but die later when functions are no longer
needed.
5) Death of neurons might also correct erroneous projections.
6) It is also possible that cells may die to limit or control cell number (McConnell et
al., 1989; Oppenheim, 1991; Burek and Oppenheim, 1998; Allendoerfer and Shatz,
1994).
Whether or not these hypotheses are true remains to be investigated.
The mechanisms regulating PCD in all these possible roles seem to involve
trophic factor supply and cell-cell interaction (either synaptic or non-synaptic). This
implies that PCD in neuronal populations is likely to be under epigenetic control
(although genetic programming can not be excluded). At the tissue level, targets,
afferents, and interaction with neighboring cells (neurons or glia) can control cell
death (Cowan et ah, 1984). In the following discussion, I shall focus principally on
the regulation of cell death by interaction with the target.
Targets are strongly implicated as a major influence in regulating survival.
These effects are proportional, e.g. the size of the target can determine the amount of
PCD. This strongly supports the hypothesis of a role of PCD in the control of cell
number and target matching (Oppenheim, 1985). One example comes from the
studies in motoneuron death in chick embryos (Oppenheim, 1981; Oppenheim et ah,
1978). 50% of chick motoneurons undergo PCD between embryonic day (E)10-12,
the stages that neuronal survival and death are dependent upon target-derived signals
(Oppenheim et ah, 1982). Removal of their natural target, limb-bud, also increases
neuronal death up to 100% (Hamburger, 1934).
In fact, similar findings had been found earlier in sensory and sympathetic
ganglia (Levi-Montalcini and Hamburger 1949; 1951). Later, in 1957, these workers
discovered the first characterised neurotrophic factor - nerve growth factor (NGF)
(see review in Levi-Montalcini, 1987). The correlation between the survival role of
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target influences and the discovery of trophic molecules led to the emergence of the
Neurotrophic Hypothesis. The hypothesis has been proposed to explain PCD
around the period of target innervation. The essence of the hypothesis is that 1)
neurons are initially overproduced and become dependent on targets later in
development; 2) in order to get rid of overproduced and inappropriately connected
neurons, the targets produce a limited supply of neurotrophic molecules; 3) the
innervating cells have to compete for the neurotrophic molecules in order to survive;
4) neurons which fail to obtain sufficient trophic support will undergo PCD.
Since the role ofNGF was originally identified in sensory and sympathetic
neurons, this hypothesis has become firmly established in the peripheral nervous
system (PNS) (Levi-Montalcini and Hamburger, 1957). It is still not known whether
this notion applies to the whole nervous system (although many have assumed it to
be generally true in all cases). The central nervous system (CNS) is generally more
complicated than the PNS. Thus, it is possible that central neurons in the brain might
use other trophic factors, different mechanisms, or even use PCD for different
purposes. The later discovery of an NGF related protein, brain-derived neurotrophic
factor (BDNF), in the brain (e.g. Barde et al., 1982) further supports the idea that the
neurotrophic hypothesis may apply in the CNS. However, in certain core CNS
structures such as the thalamus, convincing evidence of PCD and the neurotrophic
hypothesis have not been clearly demonstrated.
Increased cell death following deafferentiation has been reported in several
areas in the nervous system such as in chick cochlear nucleus (Levi-Montalcini,
1949) and in the ishmo-optic nucleus (Clarke, 1985). Glia-derived support,
extracellular matrix molecules, and local cell-cell interactions have been shown to
promote the survival of developing neurons elsewhere (see Hamburger et al., 1981,
Barde, 1989). However, when compared to the role of target, these influences are
considered to be less prominent (Oppenheim, 1985).
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Neurotrophin Signaling and its Regulation in Programmed Cell Death
Trophic factors do more than just control cell survival, and their importance
is not restricted only to embryogenesis. Their functions are diverse. Some other
prominent roles are in proliferation, synaptic plasticity, cellular metabolism, axonal
growth, differentiation, and regeneration after injury (see review by Lewin and
Barde, 1996). The factors are also important in general adult physiology, in
pathological conditions, as well as in development but this does not mean that they
are simply ubiquitous metabolites necessary for cellular maintenance and growth.
They have tissue specificity, time specificity (i.e. they may function only at a
particular stage of the development), and act via specific signaling pathways (Davies,
1988a; b).
In the nervous system, the best-known trophic factors regulating cell survival
are members of the neurotrophin family. Neurotrophins are required for the survival
and differentiation of specific neuronal populations during ontogeny. Nerve growth
factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3),
neurotrophin 4/5 (NT-4/5) and neurotrophin 6 (NT-6) are members of the family.
The receptors for these molecules consist of three high affinity receptors called
tyrosine kinase receptors (TrkA, TrkB and TrkC) and the p75 low affinity receptor.
NGF binds to TrkA, BDNF and NT-4/5 bind to TrkB, NT-3 binds to all three Trks
(Figure 1.5). All neurotrophins also bind to the p75 receptor (Meakin and Shooter,
1992; Barbacid, 1994). The receptor for novel NT-6 is still unknown and its function
in mammals has never been found. TrkB and TrkC exist as isoforms. TrkB has at
least three isoforms, one catalytic with a tyrosine kinase domain, and two non-
catalytic (Klein et ah, 1990) isoforms. TrkC comprises at least three catalytic and
two noncatalytic isoforms. Despite the similarities between the neurotrophins, cross¬
talk between some of these factors and their non-preferred receptors is rare, with the
only exceptions occurring on application of excessive and non-physiological
amounts of the trophic factors (Thoenen, 1991). All these neurotrophin receptors
(both Trk receptors and p75) control PCD of developing neurons (Carter and Lewin,
1997), but Trks and p75 may have antagonistic effects (Carter and Lewin, 1997).
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Neurotrophins signal via both tyrosine kinase receptors and the p75 receptor
and regulate several cellular activities including apoptosis (Segal and Greenberg
1996). The review of the known intracellular pathways is as follows.
A. Activation through tyrosine kinase pathway
This is a common pathway used also by several other traditional growth
factors such as fibroblast growth factors (FGFs) and platelet-derived growth factor.
Once a neurotrophin binds a tyrosine kinase receptor, the receptor dimerises with
another receptor and is phosphorylated. This activated dimer then can transduce the
signals through many intracellular pathways. A major pathway for cell metabolism is
via a proto-oncogene, Ras. The other, which is less understood, may be termed the
Ras-independent pathway.
1) Ras-dependent pathway:
1.1) Ras-MAP Kinase pathway: This pathway induces neurite outgrowth and cell
proliferation by activation of several immediate early genes (IEGs e.g. c-fos, c-jun,
cyclin Dl).
1.2) Ras dependent Phospholipase C gamma (PLC-y) pathway: The activated PLC-y
cleaves phosphatidyl inositol 4,5 bis phosphate (PIP4,5) to diacylglycerol (DAG) and
inositol triphosphate (IP3), and activates MAPK.
2) Ras-independent pathway:
2.1) PI3 kinase: it is responsible for cell survival, preventing apoptosis by acting
through protein kinase B (the protein also known as AktK), which keeps Bad
phosphorylated and hence dissociated from Bcl-xL.
2.2) SNT*1 Pathway: by an unknown mechanism, this induces the cell to exit from
the cell cycle. This pathway is characteristic only to neurotrophins (NGF, BDNF, and
1
sue1-associated neurotorphic factor-induced tyrosine-phophorylated target (Rabin et al., 1993)
sucl: yeast's (Schizoachharomyces Pombe) sucrose fermenting protein 1, a protein associated with
cell cycle (Carlson et al., 1981; Halyes et al., 1986).
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NT-3), and is not present in any other tyrosine kinase activation by other related
growth factors (such as EGF, PDGF, and FGFs).
B. Activation through the p75 receptor, the relative of the TNFa receptor
(Carter and Lewin, 1997):
Because of its low affinity for the neurotrophins and its lack of specificity in
binding with all neurotrophins, this receptor was thought to be less important for
neurotrophin function. However, later studies have shown its significant roles in
neurotrophin signaling. Firstly, by unknown mechanisms, this receptor enhances Trk
signaling by facilitating Trk dimerisation (Barker and Shooter, 1994) and stimulating
tyrosine phosphorylation (Verdi et ah, 1994). Additionally, in a more prominent
function, p75 acts as a death receptor (Casaccia-Bonnefil et ah, 1996). This receptor
activates the sphingomyelinase pathway resulting in the increased production of
ceramide. Another pathway involves the activation of a transcription factor NFkB.
Downstream mechanisms by which both ceramide and NFkB induce apoptosis are
still not clear, but are thought to involve the activation of a Bcl-2 family member
(Greenlund et ah, 1995), kinases, and proteases including caspases (Carter and
Lewin, 1997).
However, the death receptor function of p75 is found only in NGF signaling.
Neither BDNF nor NT-3 (the two main neurotrophins in the central neurons)
activates apoptosis by this pathway. Furthermore, p75 is unlikely to control PCD
(Oppenheim, 1999). p75 was not my focus in the studies of PCD in the CNS.
The signaling of the neurotrophins is summarised in Figure 1.3.
Nonetheless, some other neurotrophic factors such as CNTF (Ciliary
neurotrophic factor) use a different system for their signaling. As CNTF is related to
interleukin-6 (IL-6) and the leukemia inhibitory factor (LIF), it utilises a cytokine
receptor system named the Jak-Tyk kinases system. The detail will not be discussed
here since there is no direct evidence of a role of this factor in PCD or development
in the thalamus (Ip and Yancopoulous, 1996).
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Critical Period & Neurotrophic Switch
A striking feature coinciding with PCD in sympathetic neuroblasts is the
switching in responsiveness to neurotrophins. Initially, around El5, these cells are
strongly NT-3 dependent, and do not respond to NGF in vitro. By birth, on the other
hand, these neurons become dependent only on NGF (Birren et ah, 1993; Dechant et
al., 1993). High doses of NT-3 promote only poor survival (Birren et al., 1993;
Dechant et al., 1993). This change in neurotrophin-responsiveness corresponds with
a change from expression of trkC to that of trkA mRNA in the cells in vivo (Birren et
al., 1993). The time of this switch occurs around the time of target-innervation.
Similar findings of a switch in trophic requirements have been made in other
neuronal tissues. Extensive research led by Davies shows that neurons of the
trigeminal ganglion, vestibular ganglion, and jugular ganglion undergo a trophic
switch (see Davies, 1994a; b; Pinon et al., 1996). Later, he correlated the
neurotrophic hypothesis with the trophic switch findings. He proposed that cell death
during target innervation is due to the switch in trophic factor dependence (Davies,
1988; 1996; 1997). The suggestions of this new proposal, modifying the neurotrophic
hypothesis, are as follows. 1) Initially neurons are dependent on certain trophic
factor(s) before they innervate their targets. The factor(s) are either relatively
redundant or are present in most tissues and are generally required for cell survival.
2) Later, some intrinsic program switches the trophic responsiveness of the neurons
to a new trophic factor, which is not present in their own tissue. 3) The cells need to
find the correct target to obtain the new trophic support. 4) The control of neuronal
PCD may be by competition for target-derived trophic factors in limited supply, or
some neurons may lose the ability to respond to the new factors.
Nonetheless, not all developing neurons switch their neurotrophic
dependence. For example, Buj-Bello et al. (1992) found that nodose neurons respond
to both NT-3 and BDNF throughout their life. Vestibular neurons depend only on
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BDNF. Unlike PCD or the neurotrophic hypothesis, the trophic switch seems not to
be a universal phenomenon.
The trophic switch may not apply to all nervous tissues. However, this
switching hypothesis may provide us with a better understanding of the mechanism
underlying PCD. The upregulation of neurotrophic factor receptors that is found in
all cases where switching occurs correlates with the target innervation period. This
supports the neurotrophic hypothesis (reviewed in Davies, 1996), i.e. it suggests that
the target innervation period is a critical period and cell survival during this time is
regulated by neurotrophins. Since most of the studies of this switching event were
done in ganglionic neurons, we do not know whether trophic switching occurs in
central neurons.
Programmed Cell Death and the Neurotrophic Hypothesis in the Brain
PCD has been reported to occur in virtually every developing nervous tissue
(Oppenheim, 1991). In the brain, PCD has been found in many regions of many
vertebrate species such as the cerebral cortex (reviewed by Ferrer et ah, 1992), the
ishmo-optic system (Clarke, 1985), and the retino-tectal system (reviewed by Holm
and Isacson, 1999).
Yet, only few investigations on PCD have been carried out in the thalamus.
This tissue is an important structure in the CNS and has the cerebral cortex as its
major target. It is a core component of the forebrain lying within the diencephalic
wall, which collects and feeds not only sensory but also motor information from
several regions of the nervous system to the cortex.
Most studies of PCD in thalamus are limited to the dorsal lateral geniculate
nucleus (Sengelaub et ah, 1985; Finlay and Pallas, 1989) and the ventrobasal
complex (Waite et ah, 1992) and are based on conventional histological techniques.
Although they provided good evidence of PCD in these regions of the thalamus, the
results do not necessarily represent PCD in the rest of the regions of the thalamus.
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Spreafico et al. (1995) attempted to examine PCD in both cortex and
thalamus using a more sensitive technique - TUNEL (7dT-mediated JCTP-biotin
mck end /abeling) - but failed to analyse the actual amount of cell death in the
thalamus. To date, we still do not know the precise time, specific location and
quantity of PCD in this area. As PCD in the thalamus is poorly characterised, the
likely applicability of the neurotrophic hypothesis in this region is still ambiguous.
The influences of the target, cerebral cortex, on thalamus are documented for
thalamic axonal guidance and outgrowth (Lotto et ah, 1994; Hubener et ah, 1995),
but the roles of this target in regulating PCD in the thalamus are not fully understood.
Factors that Control Thalamic Programmed Cell Death
Both intracellular and extracellular signals can regulate PCD, but we do not
know what regulates thalamic survival during development. As reviewed in the
beginning of this chapter, the survival of many sensory, motor and sympathetic
neurons depends on the presence of neurotrophic factors (Altman, 1992). According
to the neurotrophic hypothesis, it is plausible that thalamic cells also depend on
neurotrophic factors, and it is also possible that the required neurotrophic factors are
target (cortical) derived.
However, only a few studies support the idea of a survival role for trophic
factors in thalamus and the relevance of the neurotrophic hypothesis, that target
support is pivotal for thalamic survival, is unclear. Hisanaga and Sharp in 1990
showed that diffusible substances from cerebellar cortex and neocortex have
neurotrophic effects on survival of thalamic cells (Hisanaga and Sharp, 1990). In
1996, Lotto and colleagues showed that neurotrophins (NTs) and members of the
fibroblast growth factor (FGF) family enhance thalamic survival in vitro (Lotto et ah,
1996). Unfortunately, we still do not have enough information to conclude that any
particular trophic factors do regulate thalamic survival in vivo.
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Evidence that Neurotrophins Might Play a Survival Role in Developing
Thalamus
The most prominent candidates for regulating thalamic survival are
neurotrophins. Supporting evidence comes from studies of the expression of
neurotrophins and their receptors. trkA is expressed at low level in the brain
including the thalamus throughout the animal's life. High levels of trkB and trkC
expression in some thalamic nuclei suggest the physiological significance of their
ligands in the thalamus (Ringstedt et al., 1993). Since NGF and NT-4 levels are
usually low while BDNF and NT-3 levels are high in the brain, the latter two are
more likely to play a role in thalamic development. Neurotrophins might play many
roles in thalamic development, but in my studies, I have focussed on their role in the
regulation of PCD.
The Trk molecules are normally expressed very early in development. For
example, trkB and trkC mRNA can be detected in brain from E8-E10 (Klein et al.,
1990). The expression of the neurotrophins and their receptors during development
are spatio-temporally regulated. This implies that if neurotrophins regulate cell
survival in the brain, they must act only in a particular period. In rat thalamus, trkB
and trkC are expressed strongly in certain nuclei in the first postnatal week but
expression declines gradually by 2 and 4 weeks old (Ringstedt et al., 1993).
Nevertheless, their expression patterns in the prenatal thalamus have not been
defined in detail.
To understand the physiology of these molecules, mutant mice lacking
neurotrophins and their receptors were generated; trk (the gene encoding for TrkA
receptor) knockout by Smeyne et al. (1994), trkB knockout by Klein et al. (1993),
trkC knockout by Klein et al. (1994). It is interesting that in many cases,
neurotrophin knockouts show only limited defects when compared to the knockouts
of their neurotrophin receptor counterparts (Alcantara et al., 1997). For instance,
double mutant mice lacking BDNF and NT-4 fail to reveal motor neuron deficits
(Conover et al., 1995; Liu et al., 1995) while trkB knockouts show a significant
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decrease in motor neuron numbers (Klein et al., 1993). This might be a consequence
of compensatory effects or trophic redundancy (Johnson and Oppenheim, 1994).
This idea is also supported by the work of Silo-Santiago and colleagues in 1997
showing that double trkB and trkC knockouts have more severe sensory deficits in
development than trkB or trkC knockouts alone. Thus, the knockout studies might
provide useful information on the regulation of PCD during development in the
thalamus.
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Review: Anatomy and Development of the Thalamus
Thalamus functions as the nervous system relay station
In order to gain a better knowledge of PCD in the thalamus, some basic
knowledge on this structure should be reviewed. The thalamus is divided into three
parts; epithalamus, dorsal thalamus, and ventral thalamus. Only dorsal thalamus
directly projects axons to cerebral cortex. Almost all sensory and motor information
going to the cerebral cortex is processed and distributed by the dorsal thalamus
(Kandel et ah, 1991). The functions of both structures are, therefore, interdependent.
The thalamus is also involved in autonomic reactions and the maintenance of
consciousness in conjunction with the limbic system. Since my interests are in the
relationship between the thalamus and the cerebral cortex, the term 'thalamus' as
used in later chapters of my thesis refers to the dorsal thalamus.
The major outflow of the dorsal thalamus is the thalamocortical projection.
Jones (1985) showed that every dorsal thalamic nucleus projects to the cerebral
cortex. Some fibres project only to the cerebral cortex while others project to the
cortex and branch to other basal regions of the cerebral hemisphere. These branches
give rise to thalamostriatal and other small thalamic projections.
Thalamus: anatomical description and subdivision (in rodents)
Anatomically, the thalamus refers to bulging diencephalic masses lying
between the lateral ventricles and the third ventricle. The boundaries of the dorsal
thalamus are as follows. Most of the anterior surface is covered by the reticular
nucleus (a part of the ventral thalamus) which, more posteriorly, becomes the ventral
and ventro-lateral bounderies. The medial lemniscus fiber also lies as the posterior
part of the ventral boundary. The more medial part of the anterior surface is covered
by paraventricular nucleus of the epithalamus. The upper borders of the dorsal
thalamus are the third ventricle, epithalamus and pretectum. The pretectum and the
tegmentum then form the posterior boundary. The upper lateral surface is the lateral
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ventrical and fornix (or may be exposed to the intracranial cavity during
development). The medial surface of the thalamus either contacts with the other
thalamus or with the third ventricle (Jones, 1985; Schambra et al., 1992; Paxinos et
ah, 1994; Warren, 1996). The ventral thalamus and the epithalamus are divided from
the dorsal thalamus by two thin cell sparse zones (Edgar, 1998).
(Diagram shown the position of the thalamus (gray object) relative to the
neighboring structures)
The dorsal thalamus is subdivided into several nuclei. These subdivisions are
particularly difficult to visualise in three dimensions. Depending upon their fiber
connections, most of the major thalamic nuclei can be classified into two groups.
The first group relays inputs from individual sensory and motor systems and
comprises so called specific relay nuclei, whereas the association nuclei, on the other
hand, have widespread connections and diffuse-projections (e.g. intralaminar nuclei).
The anatomy of the thalamic nuclei is shown diagrammatically in Figure 1.6 and
their functions are summarised in Figure 1.7 (modified from Kandel et al., 1991).
All anatomical divisions are derived from Jones (1985), Carpenter (1991),
Schambra et al. (1992), and Paxinos et al. (1994). The detailed description of each
nuclear group is as follows.
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Figure 1.5
Developing and mature thalamus: Sequential developing diencephalon (shaded), the
region giving rise to the thalamus, is shown in (I). Formation of the thalamus (in
sagittal and transverse planes, II) follows the extensive changes in each structure and
positions due to the differences in regional growth (1 = Epithalamus, 2 = dorsal
thalamus, 3 = ventral thalamus, and 4 = hypothalamus). The left transverse plane
shows thalamus of an embryonic brain. The right shows the adult thalamus.
Picture III represents of a human thalamus in 3-dimensions (as viewed from
• the medial wall of the 3ld ventricle). Analogous transverse planes (A-D) of El 9
mouse thalamus are depicted from anterior to posterior.
Abbreviations: Adt = Anterodorsal thalamic nucleus. Amt/Avt = Anteromedial and
anteroventral nuclei. VL/VM = ventral lateral and ventral medial nuclei, CM =
Centromedial nucleus, ldt = lateral dorsal nucleus, MD = mediodorsal (or
dorsomedial) nucleus. Lpt = lateral posterior nucleus, VPL/VPM = Ventral posterior
(ventrobasal) lateral and ventral posterior medial nuclei, DLG = dorsal lateral
geniculate nucleus, MGB = Medial geniculate body (nulceus), PoT = posterior
nuclei, Pvt = Paraventricular nuclei (epithalamus, Ret = Reticular nucleus (ventral
thalamus), Zi = Zona incerta (ventral thalamus), pf = fasciculus retroflexus and the
parafascicular nucleus.
(Kandel et al 1991, Kahle 1993, personal camera lucida drawings)
 
1) Anterior nuclear group i.e. anteroventral (AV), anteromedial (AM), and the
anterodorsal (AD, which extends to form lateral dorsal nuclei - LD). These nuclei
(except LD) lie in the most rostral part of the dorsal thalamus. AD is easy to visualise
by its wedge-shape just beside (medial to) the stria medularis. They relay limbic
information, particularly emotion.
2) Ventral nuclear group consist of the ventral (ventral lateral and ventral medial,
VL/VM), and the ventral posterior nuclei (VP, or ventrobasal complex which is
subdivided to ventroposterior medial and ventroposterior lateral). Ventral nuclei are
recognised by their loosely packed cells lying medially and more anterior to the
ventral posterior nuclei but behind the anterior nuclear group. Ventral posterior
nuclei have a distinctive appearance, being lobulated in shape.
3) Posterior nuclei (PoT) are anterodorsal to the medial geniculate body (MGB) and
anteroventral to VPL. Together with MGB, they form the most dorsal part of the
dorsal thalamus.
4) Lateral posterior nuclei (LP) (including the pulvinar, which is not seen in rodents)
is usually dorsal to the VP, under LD and VL, between DLG and PoT.
5) Medial Geniculate body (MGB) is the caudo-ventral part of the dorsal thalamus. It
lies lateral to the brachium of the inferior colliculus. These nuclei mediate hearing
information.
6) Lateral Geniculate body (LGB) is perhaps the most prominent in primates.
However, in rodents it is small and much flatter. It lies lateral to the ventral nuclear
group and ventral to the LP/LD. Only the dorsal part (DLG) of the lateral geniculate
body derives from the dorsal thalamus. These nuclei relay information for the visual
system.
7) Medial dorsal group and the intralaminar nuclei (e.g. midline nuclei,
centromedian): most of these nuclei lie along the medial wall of the dorsal thalamus.
They have both diffuse projections and limbic function. Moreover the mediodorsal
nuclei also have extra specific projections to prefrontal cortex. These nuclei
modulate the activity of both the cerebral cortex and the thalamus itself.
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Figure 1.6
Summary of major connections and functions of thalamic nuclei (Kandel et al., 1991;
Connections and Functions of Thalamic Nuclei
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Motor and premotor
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Somatic sensory cortex of parietal
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Auditory cortex of temporal lobe
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Development of the thalamus and thalamocortical connections
Like the development of all other neuronal tissues, the early formation of the
thalamic mass is achieved through the processes of proliferation and differentiation.
Emerging from the diencephalon, the thalamus is formed around Ell and El5 in
mouse (Angevine, 1970; Rennie, 1993). The gradient of its proliferation occurs
ventrodorsally (from bottom to top), caudorostrally (from back to front), and
lateromedially (from outside-in) (Angevine, 1970). Each thalamic nucleus has its
individual period for the peak of cell proliferation, which on the average occurs
around El 4. By El 7, most of the major thalamic nuclei are formed and discernible.
By the time just before birth, production of neurons and formation of the nuclei are
almost completed (Altaian and Bayer, 1988).
With regard to the establishment of the fiber connections, the innervation of
the thalamus is an early event. Many inputs including spinal tracts and trigeminal
tracts reach the thalamus between E15-E17 (Leamey and Ho, 1998). Corticothalamic
fibers arrive at the thalamus around the stage of thalamic proliferation but before
thalamocortical fibers innervate cortex (Jones, 1985). Thalamocortical fibers, the
major output of the thalamus, extend their axons to the internal capsule between El 4
and El5 in mice. After El 7, the fibers begin their radial innervation into the cortex.
During this time, a transient structure called the subplate zone in the cortex provides
a temporary target for these axons (Rakic, 1977; Chun and Shatz, 1989). Shortly
after birth, most of the thalamic fibers have terminated within layer 4. Coinciding
with this period, some cells in the lateral geniculate nucleus of the thalamus undergo
PCD (Finlay and Pallas, 1989).
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Possible Role of Developmental Genes that Regulate Thalamic
Neuronal Survival
Some genes upstream of the cell death machinery can directly control
apoptosis. As we have already seen, genes encoding for transcription factors, ces-1
and ces-2 regulate developmental cell death in nematodes. The sonic hedgehog (Shh)
gene encoding for a glycoprotein that is expressed in the notochord and floorplate,
also has been shown to promote the survival of fetal ventral spinal and
mesencephalic neurons in culture (Miao et al., 1997). Recent evidence has also
shown that this gene regulates the survival of chick spinal cord neurons in vivo
(Oppenheim, 1999). Although the precise mechanisms by which these genes control
cell death are still not known, the PCD pattern correlates well with their spatio-
temporal expression pattern in the spinal cord.
In the later part of my thesis, I have looked at the possible role of a
developmental gene, pax-6, and whether it has a direct or indirect role in cell death
regulation. Pax-6 is a transcription factor gene expressed in the CNS, eye and nose
(Quinn et al., 1996). In the forebrain, pax-6 expression is found throughout the entire
prosencephalon at around E9.5 but becomes more restricted only to the telencephalic
ventricular zone and the ventral thalamus by El4.5 (Stoykova, 1996). This spatio-
temporal pattern ofpax-6 expression suggests that it has an important role in
developmental processes. In mice carrying a point mutation of the pax-6 gene -
Small-eye (Sey) mice - many brain structures are abnormal. Cell proliferation, cell
number, and some axons such as those of thalamocortical tracts (Kawano et al.,
1999; Edgar, 1998) are severely disrupted in homozygous Sey/Sey mice. These
homozygous mice do not survive after birth.
Interestingly, even though pax-6 is not expressed in the dorsal thalamus, its
morphology is severely affected by the mutation of this gene. The dorsal thalamus in
the mutant is very small and its border is less clear as the embryo develops (Edgar,
1998). The crucial role of this gene in the dorsal thalamus has yet to be determined.
One of the explanations for the abnormal morphology in the dorsal thalamus when
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investigate at the early stages (E10.5-E14.5) is that it is caused by proliferation
defects rather than by an increase in cell death (Warren and Price, 1997). However,
cell death in this mutant after the period of innervation has not been investigated.
Grindley et al. (1995) showed that this mutant has an increase in cell death in
the nasal placode region at around E10. However it is still unclear whether this death
correlates with a direct survival role of the gene. Since there is thalamocortical fiber
disruption in Sey/Sey mice, according to the Neurotrophic Hypothesis I predicted that
there should be an increase in cell death in the dorsal thalamus at late gestation (i.e.
during the target innervation period) in this mutant. This would imply an indirect role
of the pax-6 gene in regulation of cell death, secondary to its effects on
thalamocortical axons.
Studying Apoptosis in the Developing Thalamus: in vitro and in vivo
Approaches
Apoptosis was first characterised morphologically by using conventional
histological methods and electron microscopy. The simplest in vivo method involves
haematoxylin staining (Ramachandra and Studzinski, 1995) or Nissl staining
(Oppenheim, 1986). The dyes stain the nucleus of every cell but will pick up
hyperchromatically the condensed nuclei of cells in some states such as mitosis,
apoptosis, and the pyknotic phase of enucleating red blood cells (during
development). Differentiating apoptotic cells from other densely stained cells
(mitotic and enucleating red blood cells) by these methods sometimes can be
difficult, especially during development. To overcome this problem, Gavrielli et al.
(1992) developed TUNEL for in situ detection based on the DNA fragmentation
characteristic of apoptosis. This TUNEL method has now become a gold standard for
detection of apoptosis not only in vivo but also in vitro.
There are other means apart from morphological/histological ones for the
detection of apoptosis. These include cytological and biochemical methods, and
immunoblotting in caspases assays. Flow cytometry (cytological) and DNA
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laddering detection in gel electrophoresis (biochemical) are useful for quantitative
analysis (Eisel et al., 1998). But these techniques cannot identify the precise location
where the apoptosis actually take places. Antibodies to caspases have a similar
problem and they have not been successful in histochemical applications. Moreover,
apoptosis may also occur via a caspase independent pathway and the use of caspase
detection is limited.
Although the advantage of in vivo studies is that they allow the actual event
occurring in development to be studied, there are some limitations that prevent us
from understanding the underlying processes. One of the main constraints on
studying apoptosis in vivo is the rapid rate of elimination of apoptotic cells by
phagocytes such as macrophages (or microglia in the CNS) (McGahon, 1995). In
addition, methods for experimental manipulation are limited in living animals.
Primary cell cultures allow us to define and vary the biological components
of an experiment. The cells stay in a more controllable environment and it is easier
to measure or observe the effects of experimental stimuli (Johnson, 1995). Serum-
free tissue culture has long been used for studies of the trophic effects of added
molecules (Lotto, 1995), because it excludes the huge amount of other non-specific
trophic molecules or metabolites existing in the blood which are likely to mask the
effects of the molecules under study. This technique is useful for observing the direct
effect of neurotrophic factors on cell survival. One disadvantage of primary cell
cultures, like in vivo studies, is that they contain a heterogenous population. This is
not a major issue in this thesis since thalamic cells used in here were at the ages
(E15-P2), when the thalamus has been shown to contain mainly neurons (Lotto,
1995; Lotto et al., 1997).
Measurement of Cell Viability in vitro
There are several methods for assaying cell death and viability in vitro (see
summarised illustration in Figure 1.7. (Figure obtained from Johnson, 1995). Some
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Figure 1.7
Examples of available methods for measurement of cell death: Detail is described
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Fig. 1 An overview of some of the labeling and quantitative methods that are described in this
chapter for assays of cell death and viability in vitro. (A) Cytotoxicity Assays. I. Membrane
impermeable colloidal stains that are normally excluded by living cells can readily pass through
damaged membranes of dead cells to stain cytosolic proteins. TB (Trypan blue) and Nigrosin arc-
examples. 2. Fluorescent DNA intercalating dyes that are normally membrane impermeable can
rapidly stain the nuclei of dead and dying cells. PI (propidium iodine) and EBH (ethidium homodimer
1) are examples. 3. DNA fragmentation can sometimes be detected during apoptosis by in situ
end-labeling with biotinylated nucleotides. TUNEL (terminal deoxynucleotidyl transferase (TdT)-
mediated dUTPO-biotin end-labeling) can detect these events. 4. Cultured cells can be preloaded
with salts containing reduced radioactive chromium. The oxidation of chromium yields a normally
membrane impermeable form retained by living cells. However, during cell death there is an
increased leakage of radioactivity into the media. 5. Cell death can be monitored with automated
assays that detect the presence of normal cytosolic enzymes released into the culture media. LDH
(lactate dehydrogenase) is one such marker. (B) Viability assays. 6. Nonfluorescent analogs of
fluorescein are membrane permeable. They can be converted by cytosolic esterase enzymes to
polar fluorescent compounds that are retained by living cells. Fluorescein diacetate and calcein
AM (acetoxymethyl esters) are examples. 7. Changes in intracellular free calcium can be measured
in living cells with permeable. AM (acetoxymethyl ester) analogs of the calcium ion indicators
fura-2 and indo-l. 8. Proton pumps maintain the acidic environment of some organelles (i.e..
lysosomes) in living cells. Their activity can be labeled with pH-sensitive fluorescent dyes and
stains such as AO (acridine orange) and NR (neutral red). 9. Membrane permeable salts of reduced
chromium can be used to assay the retention of radioactivity following chromium oxidation by
living cells. Leakage of oxidized chromium can also be used as an assay of cell death (see 4).
10. RI23 (Rhodamine 123) is a potential sensitive fluorescent dye specific for mitochondria in living
cells. II. The mitochondrial enzyme SDH (succinate dehydrogenase) reduces MTT (a soluble
tetrazolium salt) into water insoluble blue formazan crystals in living cells.
of the widely used methods are reviewed below (Schwartz, 1995; Schwartz and
Osborne, 1995).
1. Method based on mitochodrial activity: Mitochondrial enzymatic assay
(MTT assay)
This colorimetric assay is used to determine viability of cells in microplate
cultures (Mosmann, 1983). A tetrazolium substrate - 3-(4,5-Dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide (MTT) - is reduced by the enzyme succinate
dehydrogenase within the active mitochondria of living cells. The substrate is
converted to an insoluble dark blue formazan product in living cells which can be
quantified by using an automated ELISA microplate reading machine. Less viable
cells convert less substrate. However the quantitation is sensitive to plating density
changes. And it cannot tell us the actual number of cells undergoing cell death.
Moreover the technique determines only an overall viability of cultures but cannot
differentiate apoptosis from necrosis.
2. Detections based on the membrane properties:
2.1) Membrane lipid alteration detection
This is another method commonly used in flow cytometry that can only be
used to stain prefixed cells. It is based on the flip-over of phosphatidyl serine (PS),
which is normally on the inner side of the membrane, to the outer side of the cell
membrane in apoptotic cells (Fadok, 1992). Annexin V can then bind and detect the
exposed PS very specifically and rapidly (Eisel et ah, 1998).
2.2) Membrane integrity staining
Propidium iodide (PI) and ethidium bromide (EtBr) are two exclusion dyes
commonly used to test membrane integrity. Healthy cells and early apoptotic cells
will normally have their membrane intact and thus do not take up the dyes. Both dyes
fluoresce at the rhodamine wavelength and can be used in combination with other
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UV or fluorescein excitation dyes such as Hoechst, Acridine Orange and SYTO-13
(Sun, 1992; Ben-Sassen, 1995; Coligan et al., 1995; Crissman, 1995).
However none of the membrane testing methods alone can differentiate late
stage of apoptosis and necrosis (which cells are also highly permeabilised).
3. Detection based on nucleus properties.
3.1) TUNEL detection
This method can be used with a colorimetric peroxidase reaction or with
fluorescence. It is based on specific DNA fragmentation presented in apoptotic cells.
The detail will be discussed in the next chapter. The application of the technique is
both in vivo and in vitro. But it is only useful to detect apoptosis in particular, it is
labor-intensive, time-consuming, and costly.
3.2. Fluorochromes staining for study of chromatin
Dyes used for staining chromatin structure include acridine orange (AO -
metachromatic fluorescent), SYTO-13 (green fluorescent), Hoechst 33342 (blue in
UV filter) and DAP1 (blue in UV filter). They enter all cells and bind DNA.
Apoptotic cells are stained characteristically with these dyes (Abrams et al., 1993). In
thalamic cultures, all neurons were labelled and the prominent pyknotic cells were
brighter stained (Lotto, 1995). These dyes are useful for observing nuclear changes
of cells undergoing apoptosis.
4. Combination staining
To overcome the limitations of each technique for studying cell viability,
many have proposed a way to combine dyes that stain nucleic acids with membrane
exclusion dyes to provide a simple and rapid method to visualise cell death
(Darzynkiewicz et al., 1992; Coligan et al., 1995; Schwartz, 1995; Schwartz and
Osborne, 1995). The use of chromosomal dyes (for example, blue UV emitting
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Hoechst dye) with one of the membrane impermeant dyes such as ethidium bromide
or propidium iodide is an excellent combination for cell viability examination
(Darzynkiewicz et ah, 1992; Sun, 1992). One advantage of this combination is that
rhodamine dyes can also fluoresce as red in other filters, making both dyes visible
with one filter (i.e. EtBr is seen in UV filter if combined with Hoechst).
According to the previous study with this combination technique, Coligan
and colleagues have classified cells into 4 groups (Coligan et ah, 1980). 1) Living
cells have normal looking Hoechst positive nuclei (blue). 2) Necrotic (pathologically
dead) cells are stained red (due to the entry of EtBr or PI) and have relatively normal
size. 3) Early- apoptotic cells are cells displaying blue pyknotic nuclei 4) Late-
apoptotic cells have red pyknotic nuclei.
In my experiments, the combination of Hoechst 33342 and ethidium bromide
was used. However, neither exclusion dyes work in postfixed cells. Therefore, the
examination by this method had to be rapid. I used the photographic techniques
described in chapter 2 for the exclusion of necrotic cells and to study nuclear
morphology.
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Work and Objectives Summarised
My focus in this thesis is the study of PCD and an evaluation of the
Neurotrophic Hypothesis in the murine thalamus. The questions that I addressed
include the following. 1) When and where is the period of thalamic PCD? 2) Do any
known trophic molecules such as neurotrophins control thalamic PCD? 3) Do target-
derived (extrinsic) factors, as compared to intrinsic factors, have influences on
thalamic cell survival? 4) Is there any switch in trophic requirement occurring in the
developing thalamus and does that match with the target innervation period? 5) Is the
transcription factor Pax-6 and/or thalamic innervation essential for thalamic cells to
obtain sufficient trophic supply from the target.
The thesis is divided into 6 major experiments (Chapter 2 to Chapter 7).
In Chapter 2,1 searched for methods and criteria for studying cell death in
vivo and in vitro. This chapter deals with the regional identification of individual
nuclei in the thalamus in histological sections, application of a TUNEL technique in
vivo, and finding criteria for cell death in cell and tissue culture.
In Chapter 3,1 searched for a period of PCD in the thalamus that might
correlate with the target innervation period in vivo. Moreover, using the trkB-/- and
trkC-/- mice, I studied the role of neurotrophins and their receptors in regulating
survival of the developing thalamic cells.
In Chapter 4, I tried to find the specificity of trophic requirement of thalamic
cells during the target innervation period and whether there is a switch in trophic
requirement by testing different conditioned media obtained from different tissues
and ages on thalamic cell cultures.
In Chapter 5, I carried out an in vitro investigation of isolated organotypic
thalamic explant cultures of trkB and trkC knockout mice to exclude possible
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influences of the target or other features of the external environment that might be
involved in compensation for neurotrophin effects.
In Chapter 6,1 tested whether the pax-6 gene is involved in thalamic cell
survival. I investigated the possible direct and indirect role of this gene in causing
thalamic cell death.
In Chapter 7,1 investigated possible role of NT-3 and TrkC signaling on cell
proliferation in the brain using BrdU labeling technique.
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Chapter 2: In vivo and in vitro assessment of cell death in
pre- and postnatal thalamus
Introduction
Detection of programmed cell death in cells and tissues is important in
developmental biology, and was particularly so in my research. Most experiments
involved measurement of cell death in thalamic development. Analysis of cell death
in the thalamus was the focus of my studies. Numerous methods have been
developed for cell death detection. Cytochemical methods have recently been
extensively used both in individual cells and in tissues (see review by Willingham,
1999). However, many are not specific for the apoptotic process or PCD.
Considerable confusion exists over the interpretation and accuracy of some of these
methods and their usefulness in all settings.
Studies of cell death in vivo directly observe the actual regressive event
occurring in the developing animal. This approach will eventually provide us with a
better understanding not only of the role of cell elimination in counterbalancing cell
proliferation within the same lineage, but also of the interaction between various cell
populations in the same tissue or even those in remote tissues that communicate
through paracrine or endocrine loops. To investigate PCD in the in vivo physiological
condition, some basic requirements for any method of detecting PCD have to be
considered. These include 1) resolution at the individual cell level and 2) the
requirement that the technique for preserving tissue architecture does not interfere
with the detection method (Ben-Sasson et al., 1995). These factors become important
particularly in developing tissues of young animals where cells in certain tissues are
densely packed. Moreover, cells dying by apoptosis are removed relatively rapidly
via phagocytosis (Ben-Sasson et al., 1995). The number of apoptotic cells seen at a
particular time point might be low and difficult to quantify by normal nuclear
staining. Adequate sensitivity of the selected method is therefore essential.
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Nuclear fragmentation labeling by the TUNEL method is commonly used for
the detection of apoptosis. It has advantages in vivo due to its specificity and
selectivity. However, this method still requires care in interpretation, and the details
of tissue fixation, permeabilisation, and processing are especially important (Gavrieli
et al., 1992). False-positives can be generated (Kockx et al., 1998; Mizoguchi et al.,
1998). On the other hand, inaccessibility of tissue sites can prevent the detection of
strand breaks (Nakamura et al., 1997). In this study, I tried to optimise the protocol
and show that this TUNEL labeling method can be used in the study of apoptosis in
the developing thalamus. To obtain a more accurate TUNEL quantification, a
fluorescent technique was used instead of the normal enzymatic color reaction. Some
advantages of using fluorescent methods over the conventional colorimetric TUNEL
technique are: 1) the advantages for measurement, since counterstaining with
fluorescent nuclear dyes provides better resolution for cell counting (high sensitivity
and low background); 2) it can be useful for multiple immunohistochemistry
detection.
Before I started to verify the TUNEL method in tissue sections, I needed to
be able to accurately identify the regions of the thalamus. This was because the
fluorescent counterstains that I used stained only nuclei, and the fiber tracts and other
cellular components normally seen in Nissl or haematoxylin stainings were not
visible with fluorescence microscopy. Thus the identification of different brain
structures was not as clear as with normal Nissl or haematoxylin stained sections,
and there was a danger that thus would result in an erroneous interpretation of the
location in which PCD takes place.
For in vitro studies, on the other hand, the problems associated with
measuring cell death are different. Lower cellular densities in cultures allow us to
observe dead cells easily and cell remnants remain undisturbed since there is no cell
clearance by macrophages (Johnson, 1995). Cell culture is more accessible to study
the cellular detail of dying or dead cells. However, the isolated cells have to
regenerate and adapt to their new culture environment. Cells in culture may therefore
be selected for either survival or cell death by events that do not correspond to those
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occurring in the normal developing embryo (Johnson, 1995). Disruption of cells
during certain preparations such as tissue dissection and dissociation can cause injury
and lead to necrosis. The criteria for identification of cell death in vitro are thus
essential. This sometimes makes the tissue culture approach to cell death as difficult
as a study in vivo (Johnson, 1995; Willingham, 1999).
Here I tried to set criteria for detecting apoptosis and other mode(s) of cell
death (i.e. necrosis) in vitro. There are several methods for detection of apoptosis in
vitro. For example, we can analyse the sequence of morphological changes during
apoptosis in vitro by using time-lapse microscopy, but this technique is better suited
to monitoring small groups of cells than for quantification of large populations
(Willingham, 1999). Nevertheless, following the morphological appearance with
time lapse observation can provide some criteria by which to determine viability and
death of cells in culture. These criteria include 1) cell size, which will be greatly
reduced in the late stage of apoptosis (Willingham, 1999), 2) cell brightness under
phase contrast microscopy (dead cells are often phase-bright) (Lotto, 1994; Davies,
1996), 3) certain neuronal growth indicators, such as the measurement of neurite
outgrowth, which have also been suggested to correlate with cell viability (i.e. it has
been suggested that apoptotic cells or dead cells usually lack neurites) (Baserga,
1995; Lotto, 1994; Lotto et al., 1997). Whether or not any of these criteria alone is
sufficient to identify cell death or is correlated with a particular type of cell death is
still unclear.
In order to distinguish necrosis from apoptosis, I used a fluorochrome
combination technique (a nuclear dye, Hoechst, and an impermeable dye, ethidium
bromide - EB) to stain live cultures (see also Chapter 1). With this technique, cells
can be sorted into 4 groups: (a) viable cells with normal nuclei stained blue (red EB
excluded); (b) necrotic cells stained red (EB can enter) with normally appearing
(either larger or normal sized) nuclear structure; (c) early apoptotic cells with blue
pyknotic nuclei (red EB excluded); and (d) late apoptotic cells with red pyknotic
nuclei (Coligan et ah, 1995).
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With regard to the analysis of nuclear morphology by DNA-binding dyes,
nuclear condensation changes seen with these dyes in vitro are easier to follow than
in vivo. In contrast to normal cells, the nuclei of apoptotic cells have highly
condensed chromatin that is uniformly stained by these fluorochromes. Moreover,
Dive et al. (1992) have also reported that with Hoechst staining, apoptotic cells have
stronger blue fluorescence compared to non apoptotic cells, but one disadvantage of
this method is the variability of Hoechst uptake in different cells and its possible
change during certain treatments. Therefore, the ability to discriminate apoptotic
cells from normal cells by observing increased uptake of dye has to be tested for each
new cell system (Schmid et ah, 1994). Some fluorochromes (acridine orange (AO),
SYTO-13, and Hoechst 33342) were tested here to see whether they stain nuclei
differently. However, the method has the drawback that it is a subjective
measurement, i.e. there is no clear cut-off point between normal and apoptotic cells.
Since clear morphologically distinct apoptotic nuclei appear late during apoptosis,
this may lead to an underestimation of apoptotic cell number (Wyllie et ah, 1998).
Based on my own observations, I identified a novel group of cells with 'intermediate
nuclear condensation'. This was a population of cells that had gross nuclear
morphology similar to that of normal viable cells but with some increase in the
density of condensation or in the number of chromatin clumps together with, in many
cases, increased intensity of Hoechst staining (as occurs in apoptotic cells) (see
Results; Wyllie, 1998). The morphology of this group of cells also resembles that
described previously as displaying early nuclear change in apoptosis (Kerr et ah,
1995). I followed the change in percentage of this population in two in vitro
experimental sets in this chapter.
In the first set of experiments El 5 thalamic cells were plated at various
densities (500, 1000, and 3000 cells/mm2) to 1) observe and correlate changes in
size, phase brightness, and production of neurites of cells which might help in
determining cell viability; 2) estimate the numbers of necrotic cells in cultures; 3)
identify and categorise the cells showing intermediate nuclear condensation, as to
whether they were healthy, or dying by necrosis or apoptosis. Following the results
of the observations on nuclear changes, I questioned whether cells with intermediate
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nuclear change morphology are actually dying, by monitoring nuclear changes in
high-density thalamic cells over a period of 2 days in cultures.
In summary, this chapter deals mostly with the problems encountered in
setting up methods for determining and quantifying cell viability and apoptosis in




C3H mice were obtained from overnight mating, and the day of the vaginal
plug was deemed embryonic dayl (El). Plugged females were separated from the
male. Pregnant mice aged E13 to PI were killed by cervical dislocation. Embryos
were removed by Caesarean section and decapitated. The brains were then removed.
Only El 5 brains were used for tissue culture (for methods, see below). For tissue
embedding, the brains were fixed with 4% parafomaldehyde in phosphate buffered
saline (PBS) overnight, washed several times with PBS, dehydrated and paraffin
embedded as in standard histological protocols. Coronal sections were cut at 7pm
and mounted on 0.01% poly-^-lysine coated slides. One in every five sections was
mounted on the same slide to make sections alternate.
Tissue Cultures
For tissue culture, dorsal thalamic explants were dissected out in oxygenated
Earl's balance salt solution (EBSS) as described in Lotto and Price (1995). They
were dissociated enzymatically for 45 minutes at 37°C in EBSS containing papain
(10 units/ml) (Worthington Biochemical Dissociation Kit). Then the tissues were
triturated 8-15 times with a flame-polished (to obtain rounded smooth end) pasteur
pipette. When the explants had become cell suspensions in EBSS, they were
centrifuged at 300g for 5 minutes at room temperature. The pellet was resuspended
with 1:1:10 albumin-ovomucoid inhibitor solution, DNase solution, and EBSS
respectively. The resuspended cells were layered on top of the high density
ovomucoid inhibitor and were centrifuged at 70g for 6 minutes. The pellet of
dissociated cells was resuspended in 1ml culture medium. This volume is termed as
Vceii suspension, would be used for calculation of plating density (see below). The cell
suspension was further diluted to the desired plating density and plated in 96 well-
plates (Costar) which were pre-coated with poly-oi-ornithine or poly-/ -lysine
solution (Sigma) (see below). Once plated, the cultured cells in the well were
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incubated in an 02:C02 incubator at 37°C until the period of culture was finished.
Then cells were fixed with 4% paraformaldehyded in PBS for 15 minutes, and
washed 3 times with PBS. Nuclear marker fluorochromes were applied 15 minutes
either before (dyes added to culture medium) or after (dyes added to PBS) the
fixation.
In this study, El5 thalamus was used in dissociation studies because:
1) Conditions for culture of this tissue have been optimised (Lotto, et al., 1997).
2) The majority of the cells is neuronal (Lotto, 1994).
3) Cells survive well after 24-48h, with no apparent dependency on exogenous
trophic factors.
Identification of thalamic nuclei
Thalamic nuclei and boundaries were identified according to the Atlas of
Prenatal Mouse Brain (Schambra et ah, 1992) and the Atlas of Developing Rat Brain
(Paxinos et ah, 1994). Dorsal thalamus was identified as a mass of cells between the
external medullary lamina (eml) (from ventral thalamus) and fasciculus retroflexus
(fr - hablenulo-peducular tract) from the dorsal thalamus.
TUNEL
The TUNEL protocol on sections was performed with some modifications
from the original protocol described in Gavrieli et ah, (1992). The peroxidase
technique was replaced with a fluorescent technique. After routine rehydration, tissue
slides were treated with 20pg/ml proteinase K, further fixed for 10 minutes with 4%
paraformaldehyde, and then treated with 1% Triton-X in PBS for 5 minutes. 70-
lOOpl of TdT (terminal deoxynucleotidyl transferase) mixture was applied to each
slide and incubated for 1 'Ah in 37°C.
These TdT mixtures comprise TdT enzyme (Promega, final concentration 30
units/ml) and 50nM biotinylated-dUTP (Boehringer) in TdT buffer (30mM Tris
pH7.2, 140mM sodium cacodylate, ImM CoCL).
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The reaction was stopped by SSC washing. Slides were next washed with
PBS and then incubated with 1:200 fluorescein conjugate, Streptavidin-Alexa 488
(Molecular Probes). Tissues were finally washed by PBS, mounted and
counterstained by either Vectashield-DAPI or Vectashield-propidium iodide
(Vector). Sections pretreated with lOug/ml DNasel served as positive controls for all
of the subsequent experiments (also for ones in Chapter 3, and in Chapter 6). For
negative controls, the TdT enzyme was omitted.
The method for TUNEL in cell culture was similar to that in slides. After
cells had been fixed and washed 3 times with PBS, 60pl TdT mixture was added to
each well. All washes were the same as for sections. Finally the cells were
counterstained with lmg/ml propidium iodide (PI).
Calculation for plating density
lOpl of cell suspension in culture medium was placed on a haemocytometer. I
calculated the density of cells by counting number of cells in 5 x 5 grid square of the
haemocytometer, where the large square (25 mini-squares) is covered by
approximately lOOnl. When multiplied by 10, this gives the number of cells per pi.
To obtain the volume to make a correct plating density, the dilution factor
was determined. The calculation for the dilution factor was as follow.
Dilution factor = (number of cells/pl) x (volume to be add per well, pi)
2 2
(area of a culture well, mm ) x (plating density, cells/mm')
The total volume (V total) of culture medium needed for the given density of
cell suspension to make a determined plating density will equal the volume of the
cell suspension times the dilution factor.
i.e. Ntotal (ml) = vcell suspension (ml) x dilution factor.
42
The volume of culture medium (Vadd) to be added to the to the cell suspension will
be:
Vflrfrf(ml) — Vtotal (ml) — Vcell suspension (approximnlly I ml)
2 2
Cells were plated at low (500 cells/mm ), medium (1000 cells/mm ), or high
(3000 cells/mm2) densities. Cells were incubated for 24 hour for plating density
experiments.
For experiments to test the effects of culture period, I plated only at high
density (3000 cells/mm2). Cells were cultured for 2h, 24h, or 48h.
Fluorescence staining for cell cultures
Initially, several fluorochromes were applied to cells, either alone or in
combinations. These dyes included acridine orange (AO, green in a fluorescence
filter), Hoechst (HO, seen with a UV filter), SYTO-13 (green in a fluorescence
filter), propidium iodide (PI, red in a rhodamine filter), and/or ethidium bromide
(EB) (red/orange in a rhodamine filter). Nevertheless, later findings showed that AO,
HO, and SYTO-13 stained nuclear similarly, while PI was similar to EB. Thus, HO
was chosen for single staining while HO and EB were chosen for combination
staining. In experiments varying plating densities, the dyes (10-20pg/ml) were
dissolved in fresh medium, applied to unfixed cells (to retain the membrane integrity
of live cells, which would exclude EB) and photomicrographed. In subsequent
experiments, only lOpg/ml Hoechst in PBS was directly applied to fixed samples.
Measurements
Cells were classified and described by either one or more of the following
criteria; 1) cell size (large cells or small cells relative to neighbouring cells), 2)
phase-brightness under phase-contrast microscope (phase-dark cells or phase-bright
cells), 3) neurite production (neurite-producing cells - cells with the length of a
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process which should be at least equal to or longer than the diameter of the cell body,
or cells without neurites), 4) fluorescent dye uptake (blue cells - Hoechst positive, or
red/orange cells - EB positive), 5) nuclear morphology (either pyknotic cells or non-
pyknotic cells). In subsequent experiments, cells which were not pyknotic were
subdivided into cells with diffuse chromatin and cells with intermediate chromatin
condensation.
Healthy cells are cells that are relatively large, phase-dark, produce neurites,
have diffuse chromatin, and are Hoechst-positive. In some cases (especially in the
later experiments) the intermediate group was considered to comprise normal cells
(see Results).
Numbers of experiments and counting details
1. For in vivo experiments, four embryos were used for identification of thalamic
nuclei and TUNEL. One adult mouse was used as a control for TUNEL.
2. For in vitro experiments, around 8 mice were used for both plating density
experiments and 2-day experiments for monitoring nuclear changes. Each group
contained at least 5 wells (n = 5). For each well, cells were counted in three
randomly selected areas of 500pm2.
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Results
1. Anatomy of the thalamus viewed following Hoechst staining
At El3, dorsal thalamus was differentiated from the ventral thalamus by a
cell-sparse horizontal band called the zona limitans intrathalamica, and from the
epithalamus by another thin cell-sparse band called the pl/p2 border. In Hoechst
stained sections, these two bands were seen as strips of low nuclear staining. The
subdivision into thalamic nuclei could not be defined at this age. At El 5, some
thalamic nuclei could be seen e.g. paraventricular nucleus (pvt), dorsal lateral
geniculate nucleus (dig) and posterior nucleus. However, the many subdivisions into
other thalamic nuclei, particularly ventral nuclei, were difficult to determine and
indistinct. Classification of these unclear-bordered thalamic nuclei was as groups of
thalamic nuclei.
From El7 onwards, all major thalamic nuclei were discernible with Hoechst
staining. The thalamic nuclei are shown in Figure 2.1. In column II - b, d, f, h, and j
show El9 thalamus stained with Hoechst. The thalamic nuclear subdivisions were
visible and were identified in a similar way as under Nissl staining (Figure 2.1
column I - a, c, e, g, and i, taken from Schambra et al, 1992). However, the intensity
of the staining with Hoechst was relatively more homogeneous, while in Nissl stains
there was better contrast among structures in the tissue. This made the identification
of thalamic nuclei slightly more difficult with Hoechst but some other criteria such as
shape, cell density, and position were used to help identify individual thalamic
nuclei. At the anterior part of the thalamus (Figure 2.1 a, b), paraventricular nuclei,
the anterior part of the reticular nuclei, and the anterior nuclei were firstly seen. The
paraventricular nucleus in Figure 2.1, with lobulated shape, lies along the 3ld
ventricle and medial to a large bundle of fibers of the stria medularis. The reticular




Pictures illustrating the anatomy of the thalamus and its subdivision into the thalamic
nuclei in coronal view, according to the Atlas of Prenatal Mouse Brain (Schambra et
al., 1992) (Column I). Sample of thalamic tissue at around El 9, stained with DAPI,
shown in Column II. The boundaries of each thalamic nucleus are dotted lines,
(a) and (b) Anterior-most section of the thalamus showing the area of the
paraventricular nucleus (Pvt) and anterior thalamic nuclei (At).
(c) and (d) Section showing ventrolateral and ventromedial thalamic nuclei (VL/VM,
Here I called Vt).
(e) and (f) Section showing ventroposterior lateral and ventroposterior medial
thalamic nuclei (VPL/VPM, Here I called VP). Mediodorsal and centromedial
thalamic nuclei (MD/CM) are also shown as well as dorsal geniculate nucleus (dig),
(g) and (h) VP (VPL/VPM) in a more posterior section. MD/CM and dig are still
present and posterior thalamic nucleus (PoT) is first to appear.
(i) and (j) Area of the posterior thalamic nucleus (PoT) that is used for cell counting.
 
In a more posterior section, as in Figure 2.1c, d, the posterior part of the
anterior nuclei was found lateral to the stria medularis and was dorsal to the
ventricular nuclei and the reticular nucleus. Ventral group nuclei lay lateral to the
intralaminar nuclear group and dorsal to the reticular nucleus. Cells in these nuclei
were loosely packed.
In Figure 2.1e, f, the ventral posterior nuclei can be easily defined by their
lobulated appearance. However, in a very posterior part of the nuclei, it was difficult
to find a clear border between these nuclei and the medial geniculate nucleus at this
age (El9). It has been reported previously that medial geniculate nucleus may merge
with the ventral posterior nuclei in adults of small species (Jones, 1985). Dorsal
geniculate nuclei were distinct due to their clear borders and bright staining of the
densely packed cellular nuclei (Figure 2.1e-h).
Intralaminar, centromedial, and mediodorsal nuclei lie on the inner side of the
thalamus covered by the ventral, ventral posterior, and posterior nuclei. They lie
along the ventricle and may contact the other side of the thalamus (Figure. 2.1 g, h).
The rostral part of the posterior nucleus lies dorsally to the ventral posterior complex.
However, the boundaries of the posterior nucleus were less clear at the caudal end
(Jones, 1985) but it can be roughly identified by a loosely packed cell component,
which lies ventro-lateral to the parafascicular tract and medial to the geniculate
bodies at the posterior end of the thalamus.
More figures of thalamic nuclear divisions can be seen in the
photomicrographs of the thalamus with trkB and trkC in situ hybridisations in
Chapter 3 (Figure 3.1).
2. TUNEL labeling in thalamic sections.
Firstly, I verified the TUNEL technique by examining the reacted sections of
adult brain (cerebral cortex) 1) with the omission of the TdT enzyme during the
incubation as a negative control (Figure 2.2a-c), and 2) treated with DNasel as a
positive control (Figure 2.2d, e). Adult mouse brain was used here because apoptosis
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Figure 2.2
Photomicrographs showing positive and negative controls used for TUNEL
reactions.
(a) Negative control: Coronal section of an adult cerebral cortex with TdT omitted
and stained with propidium iodide (PI, red color in (b)). No cells are labelled.
However, autofluorescent cells can be observed (yellow cells indicated by white
arrows).
(b) Same section as (a) counterstained with propidium iodide (PI) under the
rhodamine filter. All cells are non-specifically stained.
(c) Same section as (a) under UV filter. Tissue is not stained with any dye for this
filter but autofluorescent signals (white arrows) are very strong.
(d) Adult positive control: Coronal section of an adult cerebral cortex pretreated with
DNasel and stained with propidium iodide (PI, red color in (b)). Autofluorescent
artifacts (white arrows) appeared more yellow than DNase-induced positive cells
(which appeared green, red arrows).
(e) Same section as (d) counterstained with propidium iodide (PI) under rhodamine
filter.
(f) El 9 positive control: Coronal section of an embryonic thalamus treated with
DNase to fragmentate DNA. All cells were stained with TUNEL reaction (green).




























































Photomicrographs showing examples of TUNEL positive cells in vivo in
experimental El9 brain section and in vitro in thalamic cultures.
(a) Fluorescent TUNEL reaction detects specifically pyknotic (apoptotic) cells
(green) in vivo. Section obtained from El9 posterior thalamic nucleus.
(b) Higher magnification of a TUNEL positive cell (from dotted box line in (a))
showing pyknotic morphology. Note: no adjacent cells were picked up by the
TUNEL reaction.
(c) Same section as (a) of tissue viewed under UV filter. DAPI non-selectively stains
all nuclei of cells but the pyknotic (presumably apoptotic) cells are brighter stained
(as seen in (d)).
(d) DAPI staining of the same position as in (b) (from dotted box line in (c)) viewed
in UV fluorescence at higher magnification.
(e) TUNEL reaction in culture counter-stained with propidium iodide (PI) and
Hoechst. The TUNEL positive cells appeared yellow. This may be due to high
concentration of PI used (20 pg/ml). No autofluorescent cell was found.
(f) Hoechst staining of the same position as (e) viewed in UV fluorescence.











































in adult brain is known to be very low (Blaschke et al., 1996). In positive controls,
DNasel caused DNA fragmentation like that in apoptosis. Any TUNEL labeling in
the positive control should come mostly from the DNasel digestion. Virtually all
cells treated with DNasel, including cells that do not show pyknotic morphology, had
their DNA broken and were labeled green with fluorescent TUNEL (Figure 2.2d, e).
Some yellowish signal was seen in certain cells but was due to endogenous
autofluorescence, which may quench TUNEL. This was only found in blood vessels
(blood derived cells/endothelium), and in the pial region. Contrary to the true
TUNEL labeling, autofluorescence was non-specific and could be seen also with
rhodamine and UV filters. These auto fluorescent objects were also seen in the
negative control in the adult cortex even though the TdT enzyme was omitted (Figure
2.2a-c).
In Figure 2.2f, g, I further confirmed that TUNEL could be used in the
embryonic tissue (El9 thalamus), with the treatment with DNasel as positive control.
Moreover, in the experimental sample, when El9 thalamus (posterior area) was
reacted with the TUNEL reaction, only cells showing apoptotic figures (chromatin
condensation and fragmentation) were labeled (Figure 2.3a-d). This suggested that
TUNEL was specific to apoptosis. Although only pyknotic cells were labeled, the
labeled cells appeared more yellowish in culture than in vivo (Figure 2.3e, f)- The
change in color may have been due to some difference in the fixing method or to the
high-concentration of the PI counterstain.
3. Thalamic cells in culture
3.1 Cell morphology and viability in different plating densities
Once plated, most cells were round, without neurites and phase dark but their
cell size was variable. This variety in cell size may reflect different cell
types/subpopulations existing in the developing thalamus in vivo (Jones, 1985), and
does not necessary reflect viability of cells in vitro. Thus, the use of cell size as a
criterion for assessing cell viability would not be simple and I did not use this
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Figure 2.4
Photomicrographs of cultured thalamic cells at different plating densities.
(a) and (b): Phase contrast and fluorescence microscopic views of thalamic cells
(stained with Hoechst and ethidium bromide) at 500 cells per mm2 plating density,
(a) Phase bright cells are seen (red arrows). Cells either have short processes or do
not have any at all. (b) Some pyknotic cells with either ethidium bromide (orange) or
Hoechst (blue) are clearly seen.
(c) and (d) Phase contrast and fluorescent microscopic views of thalamic cells at
1000 cells per mm2 plating density, (c) More cells produce neurites and start to make
contacts. Some phase bright cells are shown with arrows, (d) The proportions of
pyknotic nuclei are reduced.
(e) and (f) Phase contrast and fluorescence microscopic views of thalamic cells at
3000 cells per mm2 plating density, (e) Most cells are phase dark and produce
neurites. (f) A higher proportion of live cells are seen, stained with Hoechst with
diffuse chromatin in their nuclei.






































































criterion further. Thalamic cells in 24h cultures had different sizes, phase
brightnesses, extents of neurite production and fluorescent dye uptakes. Cells with
these appearances were found in all plating densities but in different proportions
(Figure 2.4, finer detail of nuclear morphology and dye uptake classification are in
Figure 2.5). Most of the plated cells that produce neurites are multipolar cells.
Extensive production of neurites can be seen at this period. These cells have at least
one thick neurite, which is an axon-like process and sometimes has a growth cone.
These multipolar cells in cultures are morphologically similar to those thalamic
neurons found in vivo.
a) Cell brightness under phase contrast microscopy
The proportions of phase bright cells were different at different plating
densities (Figure 2.6, row 1). 59% of thalamic cells at low density (500 cells/mm2, n
= 5) were phase dark while 66% of cells in high density (3000 cells/mm2, n = 5) were
phase dark. However, there were only 54% of phase dark cells at 1000 cells/mm2
plating density (n = 5) (which is even lower than the percentage at low density).
Thus, it was not clear that the percentages of phase dark cells were directly
propportional to the increase in plating density. Moreover, although most dead cells
(cells with pyknotic morphology, see below) appeared to be phase-bright, there were
some phase bright cells which were healthy-looking, with neurites.
b) Production of neurites
As the plating density was increased, markedly more cells produced neurites.
60%, 78% and 95% of cells produced neurites at plating densities of 500 cells/mm ,
1000 cells/mm2, and 3000 cells/mm2 (n = 5 each) respectively (Figure 2.4, 2.6, row
3). This suggested that an increase in cell density in vitro would support more cells to
either grow or survive or both. Although this growth of neurites seemed to be related
with the survival of thalamic neurons, it is not known whether this change
(production of neurites) is a direct effect of the increase in the viability or whether
there is some other separate mechanisms controlling this growth. Some dead cells
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may not have fully retracted their neurites before death, and some viable cells may
not produce neurites.
c) Nuclear morphology of thalamic cells in vitro as seen by several
nuclear fluorochromes
Several dyes such as acridine orange (AO), SYTO-13, Hoechst, DAPI, PI and
EB were tested. As previously described, both PI and EB stain all nuclei in fixed
tissue, but in living tissue PI and EB only enter damaged cells so they are not much
use for vital staining of nuclear morphology. I have tested all these dyes and found
no apparent difference among them in their ability to reveal nuclear morphology.
Thus only one dye was chosen for subsequent studies of nuclear structure. In the case
of cell culture I used Hoechst, while EB was used mainly as a membrane exclution
dye in the combination staining.
The initial analysis of nuclear morphology revealed two major populations of
cells: non-pyknotic and pyknotic cells. Percentages of non-pyknotic cells increased
continuously (65%-74%-80%) when the plating density was increased from low
plating densities of 500 cells/mm2, to 1000 cells/mm2 and high density, 3000
cells/mm respectively (Figure 2.6, row 3). However, this method could not
differentiate necrotic populations (some of which are non-pyknotic). Moreover, there
was a problem in identifying some cells, which had an intermediate morphology in
between pyknotic and non-pyknotic cells. This was because there was no clear cut¬
off point between normal and apoptotic cells.
d) Nuclear morphological analysis with a new 3-fold classification
When cultured cells were classified into three categories - cells with diffuse
chromatin (Figure 2.5a, b, and f), cells with intermediate condensed chromatin
(intermediate cells) (Figure 2.5c, d, e), and pyknotic cells (Figure 2.5g, h),
percentages of cells with diffuse normal chromatin increased in proportion to the rise
of plating density (from 22%-26%-41%, n = 5 each) (Figure 2.6, row 4). The ratios
of pyknotic cells also decreased gradually as the plating density was increased.
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Figure 2.5
Photomicrographs showing thalamic nuclei with different nuclear morphology,
double-stained with Hoechst and ethidium bromide (enlarged from selected cells in
Figure 2.3c).
Group 1: (a)-(e), this group can be subdivided into two other broad categories.
1.1) (a) and (b) are examples of cells with diffuse chromatin.
1.2) (c), (d) and (e) are cells of intermediate nuclear morphology ((c), cells with
clumps of chromatin; (d), cell with bright homogenous Hoechst staining, and (e),
small cell with unclear nuclear structure).
Group 2: (f) necrotic cell lets ethidium bromide enter the nucleus and is stained
orange.
Group 3: (g) early-apoptotic cell is stained blue with pyknotic nucleus.
Group 4: (h) late-apoptotic cell is stained orange (due to the increase permeability to
ethidium bromide) with pyknotic nucleus.
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However, the change in percentage of intermediate cells was discontinuous when
plating density was increased (43%, 48%, and 39% at 500, 1000, and 3000 cells/mm2
plating densities accordingly)(Figure 2.6 row 4). This led to the speculation that the
intermediate cells may be either cells in an intermediate state that were preparing to
die (either by necrosis or apoptosis) or cells in other cellular state(s) of metabolism
which were not dying. I attempted to further investigate this by monitoring changes
in proportions of these cells over a period of 2 days in culture (see below).
e) Fluorochromes for combination staining
With a combination of Hoechst 33342 (blue) and ethidium bromide (EB, red),
dead cells with comprimised membranes were clearly visible by red staining with
EB. The percentages of these cells and Hoechst stained cells at different plating
densities are shown in Figure 2.6, row 5. High-density cultures had lower proportions
of EB positive cells. This method could not differentiate early apoptotic cells and
necrotic cells and thus was less useful without combining it with the nuclear
morphological analysis. When analysing the cell color with an appearance of
pyknosis, percentages of cells with non-pyknotic nuclei with blue color were ranging
from 63% to 80% (n = 5 each), from low- to high- plating densities. The proportion
of non-pyknotic cells stained with EB (which represents the number of necrotic cells)
is very low (< 1%). Pyknotic cells with blue color were ranging from 19.07%,
14.24%, to 12.94% (from 500 to 3000 cells/mm2, n = 5 each), while late apoptotic
cells (pyknotic with red/orange color) were decreased from 16.14% to 7.93% when
the density was increased.
f) Correlation among different morphological criteria in determination of
cell viability
Since the proportion of necrotic cells was very low under all conditions and
could be disregarded, the analysis of combination staining was no longer essential for
subsequent experiments (as I could determine nuclear morphology by Hoechst
alone). Three criteria were considered in this analysis including phase brightness,
neurite production, and pyknotic morphology (the analysis of the intermediate cells
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Figure 2.6
Diagrams showing the percentages of different types of cells in cultures sorted by
different criteria at different plating densities. Each plating density (500 cells/mm ,
1000 cells/mm2 and 3000 cells/mm2) is shown in column I, II and III. Each category
is sorted in rows 1-5: row 1 = cells sorted by phase brightness, row 2 = cells sorted
by the production of neurites, row 3 = cells sorted by pyknotic morphology into
either pyknotic or non-pyknotic (when differentiate cells with intermediate nuclear
morphology from the diffuse ones, the proportions of cells were shown in row 4),
and row 5 = cells sorted by the fluorescent dye exclusion. Red areas indicate





































I. (500 cells/mm2) II. (1000 cells/mm2) III. (3000 cells/mm2)
Figure 2.7
Set diagrams showing the proportions of different types of cells. Diagrams of
thalamic cells at plating densities of 500 cells/mm2, 1000 cells/mm2 and 3000
cells/mm are shown in (a), (b) and (c) respectively. Phase-dark cells are within a red
circle, cells producing neurites are within a blue circle, and non-pyknotic cells are
within a green circle. Areas A-G in (a)-(c) are proportions of (A) pyknotic phase-
dark cells without neurites, (B) pyknotic phase-bright cells producing neurites, (C)
non-pyknotic phase-bright cells without neurites, (D) pyknotic phase-dark cells
without neurites, (E) non-pyknotic phase-dark cells without neurites, (F) non-
pyknotic phase-birght cells producing neurites, and (G) non-pyknotic, phase-dark
cells producing neurites. Proportion of cells in each category is shown as average
percentages (per total number of cells counted in each plating density). For example
area E of (a) shows that 12.82% of cells in low plating density culture are phase dark
and non-pyknotic, but do not produce neurites. The rest of the percentages not shown
here are proportions of dead cells. Note: many healthy-looking cell share overlapping
criteria in area G.
 
was not completed at the time of this present analysis, and I classified nuclei of cells
only into 2 types - non-pyknotic and pyknotic cells).
Populations of thalamic cells after culture at different plating densities were
displayed in set diagrams, as shown in Figure 2.7a, b, and c, given that the total
population of cells in each plating density in the square equals 100%, red circles
represented the proportion of phase dark cells, blue circles represented cells with
neurites and green circles represent non-pyknotic cells. Overlapping areas (D-G)
represented the proportions of cells that share those appearances (e.g. in area G of a
set at 500 cells/mm' in Figure 2.6a, there was an average of 42.85% of cells which
were phase-dark, non-pyknotic and produced neurites). The rest of the cells outside
the circles were phase-bright, pyknotic cells without neurites.
A major population of cells in all plating densities was healthy looking with
phase-dark, neurites and was non-pyknotic (from 40-65%, area G in Figure 2.7a-c).
The highest proportion of this population was found at 3000 cells/mm2 plating
density. However, the population of cells with these morphological appearances
neither absolutely overlapped with each other at any given plating density, nor
followed the same trends as each other when the density was increased. Some phase-
dark cells either showed pyknotic morphology, or produced no neurites, or both
(Figure 2.7a-c, area D, E, and A). Some non-pyknotic cells were phase-bright, or had
no neurites (Figure 2.7a-c, area F, E, and C) while cells with neurites were either
phase-bright, or pyknotic (Figure 2.7a-c, area D, F, and B). Although sometimes the
proportions of cells lacking one of these health-determining criteria were small, this
changed in different plating densities. For example, there were a much higher
percentages of non-pyknotic, phase-dark cells without neurites in low density culture
(-12.82%, area E, Figure 2.7a) than in the medium and high density culture (< 3%,
area E, Figure 2.7b, c).
As a result of the fact that populations of phase-dark cells, non-pyknotic cells,
and cells having neurites did not always correspond with each other, determining cell
viability in culture using one single criterion was difficult. On the other hand,
identifying viable cells with all these criteria would make my future experiments
more tedious and might exclude some populations of cells that are in fact also
healthy. To minimise the criteria used for determining viability and to choose a
plausible criterion for measuring cell survival, I selected the nuclear morphological
appearance as a criterion for future viability assessment. This was because 1) the
study of nuclear change is a conventional method for assessing cell death
(particularly apoptosis), as is well documented in many in types of investigations in
tissue culture (Johnson, 1995) and 2) this criterion is consistent with results using
nuclear fragmentation labeling (TUNEL) in vivo. In addition, unlike results from use
of phase-brightness and production of neurites, the changes in proportions of
pyknotic cells always correlated with changes of plating density. Also, as shown in
Figure 2.7, the significant population of cells showing pyknotic nuclei were those
with neurites and it is more likely that there were non-viable than vice-versa i.e. die
after producing neurites.
However, as stated in section d), cells with intermediate chromatin
condensation were sometimes difficult to classify into dead or live cells. I thus
followed the change in percentages of these cells in high-plating density cells in 2h,
24h, and 48h cultures, to see whether the proportion of this intermediate group of
thalamic cells either increased or decreased with time.
3.2) Monitoring thalamic cells in 2h, 24h, and 48h culture periods
In 2h high-density cultures, many cells had started to produce neurites (12.58
+ 1.52%, n = 5). Some also had growth cones. Most neurites were short and did not
reach neighboring cells. By 24h, the majority of cells (95.54 + 0.73%, n = 5) had
produced neurites and formed contacts with other cells but, by 48hours, the
percentage of cells which had produced neurites was marginally but significantly
decreased (91.78 ± 2.37%, n = 5) (p < 0.05, reduced from the proportion of 24h cells
which contained neurites).
The percentage of cells with pyknotic morphology increased over the period
of culture, and the percentage of cells with diffuse chromatin was decreased after 2
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Figure 2.8
Graph showing changes in the proportion of cells with different nuclear morphology
after 2 hours, 24 hours, and 48 hours in high-density cultures (3000 cells/mm2):
Number of cells with pyknotic morphology is increased and number of cells with
diffuse chromatin is decreased over time of culture. Percentages of cells with
intermediate morphology show a small decrease.
2h 24h 48h
days in culture (Figure 2.8, see table below). The change in the percentage of
intermediate cells showed the same trends as the change in the percentage of the
population of cells with diffuse chromatin (it was reduced after 48h in cultures). The
percentages of each cell population are shown in the following table:
Nuclear % Survival, (n = 5 each)
Appearance 2h 24h 48h
Diffuse 57.18 ± 0.93 % 57.67 ± 3.65 % 43.66 ± 1.28 %
Intermediate 26.31 ±1.72% 21.27 ±3.66% 21.54 + 0.63 %
Pyknotic 16.51 ± 1.73 % 21.06 ± 0.45 % 34.79 ± 0.80 %
From the results of the observation of the population of intermediate cells at
high plating density and following these cells for up to 2 days in culture, there is not
enough evidence to classify these cells as non-viable. Moreover, when analysing cell
cultures with the TUNEL reaction (see Figure 2.3e), all TUNEL positive cells were
pyknotic cells (Figure 2.3e, in comparison with Heochst in Figure 2.3f). No cells
with intermediate chromatin changes were labeled with TUNEL.
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Discussion
1. Identification of thalamic structure using DNA fluorochrome
DNA binding fluorochromes stained only nuclei but not other structures like
the cellular boundaries, cytoplasmic content, or neuronal fibers. This caused some
problem in identification of many brain areas, which could normally be seen with
Nissl staining (Schambra et ah, 1992). However, in this study, I have confirmed that
identification of dorsal thalamic nuclei using Hoechst is possible. With Hoechst, the
nuclear structures can be differentiated by comparing the shape, boundaries and
location of each thalamic nucleus with neighbouring structures. This method was
used for further studies with in vivo fluorescent TUNEL.
2. TUNEL application in PCD studies
A conventional means of estimating PCD in developing brain is to compare
number of live cells at two time-points and calculate cell loss (Hamburger, 1934;
Hamburger and Levi-Montalcini, 1949). However, the major disadvantage of this
method is that it does not always indicate that the cell loss is due to cell death, and it
cannot tell whether the cell death was due to apoptosis or PCD (Oppenheim ,1999;
Finlay and Pallas, 1989). A more direct approach is to quantify the actual dying cells
using techniques that detect properties of cells that are characteristic for apoptosis.
By labeling the ends of DNA strand breaks, the TUNEL method detects
apoptotic cells that are undergoing DNA fragmentation. There are several advantages
to methods that employ TUNEL (quoted from Coligan et ah, 1995).
"...1) Because the end labeling is performed inside the
cells, TUNEL is by far the most direct method for analyzing
cells in which DNA fragmentation is occurring.
2) Because DNA fragmentation is one of the earliest events
in apoptosis, cells undergoing programmed cell death are
detected at a very early stage in the process.
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3) The accuracy of all-or-none labeling of TUNEL provides
the clear distinction between cells undergoing apoptosis and
the rest of the cells.
4) The TUNEL method is more sensitive than methods using
vital dyes such as propidium iodide or Hoechst; hence DNA
fragmentation may be detected 4-6hr before cell
lysis/clearance (Kishimoto et al., 1995; Sellins and Cohen,
1987).
5) TUNEL staining is compatible with multiple-color
staining, thus allowing definition of the cell surface
phenotype of apoptotic cells (Kishimoto et al., 1995)
6) It is suitable most to tissue sections, thus allowing in situ
viusaliasation of dying cells without having to use electron
microscopic analysis. (Gavrieli et al., 1992)...."
TUNEL (Terminal-dideoxyribonucleotidyl Transferase (TdT) mediated
dUTP nicked end labelling) was first introduced for detection of apoptosis by
Gavrielli et al., (1992). However several researchers argued that TUNEL may not be
specific or selective for apoptosis. Failure of TUNEL detection in the nervous system
has also been reported (Herrup and Busser, 1995). Moreover, there were also reports
that this method cannot distinguish between necrotic and apoptotic cells (Grasl-
Kraupp et al., 1995; Charriaut-Marlangue and Ben-Ari, 1995). On the other hand,
Didenko and Hornsby (1996) argued that TUNEL is specific enough for apoptosis
since it selectively labels 3' overhanging DNA fragments which are characteristic of
apoptosis. My studies revealed that all TUNEL positive cells were associated with
pyknotic morphology and thus it can be assumed that TUNEL positive cells
specifically label apoptotic cells, at least in the developing thalamus. Later findings
(Chapter 3) also showed that these TUNEL positive cells were commonly found in
embryonic and perinatal thalamic cells which suggested that PCD in the thalamus
occurs via apoptosis.
One practical drawback of the TUNEL method is that it is more costly than
other methods but it is still particularly useful for in vivo studies because it gives a
high sensitivity and resolution. It can readily pick up dead cells which may be
present in only a small quantity amoungst a high density of viable cells. In tissue
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culture, however, this technique might not be necessary, as more dead cells are
clearly visible due to the lack of cell clearance. Moreover, cells in culture are less
packed and can be easily seen with normal DNA binding fluorochromes.
There are some advantages of using fluorescent detection for TUNEL over
the conventional peroxidase colorimetric TUNEL detection in light microscopy. For
example, fluorescent TUNEL can easily be counterstained with DNA binding
fluorochromes so that 1) TUNEL positive cells can be quantified as a percentage of
total cells in a particular region and 2) TUNEL positive cells can be identified as
apoptotic cells from the pyknotic morphology visualised by DNA binding
fluorochromes. Moreover, this produces higher resolution and is more accurate and
reliable (Coligan, 1995). Elowever, there is one drawback when fluorescent TUNEL
is applied; the problem of autofluorescence. This artifact can be distinguished from
TUNEL positive cells by using the following criteria: 1) auto fluorescent cells exhibit
a more yellowish-green color with a FITC filter and the signals can be seen with all
fluorescence filters, while TUNEL positive cells appear as deep green color in FITC
filter. 2) Most autofluorescent cells are non-neuronal derived (i.e. endothelial,
enucleating blood cells, and pial cells) and the morphology of these cells is non-
apoptotic (non-pyknotic).
As described in the Results section, some thalamic nuclei have no clear
margin throughout the brain sections. It is difficult to quantify the total number of
TUNEL positive cells in these thalamic nuclei individually. Thus, in subsequent
experiments, I decided to determine the extent of cell death by quantifying TUNEL
positive cells per total counted cells (with propidium iodide, PI, or blue DAP1
counterstaining) in a window as a ratio of cell death per 1000 cells. This would allow
me to investigate changes in the rates of cell death throughout the developmental
period and to compare these with rates in other mutant tissues (see Chapter 3 and 6).
3. Setting up cell death criteria in vitro
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3.1) Phase contrast microscopy and neurite production
As seen in the Results section, neither phase-dark cells nor cells with neurites
were always healthy. Although many cells undergoing apoptosis were phase-bright,
not all phase-bright cells were dying. Other reports indicated that several types of
cells in cultures that are viable (such as embryonic motoneurons and olfactory
receptor neurons) are phase-bright (Cohen and Wilkin, 1995). Davies and Wright
(1995) also found that embryonic sensory neurons undergo morphological transition
in culture. The neurons have small, spindle-shaped, phase-dark cell bodies and short
neurites. Subsequently, they develop spherical, phase-bright cell bodies and extend
long neurites.
With regard to the use of neurite production to determine viability, even
though viability of thalamic cell culture is strongly correlated with the production of
neurites (Lotto et al., 1997), some cells that are clearly pyknotic do not fully retract
or disintegrate their neurites (see Results). Cell viability does not necessarily
correspond with neurite growth. For example, in thalamic cells, factors influencing
neurite outgrowth might be different from factors controlling cell survival. Previous
studies have shown that, while diffusible molecules produced within cerebellum
promote more thalamic cell survival than molecules within the cerebral cortex
(Hisanaga and Sharp, 1990), the latter produce the reverse effect on neurite
outgrowth (Lotto and Price, 1995). Thus, the measurement of neurites can not be
used as a definite criterion for determining cell death in vitro.
3.2) Studies with DNA binding fluorochromes
The only advantage of combination staining over single nuclear staining is
that it can distinguish necrotic cells (Coligan et al., 1995). Early- (blue) and late-
(red) pyknotic cells are clearly dead and there is no need to differentiate the two. In
embryonic thalamic cell culture, the percentage of necrotic cells is very low, and it is
time-consuming to perform combination staining in the fresh specimen. In
subsequent experiments, I thus ignored the necrotic population and used a single dye
in fixed samples.
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Nuclear analysis by Hoechst staining is well documented to be among the
best, simplest, and most specific method for identification of apoptotic cells in vitro
and flow cytometry (Ramachandra and Studzinski, 1995). Overall shrinkage and
nuclear condensation can be recognised with a UV filter of a fluorescence
microscope. Occasionally, these dead cells break down in to apoptotic bodies
(fragments or vacuoles of chromatin). In my experiments, I have shown pyknotic
cells stained by this means gave an indication of apoptosis as clear as with TUNEL
labeling. The TUNEL method might be redundant for measuring apoptotic cells in
cultures. Thus, I used this single staining method to determine cell viability in
cultures. As for the classification of cells with intermediate chromatin condensation,
I decided to classify these cells as viable cells as they did not show a clear indication
of apoptosis and were not TUNEL positive.
4. Effects of plating density on thalamic survival
Thalamic cells require proper conditions to survive and grow in culture. In
this experiment, high plating density provides a suitable environment to ensure the
viability of El 5 thalamic cells. The most probable explanation of this result is that
increasing the plating density increases direct cell-cell interactions and/or the
concentration of released neurotrophic molecules that are necessary for survival
(Lotto et al., 1997). The increase in thalamic cell contact in high-density culture
might increase neuronal activity (probably also synaptic transmission), and thus
mediate neurotransmitter and/or neurotrophin release. This hypothesis is supported
by two main previous reports: 1) Survival and neurite outgrowth of embryonic
thalamus are promoted by potassium induced depolarisation in explant cultures
(Magowan and Price, 1996). 2) Survival of thalamic cells at low density is equal to
that of thalamic cells at high density if they were supplied by neurotrophins or FGFs
(Lotto et al., 1997). However, we can interpret this result in another way, i.e. that
thalamic neurons do not always require cell-cell contact as long as they are provided
with enough trophic support. It is still unclear whether thalamic neurons at this age
depend solely on their intrinsic trophic factors throughout development. Hisanaga
and Sharp (1990) provided evidence that diffusible trophic factors from external
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neuronal tissue can promote the survival of developing thalamic neurons. These
questions will be further investigated in Chapters 3-5.
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Chapter 3: Thalamic cell death studies and the role of the
neurotrophins
Introduction
Programmed cell death (PCD) is a common phenomenon found in diverse
structures of the developing nervous system such as sensory and autonomic ganglia,
cranial and spinal motoneurons and cerebral cortex (Oppenheim, 1991). However,
PCD in the thalamus is poorly understood (Spreafico et al., 1995). The time of PCD
and the factors controlling PCD in the thalamus have to be identified. The first can
be achieved by using TUNEL to analyse the quantity and distribution of PCD in the
dorsal thalamus during development. However, the second is more complicated to
investigate. The Neurotrophic Hypothesis proposes that neurotrophic factors, in
particular neurotrophins, are factors that play a major role in regulating PCD. Prime
candidates for controlling thalamic PCD are members of the neurotrophin family.
The members of the neurotrophin family include nerve growth factor (NGF),
brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-
4/5 (NT-4/5). Three high affinity tyrosine kinase (Trk) receptors have been isolated;
NGF binds TrkA, BDNF and NT-4 bind TrkB and NT-3 binds Trks TrkA, B, and C
(see also Chapter 1; Chao, 1992). These neurotrophins and their receptors are
required for the survival and differentiation of specific neuronal populations during
ontogeny, predominantly in the peripheral nervous system (Barbacid, 1995; Farinas
et al., 1996).
In thalamus, all of these neurotrophins have been shown to promote survival
of embryonic thalamic neurones at around El 5 in vitro (Lotto et al., 1997). BDNF
and NT-3 mRNAs are expressed from early midgestation. All of the Trk receptor
mRNAs can also be first detected in the nervous system around early midgestation
(Barbacid et al., 1991). In particular, trkB and trkC mRNAs, being widely expressed
in many CNS regions and having significantly overlapping patterns, are thought to
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play a regulatory role in CNS development (Ernfors et al., 1992; Merlio et al., 1992).
In postnatal thalamus, strong expression of trkB and trkC (but not trkA) can be found
in many defined nuclei (Ringstedt et al., 1993). The prenatal expression patterns of
these mRNAs are not known. In this study, I carried out in situ hybridisation for
mRNAs of TrkB and TrkC receptors (Barbacid, 1994, the probes detected both
catalytic and non-catalytic forms of trkB and trkC mRNAs) in normal embryonic
thalamus. There were two objectives for this: 1) to demonstrate the patterns of trkB
and trkC expression in the embryonic thalamus (which has never been studied in
detail) and 2) to study whether the hybridisation patterns correlate with the PCD
patterns in the developing thalamus.
In vivo, it is not know whether neurotrophins regulate thalamic PCD. In
postnatal life they control cell differentiation and plasticity (Spreafico et al., 1995;
Alcantara et al., 1997; Maffei et al., 1992; Cabelli et al., 1995; Riddle et al., 1995).
Despite early mRNA expression, the role of neurotrophins and their receptors
particularly in PCD regulation in embryonic thalamus is still unclear.
Mutant mice lacking the genes encoding each of these neurotrophins or their
receptors have been generated, to study the requirement for neurotrophin signaling in
the survival of distinct PNS neuronal populations during embryonic development
(Snider, 1994; Barbacid et al., 1995; Farinas et al., 1996). However, very few gross
defects have been detected in the CNS of these mutant mice (Klein et al., 1993;
Conover et al., 1995; Liu et al., 1995). Additionally, the effects of mutations in
neurotrophin genes are generally subtler than mutations of their companion receptor
genes. This suggests that some cells may obtain trophic support from more than one
factor signaling through a common receptor pathway (Johnson and Oppenheim,
1994). The in vivo study of mutations of neurotrophin receptors often provides better
evidence for their role.
In this chapter, I thus studied thalamic PCD in mice lacking TrkB and TrkC
receptors at different ages throughout the embryonic and early postnatal periods.
These periods are around the time when thalamic fibers innervate cortex (which
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should be the period when thalamic cells develop a trophic requirement, according to
the Neurotrophic Hypothesis). I analysed PCD in the thalamus of mice heterozygous
for targeted mutations in trkB or in trkC sequences encoding the catalytic domains of
the TrkB or TrkC tyrosine kinase receptor isoforms (Klein et al., 1993; Klein et al.,
1994). Mice lacking TrkB were first generated by targeted mutation. A
phosphoglycerate kinase 1 (PGKl)-neo cassette (McBurney et al., 1991) were
inserted to disrupt the domains III-V (exon K2, Klein et al., 1993) of the tyrosine
kinase domain. Cells were dual selected in the presence of G418 and gancyclovir and
screened by the PCR method. The selected cloned ES cells were then used to
produce heterozygous trkB+l- mice (Klein et al., 1993). A similar method was done
for targetting trkC, the inserted PGKl-neo cassette disrupts K2 exon and is spliced
out and leading to an aberrant transcript that contains a frame shift mutation between
exons K1 and K3. This trkC mutation results in the synthesis of abnormal TrkC
receptors of 667 amino acids (against original 825 residues)(Klein et al., 1994).
Later in this chapter, to strengthen the evidence, several sets of cell culture
experiments are described which show that at least one neurotrophin (BDNF) and its
receptor (TrkB) are likely to be involved in thalamic PCD at a particular period of
development. These experiments were done in collaboration with a postdoctoral
fellow, R. B. Lotto. First, we tested whether thalamic cells in culture have a better
survival when provided with certain neurotrophins and/or trophic factors from
medium preconditioned with cerebral cortex. Then we further tested the neurotrophic
requirement of thalamic cells by applying the neurotrophic signaling kinase inhibitor,
K252a (Tapley et al., 1992; Kang and Schuman, 1995), and specific blockers to




1) Mice prepared for in situ hybridisation
Four El9 C3H pregnant mice were used in this study. El 9 embryonic brains
were dissected and processed histologically as described in Chapter 2. Coronal
sections were cut at 7pm and mounted on 0.1% TESPA (in acetone solution) coated
slides (instead of using normal poly-£-lysine). All procedures were performed under
RNase-free conditions, i.e. gloves were worn to avoid enzyme contamination from
the investigators to the tissue.
2) Transgenic mice prepared for TUNEL studies
Heterozygous mice for a null mutation of trkB or trkC were mated to give
wild type, heterozygous, and homozygous offsprings. Embryos were removed at the
assigned stage of pregnancy. Parts of the embryos (either legs or tails) were removed
for PCR genotyping. Brains were obtained from E13, E15, E17, E19, PI, and P4
mice. Embedding was done as described in Chapter 2. Coronal sections were cut at
7pm and mounted on poly-/,-lysine coated slides.
Riboprobe preparation
Plasmids containing sequences recognising trkB and trkC extracellular
domains were provided by Julia Clausen & Tom Pratt (obtained from Bristol-Myers
Squibb).
The trkB antisense riboprobe was transcribed from a 0.5kb fragment derived
from the linearised pFRK-16 plasmid (Klein et al., 1989) using EcoR V restriction
enzyme and T7 RNA polymerase. Sense probes were generated from the same
plasmid for controls, using Sma I restriction enzyme and SP6 RNA polymerase.
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The trkC antisense riboprobe was transcribed from a 0.5kb fragment derived
from the linearised pFL-25 plasmid (Klein et al., 1991) using EcoR I restriction
enzyme and SP6 RNA polymerase. Sense probes were generated from the same
plasmid for controls, using Hind I restriction enzyme and T7 RNA polymerase.
Both trkB and trkC probes would detect mRNAs encoding both truncated and
full length receptors. In each case, lpg of each of these plasmids was used as a DNA
template and linearised with appropriate restriction enzymes according to methods
provided by the manufacturing company (Roche). The DNA was extracted by
standard phenol-chloroform extraction and ethanol precipitation.
The in vitro transcription was carried out by mixing the extracted template
with appropriate RNA polymerase (see above) 2U/pl in 20mM Tris-HCl, pH8.0,
6mM MgCb, lOmM DDT, lOmM NaCl, 2mM Spermidine, RNase Inhibitor lU/ju.1,
ImM each ATP, CTP and GTP, 0.65mM UTP and 0.35mM D1G-11UTP at 37°C for
2h. The reaction was completed by an incubation with 2U/pl of RNase-free DNase
(Roche) at 37°C for 15 minutes and ethanol precipitation in 20mM EDTA pH8.0, 0.1
volume LiCl at -70°C for lh. Following centrifugation for 5 minutes at 4°C, samples
were washed in 70% ethanol, dried, resuspended in lOOpl DEPC-treated water and
stored at -70°C. Labeled RNA was quantified by dot-blot analysis (Roche). Only
transcription reactions yielding lpg/ml RNA were used as riboprobes for in situ
hybridisation.
In situ hybridisation
For prehybridisation steps, brain sections on slides were dewaxed,
rehydrated, and washed in SSPE solution. They were then treated with 20pg/ml
proteinase K, post-fixed with chilled 4% paraformaldehyde, 0.2M HC1, and
acetylated (to reduce background) with 0.5% acetic-anhydride in 0.1M
triethanolamine (TEA). At the hybridisation steps, 1 added l-2pl DIG-riboprobes
(100-200ng) in 60pl hybridisation mix (50% formamide, 10% dextran sulfate, 0.5%
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lOOx Denhardts, 0.2mg/ml tRNA, and 0.05% SDS in SSPE) on each slide. The
reactions were incubated overnight at 50°C in a humidified atmosphere. On the
following day, slides were washed with 2x SSC (10 minutes, 50°C), 2x SSC in 50%
formamide (45 minutes, 65°C), 4x SSPE (5 minutes, 50°C), 20ug/ml RNAseA in 4x
SSPE (30 minutes, 37°C), 2x SSC in 50% formamide (45 minutes, 65°C), and then in
pre-warmed 50°C 2x SSC. The hybridised slides were processed through DIG
antibody detection steps. Tissues were washed with 0.1% Tween 20 in PBS, 1%
blocking buffer, and incubated in 1:5000 anti-DIG-AP (alkaline phosphatase)
antibody solution overnight. 2% NBT/BCIP stock solution in alkaline phosphatase
buffer was applied for color detection. Tissues were then counterstained by 1%
PyroninB and mounted. Expression was analysed under the microscope. Anatomical
descriptions in this study were according to Paxinos et al. (1994) and Schambra et al.
(1992).
Mutant Genotyping
Frozen foetal/pups' lower trunks (E13), legs (E15-E17), and tails (E19-P4)
were digested by protinase K, followed by standard phenol-chloroform-isoamyl
DNA extraction, PCR, and gel eletrophoresis (2% agarose) according to Schimmang
et al. (1995). Primers used are summarised below.
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PCR Products:
Knockout Allele Primers 573' (Oswel seq name)* PCR product size (bp)
(approx.)
TrkB Normal allele TRK1 5' common(T6966)/TRK 3' WT(T6967) 900
Targeted allele TRK1 5' common(T6966)/TRK 3' Targetted(T6968) 1000
TrkC Normal allele TRK4 5' common(T6969)/TRK 3' WT(T6964) 400
Targeted allele TRK4 5' common(T6969)/TRK 3' Targetted(T6965) 500
TrkB: a) Common 5' primer
b) 3' WT primer =
c) 3'Targetted primer =
TrkC: a) Common 5' primer1
b) 3' WT primer =







TUNEL technique & identification of thalamic nuclei
TUNEL protocol was performed on sections as described in Chapter 2.
DNase-induced (lOpg/ml) positive control slides and negative control (TdT omitted)
slides were run together with other slides in every single experiment.
TUNEL cell counts
Counts were made in the most distinctive area of each thalamic nucleus of
each slide. At 40x magnification, TUNEL positive cells were identified by green
fluorescence under the fluorescein filter (they differ from yellowish green cells,
which are autofluorescent background, see Chapter 2 - Figure 2.2) and counted
within the grid window (10 x 10 square area). Apoptosis was further confirmed by
nuclear morphology (pyknosis and/or apoptotic bodies) under DAPI or PI staining.
The numbers of TUNEL positive nuclei and of total nuclei (obtained from counting
DAPI or PI stained nuclei) per grid window were counted. The ratio of the number of
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TUNEL positive cells to the total number of cells in a thalamic nucleus was
expressed per 1,000.
There are four major methods of cell counting in histologically sectioned
material: 1) serial reconstructions; 2) stereological methods; 3) assumption-based
methods; and 4) profile counts (for detail see Coggeshall and Lekan, 1996). The
method of cell quantification used in this study was regarded as 'densities and ratios'
type of profile counting method. This method is one of the simplest and the mostly
commonly used methods. However it can be biased and the accuracy depends on
whether situations that cell size, shape and the orientation of the compared profiles
are not varied. The two populations of cells (TUNEL positive and non-labeled cells)
counted in this study were similar in size (3-6pm, and 7-10pm) so this method was
used in this study. Statistical analysis was carried out by Students' t-test.
Numbers of embryos used in the TUNEL experiment are summarised below.
Ages E13 El 5 E17 E19 PI P4
Wild type mice 3 4 5 5 3 3
TrkB-/- mice 3 4 3 4 3 4
TrkC-/- mice 3 3 3 3 3 3
Tissue culture
Detailed methods are described in Chapter 2. In this Chapter, cells were
plated at high density (4,500 cells/mm2), except in experiments testing the blocking
effect of BDNF antibody where some were plated also at low density (1,000
cells/mm2) (Figure 3.6). In each culture well, numbers of live and dead cells in 10
randomly selected 0.2 x 0.2mm windows were counted blind to give the percentage
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of viable neurons; data from multiple wells under each condition were combined to
give averages.
Addition of substances to the cultures
This work was done in collaboration with R.B. Lotto. The following
procedures were mostly done by R.B. Lotto. The experiment with neutralising the
effect of BDNF by adding anti-BDNF antibody was done by me. CCM was obtained
by dissecting the El9 cortex, sectioning at 500pm x 500pm using a Mcllwain tissue
chopper, culturing the slices on Costar Transwell inserts (40 slices in 500pl of
medium) for 24h at 37°C, and removing the medium, which was stored at -20°C.
Control medium was also incubated for 24h and stored at -20°C. After thalamic cells
had been cultured for 3 days, 60pl of medium was removed and replaced with 70pl
of either control medium or CCM and lOpl of phosphated buffered saline containing
K252a, one of the Trk IgGs, anti-BDNF, turkey serum, one the neurtrophins or
nothing (final concentration are given with results). Extra volume was replaced to




trkB and trkC mRNAs are expressed in several distinct embryonic
thalamic nuclei in restricted patterns
The trkB expression pattern in the embryonic brain at El9 was heterogeneous
(Figure. 3.1, left column). Strong expression was found throughout the cerebral
cortex and in certain thalamic nuclei. In thalamus, most thalamic nuclei were labeled
with the trkB probe. The highest expression was found in the anterior (including
anteroventral/anteromedial) thalamic nuclei (AT), the reticular nucleus (part of the
ventral thalamus), and the dorsal lateral geniculate nucleus (DLG). Slightly less but
still strong expression of trkB was found in the ventral posterior thalamic nuclei (VP,
ventroposteromedial and ventroposterolateral nuclei - VPM/VPL) and the
paraventricular thalamic nuclei (PVT). The rest of the thalamic nuclei express trkB at
a low level, except the ventral thalamic nuclei (VT, ventrolateral and ventromedial -
VL/VM) which are both devoid of trkB expression.
The trkC mRNA probe strongly labeled the cerebral cortex and the
hippocampus (Figure. 3.1, right column). Posterior cortex seemed to express trkC
more strongly than the anterior area. In the thalamus, the distribution of trkC
expression was similar to that of trkB but was different in intensity. The highest trkC
expression was found in the anterior thalamic nuclei (AT). Ventral posterior nuclei
(VP) were also labeled relatively strongly. Similar to that of trkB, trkC expression
was not detected in the ventrolateral or the ventromedial nuclei. In contrast, trkC was
not expressed in the reticular nucleus. The labeling intensity in the dorsal lateral
geniculate nucleus was high but slightly less than that of trkB. The expression in the
paraventricular nucleus was low. However, posterior and lateral dorsal nuclei
expressed trkC at higher levels than trkB.
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Figure 3.1
In situ hybridisation photomicrographs of trkB and trkC mRNA in El 9 thalamus and
cortex. In (a) an anterior coronal sections cuts across paraventricular thalamic
nucleus, and trkB mRNA is expressed in paraventricular thalamic nucleus (PVT) and
cerebral cortex, (b) Adjacent section shows trkC expression patterns. In (c) and (d)
sections cuts across anterior group of thalamic nuclei. Strong trkB expression is
found in anterior group of thalamic nuclei (AT). trkB (c), but not trkC (d), is also
strongly expressed in the reticular thalamic nuclei (Ret) of the ventral thalamus, (e)
and (f) are further sections across anterior and ventral groups of thalamic nuclei.
VL/VM (ventrolateral and ventromedial nucleus) is void of trkB (e) or trkC (f)
expression. In (g) and (h), more posterior sections cut across VL/VM, ventral
posterior (VP), and dorsal lateral geniculate (DLG) nucleus of the dorsal thalamus.
Strong expressions of both trkB (g) and trkC (h) mRNAs are in DLG and VP. In
sections with the most posterior part of the thalamus, moderate expressions of both
trkB (i) and trkC (j) mRNAs are found in posterior thalamic nucleus (POT).
trkC mRNA is also strongly expressed in hippocampus and the cortex (b, d, f, h and
500|am
If the functions of the proteins depend on the level of the mRNA expression,
the strong and overlapping expression of trkB and trkC would indicate that these two
receptors may play an important role in the development of the anterior thalamic
nuclei. While trkB is likely to regulate development of the dorsal lateral geniculate
nucleus and the ventroposterior complex, trkC is likely to function in the posterior
nucleus. These functions may also include PCD regulation.
Cell death in thalamus occurs with a peak soon after birth
Apoptosis in the normal thalamus was first detected at the earliest of the
embryonic ages studied, i.e. hi 3. At this age, although the thalamus has developed
and is identifiable, subdivision into the individual thalamic nuclei is not possible.
Ratios of dead to live cells were thus measured in the whole dorsal thalamus (DT).
The cell death rate was very low at E13: 1.95 (+ 0.26 s.e.m.) cells per 1000 cells
(Figure 3.2a). From El5, some thalamic nuclei were distinguishable (at this age, I
differentiated the thalamic nuclei into paraventricular nucleus, ventral nuclear group,
dorsal lateral group, and posterior nuclear group). The amount of cell death remained
low in almost every nucleus aged E15, E17 and E19, with the apoptotic ratio being
0.5-2 cells per 1000 cells. Among these thalamic nuclei, ventral medial/ventral
lateral groups had the lowest rates of cell death at all ages (~ 0.3 apoptotic
cells/1 OOOcells) (Figure 3.2b-d, 3.5c). Slight increases in cell death were found in the
posterior thalamic nucleus and the dorsal lateral geniculate nucleus at E19 (3.6 and
2.7 cells/1 OOOcells, respectively).
Soon after birth, there was a general marked reduction in cell density, and cell
death was more clearly observed (Figure 3.2-3.4). At PI, increased cell death was
found in all thalamic nuclei, particularly in the ventroposterior nuclei (Figure 3.3a,
3.5e&g). I found as many as 55 apoptotic cells per 1000 cells in this VP region, the
highest cell death ratio observed in this study. The average cell death rate in the
whole thalamus (Figure 3.4b) at this age was 13.11 cells per 1000 cells (+ 1.51
s.e.m.). The second highest cell death rate was found in posterior nucleus (16 dead
cells per 1000 cells). Again the lowest cell death rate was observed in the ventral
nuclei (around 4/1000 cells).
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At P4, the last age studied, cell death was still high. 10.6 apoptotic cells per
1000 cells was the average. The ventral posterior nuclear group (VPL/VPM) had no
longer maintained its high cell death rate (reduced to 14.76 + 6.26 cells/1 OOOcells). A
marked increase in cell death was found in the dorsal lateral geniculate (DLG), with
a rate of 26 cells per 1000 cells (comparing to just about 9 cells per 1000 cells at
El9) (Figure 3.3b)
A summary of the developmental PCD in thalamus as a whole is shown in
Figure 3.4b. The rate of PCD in thalamus as a whole increased gradually as the
thalamus matured and reached the peak at PI as a result of the increase in PCD in
every thalamic nucleus at this age, although rates of cell death among thalamic nuclei
are different.
Roles of TrkB and TrkC in thalamic PCD
The gross morphology of the trkB-/- and the trkC-/- brain was relatively
normal at all ages studied. In postnatal animals after day 4, trkB and trkC
homozygous mutant mice showed reduced body size. trkC-/- neonates also showed
some defects in movement possibly due to abnonnal muscle coordination. The
patterns of cell death in the trkB and the trkC thalamic mutants were generally
similar to wild types but there were noticable exceptions. In trkC knockouts,
unexpectedly, I found a slightly lower cell death rate at El3. Cell death in El3 trkC
knockout thalamus was only 0.3 (+ 0.2 s.e.m) cells per 1000 cells which is
significantly lower than wild type thalamus (p < 0.05, Student's t-test) (Figure 3.2a,
3.6a-c). On the other hand, there was no significant difference in apoptosis of trkC-/-
thalamus compared to that in the thalamus of wild types in all other areas at the rest
of the ages studied (E15-P4) (Figure 3.2, 3.3 and 3.4).
In trkB knockouts, cell death started to rise at El7. The most dramatic
increase in apoptosis was found in the DLG (Figure 3.2, 3.4a, 3.6d-e) (13 + 0.7/1000
cells compared to 1.5 + 0.9/1000 cells in El7 wild type, p < 0.01). This change in the
rate of cell death in the DLG alone, however, was significant enough to increase the
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Figure 3.2
Graphs showing number of TUNEL positive cells per 1000 cells against different
areas of wild type, trkB-/- and trkC-/- thalamus at different embryonic ages.
(a) Thalamic cell death at El3: the ratios of TUNEL positive cells are only counted
in the whole dorsal thalamus as the nuclei have not differentiated. A small reduction
in cell death is observed in TrkC knockout thalamus (p < 0.05).
(b) Thalamic cell death at El5: some thalamic nuclei have differentiated. Cell death
at this age is low and no significant difference in the mutant cell death is found at this
age.
(c) Thalamic cell death at El7: average cell death in each nucleus is below 5
cells/1000 cells. A significant increase in cell death is observed in trkB mutant dig (p
< 0.05) which also makes the average cell death in this mutant thalamus increase as a
whole {p < 0.05).
(d) Thalamic cell death at El9: average wild type cell death in each nucleus remains
low. A small but significant increase in cell death is observed in AT, VPL/VPM, and
in the DLG of the trkB mutant (all p < 0.05) but these do not make the average cell
death in this mutant thalamus increase as a whole.
Abbreviations: WT, Wild type mice; trkB (-/-), tyrosine kinase B receptor knockout
mice; trkC (-/-), tyrosine kinase C receptor knockout mice, DT, Dorsal thalamus;
PVT, Paraventricular thalamic nucleus; VT, Ventral thalamic nuclei (including
VL/VM - Ventrolateral/Ventromedial and VPL/VPM - Ventroposterior
lateral/Ventroposterior medial nuclei); AT: Anterior thalamic nuclei; MD/CM,
Mediodorsal and centromedial group of thalamic nuclei; POT, posterior thalamic
nuclei; DLG, Dorsal lateral geniculate nucleus; Total = average rate of cell death in





















Graphs showing number of TUNEL positive cells per 1000 cells in different areas of
the thalamus at postnatal days 1 and 4.
(a) Thalamic cell death at PI: The rate of cell death goes up to at least 10 cells/1000
cells. High rates of cell death in VPL/VPM are found in all wild type, trkB-/-, and
trkC-/- animals. Significant increase in cell death is still found in trkB dig comparing
with wild type.
(b) Thalamic cell death at P4: The rate of thalamic cell death remains high but there
is a reduction in cell death in VPL/VPM. No significant difference is found in the
mutants.
Abbreviations: see Figure 3.2.
 
Figure 3.4
Summary graphs showing TUNEL positive cells per 1000 cells in wild type and
mutant thalamus plotted against developmental ages.
(a) Cell death in dorsal geniculate nucleus (dig): increased cell death is found in
trkB-/- dig (red) from El7 to PI. At P4, a rise in wild type cell death goes up to equal
the level of PCD in the mutant (black line).




Photomicrographs showing distributions of TUNEL positive cells in wild type PI
thalamus: TUNEL in (a) paraventricular thalamic nucleus (PVT), (b) Anterior
thalamic nuclei (AT), (c) ventrolateral/ventromedial thalamic nuclei (VL/VM), (d)
mediodorsal and centromedial group of thalamic nuclei (MD/CM), (e)
ventroposterolateral/ventroposterior medical thalamic nuclei (VPL/VPM), (f)
posterior thalamic nuclei (POT). Dorsal lateral geniculate nucles is not shown here.
At higher magnification, more apoptotic cells is found in ventral posterior nuclei (g).
Red arrows depict TUNEL positive cells.
 
Figure 3.6
Photomicrographs showing distributions of TUNEL positive cells in El3 and El 7
thalamus of the wild types and the mutants.
(a)-(c) El3 thalami (wild type, trkB-/-, and trkC-/- accordingly): a small reduction in
the rate of cell death is observed in trkC knockout thalamus (c).
(d) and (e) El7 dorsal geniculate nucleus: in trkB mutants (e), there are more
TUNEL positive cells than wild type (d). Red arrows depict TUNEL positive cells




rate of El 7 cell death in thalamus as a whole in the mutant. If I omitted the result in
DLG, there was no significant increase in the rate of cell death in the mutant. At El 9,
the rate of cell death in trkB-/- DLG declined but remained significantly higher than
in the wild type DLG (6.6/1000 cells, compared to 2.7/1000 cells in wild type,/? <
0.05). Other regions were also found to contain more apoptosis in trkB-/- thalamus,
1.e. anterior thalamic nuclei (2.4/1000 cells vs. 0.5/1000 cells in wild types, p <
0.05), and ventral posterior nuclei (4.79/1000 cells vs. 1.75/1000 cells in wild types,
p < 0.001). The total amount of cell death in trkB mutant thalamus was therefore
increased (/? < 0.05; Figure 3.4a). In contrast to the previous report (Alcantara et al.,
1997), the increased cell death in ventral posterior nuclei in the knockouts was found
only at El 9, and the high rate was not extended to later postnatal ages.
At postnatal ages, there was still an increase in cell death of trkB knockout
DLG (21.8/1000 cells vs. 8.78/1000 cells in wild types,/? < 6.05), but overall cell
death at PI was not significantly increased. At P4, there was no significant difference
in cell death in any nucleus.
II. In vitro
Thalamic neurons at the age of cortical innervation in vitro require
neurotrophic support
I have previously shown that El5 thalamic viability in 24h culture in
enhanced if cells are plated at high-density. However, viability of El 9 thalamic cells
was poor under the same condition (high-density) (Figure 3.7a). When El 5 thalamic
cells were cultured at high-density up until an age equivalent to El9 or the time of
birth (4-6 DIV), most cells died (these cells normally survive only up to 3 DIV). This
suggested that intrinsic factors presented in the high-density environment were no
longer sufficient for the late thalamic neurons. Thalamic cells at this stage are known
to depend on target(cortical)-derived trophic support. We examined this trophic
influence by adding medium preconditioned with cortical explants (CCM) and found
that the CCM maintained El 5 thalamic cells in culture for up to 6 DIV (Figure 3.7a).
Detail investigation of basic properties and specificity of the conditioned medium
72
Figure 3.7
Graphs showing thalamic viability in high plating density of 5-day culture with
treatments of cortical conditioned medium, neurotrophins and their blockers (taken
from R.B. Lotto).
(a) El5 and El9 thalamic viability without treatment: El5 thalamic cells survive up
to 3 days and die soon after. One-day culture shows a poor viability of El 9 thalamic
cells.
(b) El5 thalamic viability with El9 cortical conditioned medium (CCM): the cells
are rescued by the conditioned medium after 5 days in culture.
(c) El 5 thalamic viability in the presence of CCM and tyrosine kinase receptor
blockers (K252a): K252a blocks the trophic effect of CCM in dose dependent
manner.
(d) El 5 thalamic viability in the presence of CCM and specific TrkA or TrkB IgGs:
survival of thalamic neurons in CCM is sensitive to high concentration of TrkB IgG.
(e) El 5 thalamic viability in the presence of CCM and BDNF antibody in turkey
serum: anti-BDNF antibody inhibits the effects of CCM on thalamic survival. Note:
turkey serum has no effect on thalamic cells in CCM.
(f) El 5 thalamic viability in the presence of BDNF or neurotrophin-4: neither
neurotrophins can reproduce the CCM effect.
 
will be shown in Chapter 4. However, we do not know whether this trophic effect of
the CCM was mediated by neurotrophins.
Mechanism by which cortical factors rescue thalamic cells involves
neurotrophin signaling
When applying CCM containing 500pM or lpM K252a (the protein kinase
inhibitor specific for neurotrophin signaling) on the third day of culture, the viability
assessed two days later was significantly reduced in a dose-dependant manner
(Figure 3.6c). This result indicated that one or more neurotrophins in CCM are
essential to the thalamic cells. Interestingly, western blot analysis had shown that
only BDNF, but not other neurotrophins, was detected in El9 CCM (Dr Leila Vali,
unpublished observation). Then we tried to inhibit the activities of either TrkA or
TrkB receptors by adding TrkA IgG or TrkB IgG chimeric molecules with CCM on
the third day of culture. At 38pg/ml, the concentration shown to have a specific
inhibitory effect (Shelton et al., 1995), TrkB IgG inhibited the survival promoting
effects of CCM on days 4 and 5 of culture; a low dose, 8pg/ml was not effective
(Figure 3.6d). Similar inhibitory effects were found when polyclonal anti-BDNF
antibody in turkey serum (1:12 dilution, Ghosh et al., 1994) was added with CCM on
the third day of culture (Figure 3.6e). In contrast, TrkA IgG was ineffective even at
38pg /ml (Fig3.6d).
However, at all doses known to be effective in other systems and in thalamic
cells at earlier ages (Lotto et al., 1997), BDNF alone failed to maintain thalamic
survival after 3 days in culture. The other TrkB ligand NT-4 was also ineffective
(Figure 3.6f).
In order to test if BDNF is also required by earlier thalamic neurons, BDNF
and anti-BDNF antibody were added to 2-day cultures of low- and high-density
thalamic cells. At low plating density (Figure 3.8a), similar to the previous findings
(Lotto et al., 1997), BDNF (lOng/ml) promoted thalamic survival, and predictably,
the anti-BDNF antibody antagonised the effect of BDNF. But the antibody alone did
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Figure 3.8
Graphs showing El5 thalamic viability in 2-day cultures in response to the treatment
with BDNF and BDNF antibody, (a) Thalamic viability in low plating density:
BDNF significantly promotes thalamic survival. This effect is blocked by the BDNF
antibody. The antibody alone does not have an effect on thalamic survival, (b)
Thalamic survival in high plating density: thalamic survival is not affected by BDNF,
anti-BDNF, or the combination.
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not have an effect on low-density cells. At high plating density (Figure 3.8b),
however, BDNF had no effect on this culture. Anti-BDNF antibody, when applied
alone, did not reduce thalamic viability of these cultures. These results indicated that
although BDNF can promote thalamic viability at this age in low density, it may not
be a major requirement for thalamic cells to survive in vivo (as at high plating
density, cells can survive even with the anti-BDNF antibody). Moreover, this single
application of the antibody suggested that the antibody itself was not toxic at the
concentration (1:12) used in this study.
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Discussion
1. Significance of trkB and trkC expression in embryonic thalamus
In support of the in situ hybridisation results, TrkB and TrkC have been
detected by immunocytochemistry in cultures of El 5 thalamic cells (Lotto et ah,
1997). Consistent with previous reports in postnatal brain (Ringstedt et ah, 1993),
trkB and trkC mRNAs are specifically expressed in several thalamic nuclei of
embryos. High levels of trkB and trkC expression in the anteroventral nucleus
suggested that trkB and trkC regulate limbic system development. Probably with no
less importance, both trkB and trkC may play a major role in the development of
many sensory nuclei as they are expressed at a considerable level in those nuclei. At
least one sensory region of the thalamus, the dorsal lateral geniculate nucleus, is
known to require neurotrophins in development (Ernfors et ah, 1992; Cabelli et ah,
1995; Cabelli et ah, 1997). On the other hand, motor relay nuclei (ventral nuclei) did
not express either of the receptor mRNAs. Thus it is unlikely that these two receptors
have a role in development of these nuclei (later, I also found that these nuclei have
lower cell death at the time of birth compared to other nuclei, suggesting that
survival of the neurons in these nuclei may not be under the control of
neurotrophins). The correlation between the receptor expression patterns and the
distribution of PCD among these nuclei will be discussed below.
2. Evidence that PCD occurs naturally throughout development of the
thalamus
2.1. Features and distribution of PCD in developing thalamus
Since the methods used for this study are based on TUNEL labeling and
nuclear pyknosis, we can assume that any cells positive by these criteria are dying by
apoptosis. I found that many, if not all, dying thalamic cells undergo apoptosis. The
distribution of the dead cells within each thalamic nucleus at all ages was found to be
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scattered (this is another characteristic of apoptosis, unlike necrotic cells which are
often found in clusters, Kerr et al., 1972) (Figure 3.4). The appearance of apoptotic
cells was scarce. Similar findings were also illustrated in photomicrographs and
drawings in Spreafico et al., (1995) and Waite et al., (1992) (but those studies had
insufficient quantitative analysis for the whole thalamus). The estimation of the
amount of cell death during development is actually difficult for several reasons.
Thalamic cells may undergo PCD via non-apoptotic mechanisms (excluding
necrosis) and thus the quantitative methods using TUNEL and pyknotic morphology
underestimate the real extent of cell death (Clarke, 1990). Paradoxically, however,
there is not enough evidence to date that other types of cell death occur extensively
during CNS development (Oppenheim, 1999).
In this chapter, we did not measure the actual number of cell death, but rather
the percentage of dead/dying cells over total cells in a specified area (profile count),
because the estimation of the number of dead cells is subject to error. To accurately
estimate the number of dead cells in each area, they need to be quantified by serial
reconstruction (Coggeshall and Lekan, 1996). This is a labor-intensive process and it
was not essential to my objective in this study because our main interest was to
observe changes in patterns of cell death in thalamic development rather than the
number of dead cells.
Regarding cell clearance, changes in the activities of macrophage or
microglia may affect the time of clearance of the apoptotic cells. For example, if
apoptotic cell clearance by microglia were to be prolonged, we may observed a
higher number of apoptotic cells than usual at a particular time. If this happens in the
mutants studied, it may cause a misinterpretation in cell counting when I compare the
rate of cell death between the mutants and the wild type animals. However, since
trkB mRNA could not be detected in microglia of normal mice (Frisen et al., 1993),
the mutation in functional trkB is unlikely to directly affect microglial function in
cell clearance. Thus the increased percentages of dead cells found in this mutant is
likely to be due to a real increase in cell death rather than a delay in cell clearance.
TrkC, on the other hand, is thought to have a physiological role in glial proliferation
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and differentiation and its mRNA can be detected in many glial populations (Kumar
and de Vellis, 1996; Kumar et al., 1998; 1999; Barres et al., 1994; Engel and
Wolswijk, 1996). However, it is not known whether TrkC directly functions on cell
clearance by microglia. And since I found no obvious significant change in cell death
in these animals, I shall have no further discussion about this issue.
In vitro quantifications are less problematic since the population of cells in
culture is in a limited area and is two-dimensional. Providing that plated cells
distribute equally, the ratio between dead cells and the total cell number reflects
directly the viability of the cultured population (Coggeshall and Lekan, 1996;
Coligan et al., 1995). As mention earlier on the subject of cell clearance, the
percentages of cells that die under various conditions in vitro, where dead cells are
not subject to clearance, did not necessarily correspond with the percentages of
TUNEL-positive cells in vivo, where dead cells are rapidly cleared.
2.2. Time and phases of the occurrence of PCD in the thalamus
As the cell density falls and the size of the thalamus increases in postnatal
development, the percentages of apoptotic cells increase up to 6 times (from 0.2 to
1.2 percent). This suggests that physiological cell death may contribute to the cell
density regulation and may shape the brain's morphology (Merry and Korsemeyer,
1997; Oppenheim, 1991). We found that there are at least 2 stages of cell death: a)
early on, dying cells are randomly distributed, while (b) later, dying cells are present
in some specific nuclei more than other. These two stages of cell death indicate at
least two different physiological roles: 1) cell removal by the control for homeostasis
during proliferation and 2) cell death by competition for neurotrophic factors.
a) Cell death in the neuroproliferative period of the thalamus
The cell death that occurs in the early stages of development could not be
explained by a target-dependent mechanism. This is because it occurs when
thalamocortical fibers have not completely formed and thalamic cells are still highly
proliferating. Similar patterns of cell death can be found in the early phase of cell
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death in spinal cord when cells are highly proliferative and the spinal cord is
differentiating the ventral and the dorsal spinal regions (Oppeheim et ah, 1999).
Apoptosis at this stage can be found preferentially in mitotically active precursor
cells rather than in postmitotic cells (Homma et ah, 1994).
Previous studies have shown that massive cell death occurs in all
neuroproliferative regions in the CNS and have suggested that the majority of cells
that undergo cell death are proliferating cells (Blaschke et ah, 1996; 1998). In
particular in the thalamus, it has been reported that up to 40% of proliferating cells
undergo PCD (Blaschke et ah, 1998). However, my findings seem to oppose these
observations, partly because of the different technique used to measure apoptosis
(they used a technique called TUNEL+ which was claimed to be more sensitive than
original TUNEL but I found that the increased sensitivity might be due to non¬
specific staining). In this study, I found that the quantity of cell death in this period is
much less than the substantial cell death at the late stage of development where more
cells are postmitotic and are innervating their cortical target (see results). The
significance of and the mechanism underlying this death among proliferative cells
are unknown, but it is likely to be different from cell death that occurs among mature
neurons making connections with their synaptic targets.
b) Cell death occurring during cortical innervation
Most thalamic nuclei show a marked increase in cell death around the same
time, in the early postnatal period (PI), which makes the rate of thalamic cell death
as a whole rise. This increase in cell death appears in distinct, reproducible patterns,
which occurred in a stereotypic manner at specific times in development. This
therefore represents the normally occurring PCD that is an essential part of
embryonic development. In particular, the striking results obtained in the ventral
posterior nuclei are similar to those reported in a previous study by Waite and
colleagues (Waite et ah, 1992). They found that the nuclei reached a peak of cell
death in the perinatal period (P0-P2 in rat, compared to our findings at PI in mouse)
and then the rate of cell death declined soon after. In the study of the visual relay
nucleus, the dorsal geniculate, the peak of cell death corresponded with target
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innervation and the start period of the target dependency (Finlay and Pallas, 1989),
which was around E17-P2 (Lotto, 1994).
Although each thalamic nucleus is born at a different time, the increase in cell
death in all thalamic nuclei appears to be around the time of target innervation. This
suggests that death of cells is not predetermined by the time of their birth or the
differentiation of the cell itself but likely to be regulated by the influence of
environment at the time of innervation. The most probable factor is the limited
supply of target-derived trophic support. Nevertheless, these rises in cell death in all
thalamic nuclei at this period occur at different rates. This implies that regulation of
cell death in each individual thalamic nucleus is probably independent from that in
the others (e.g. they might be controlled by different neurotrophic factors), and/or is
determined by differences in their target fields/cell numbers that these nuclei are
responsible for innervating (Finlay and Pallas, 1989; Spreafico et al., 1995;
Oppenheim, 1999).
3. The roles of neurotrophins and their receptors in regulating thalamic PCD
3.1. In vivo: PCD in trkB and trkC mutant thalamus
TrkB, but not TrkC, regulates cell death in thalamus
Although trkB and trkC mRNAs were expressed in overlapping patterns in
many regions of the thalamus, studies of cell death in mice lacking one of these
functional receptors revealed different results. There was increased cell death in the
trkB mutant. To rule out a non-specific cell death due to secondary consequences of
the mutation, TrkC mutant mice can be used as a control as they also have one
functional neurotrophin receptor disrupted but show no significant increase in cell
death in late gestation when compared with wild types. In El9 trkB knockout mice,
increases in cell death were found in all thalamic nuclei that would normally express
trkB, i.e. AVT, VP, and DLG). This evidence strongly suggests that TrkB functions
as a survival regulating molecule in these thalamic nuclei at this late stage of
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development. In contrast, despite a high level of expression of trkC in thalamus,
there is no difference in thalamic cell death in trkC mutants. Thus it is possible that
trkC might play other role(s) than being a survival receptor for the thalamus. Lewin
and Barde (1996) suggested that NT-3 could regulate neuronal number by
influencing the generation of neurons from precursor, via its mitogenic effects and
stimulation of cell cycle exit. In order to investigate this issue properly, 1 have
conducted a BrdU proliferation study in both cortex and thalamus of trkC mutant
mice as described in Chapter 7.
In fact, the increase in total cell death in the whole thalamus (in particular in
DLG) of the trkB mutant appeared not only at El 9 but was found as early as El 7 and
extended until the time of birth (PI). This period is also known to be the time of
target innervation (Catalano et al., 1991; Ferrer et al., 1992; Lund and Mustari,
1977). This increase in cell death in the trkB mutant thalamus, however, precedes the
natural peak of cell death in normal thalamus (which occurs around PI). This means
that many thalamic cells begin to require TrkB signaling for survival well before the
natural period of cell elimination.
Although there was a dramatic rise in cell death in VP at PI and this area
would normally express trkB, there was no increase in cell death in VP of the trkB
mutant at this age as I initially expected. There is no obvious explanation for this but
it is possible that either 1) VP cells of the mutant that require TrkB signaling die
before the peak of normal PCD is reached (at E19, before PI) or 2) dead cells at PI
might be a different population of cells which does not require TrkB signaling.
Despite the fact that the percentages of cell death in mice lacking tyrosine
kinase domain of the TrkB is higher than the wild type thalamus, the differences in
the percentages between the two are seemingly low. The pattern of cell death during
the peak time of the thalamic PCD (particularly at PI) is not much affected by the
mutation. Thus there may be other mechanisms than TrkB kinase signaling involved
in regulating thalamic PCD, in particular, in the areas that do not normally express
trkB. The examples for such mechanisms include: 1) compensatory effects by other
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neurotrophins (either the known or unknown factors), 2) signaling of TrkB ligands
(BDNF & NT-4) via non-catalytic domain of the tyrosine kinase receptor or p75 to
keep thalamic cells survived, 3) maintenance of thalamic survival by non-target-
derived mechanisms such as afferent fibers, and cellular interactions (e.g. regulation
by autocrine or cell-cell contact mechanisms) (Oppenheim 1991, Magowan and Price
1996, Lotto et ah, 1997).
Regarding the possibility that the increase in cell death found in the trkB
mutant is due to signaling compensation via other kinase receptors, it is likely that
trkC is the candidate for this compensation. This is because both trkB and trkC are
often expressed in overlapping patterns in the developing thalamus. Double mutation
of these two receptor genes may help to gain a better understanding of their role in
controlling thalamic PCD. Indeed previous studies have shown that double trkB-/-;
trkC-/- knockouts showed severe sensory deficits. However, their studies did not
show any significant defect in CNS structure (Silos-Santiago et ah, 1997).
In DLG, although we found that there is an increase in cell death in the trkB
mutant, it has also been reported that TrkB binding ligands regulate synaptic
plasticity in later stages of visual development (review by McAllister et al., 1999).
Injection of NT-4 can rescue lateral geniculate nucleus cells from the effects of
monocular deprivation (Riddle et ah, 1995). This rescue effect in late postnatal
animals was only to bring back shrunken cell bodies to their normal size, and does
not involve the prevention of apoptosis. Together with my data, there is strong
evidence to believe that TrkB plays more than one role in thalamic development, first
a survival function, and later in plasticity.
Considering the possible role of the putative TrkB ligands, BDNF and NT-4,
in regulating thalamic cell death, the expressions of both neurotrophins are different
and dynamic during development. Both BDNF and NT-4 are produced at early
embryonic ages. BDNF is produced early (E9) and continues to increase postnatally
until the first postnatal week (Dugich-Djordjevic et al., 1992; Friedman et al., 1991).
In contrast, the level of NT-4 is maximal in the midgestation period (El 5) and
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gradually declines with the lowest level being around birth. Since the times of
expression are different, it is possible that thalamic nuclei, especially DLG, might
require these neurotrophins at different time points and these neurotrophins therefore
regulate the time of PCD. For example, in early age, NT-4 may be a major trophic
molecule which transiently supports DLG neurons (as it is highly expressed in early
age), while trophic molecules in the young cells might be redundant. When the cells
mature and the availability of other neurotrophins is more limited, BDNF becomes
the major source of neurotrophin (as the BDNF production is increased around El 5-
E17). These cells may become more restrictive and require only BDNF molecules in
later stages.
3.2. In vitro: BDNF is required for the late embryonic thalamic cells
Early thalamic cells (at El 5) are promiscuous and respond to several
neurotrophic factors including neurotrophins and fibroblast growth factors (Lotto et
ah, 1997). However, single application of several neurotrophins failed to rescue
thalamic cells at the older ages (see Results). Thus the maturing thalamic cells may
need more than one trophic factor and/or need other neurotrophic factors to survive.
Diffusible factors from cerebral cortex are known to promote growth and
survival of thalamic cells (Hisanaga and Sharp, 1990; Lotto and Price, 1995; Bolz et
ah, 1990). But the factors involved have not been successfully identified. One
neurotrophin, BDNF, has been found to be a component of the cortical conditioned
medium (L. Vali, unpublished observation). Further evidence supports the possibility
that late thalamic cells require BDNF comes from the observation that K252a, TrkB
IgG, and anti-BDNF antibody successfully block the effects of the cortical
conditioned medium, whereas TrkA IgG could not. This also corresponds with our in
vivo data on TrkB mutant. Nevertheless, BDNF or any neurotrophin alone cannot
support thalamic cells older than El7.
Collectively, our results suggested the following. 1) Before cortical
innervation, thalamic cells may have sufficient trophic support because of their
promiscuity. 2) Thalamic cells may narrow their responsiveness around the time of
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cortical innervation, and become dependent on trophic molecules that are released
from the target. 3) Thalamic survival is regulated partly by a neurotrophin - BDNF
(via TrkB signaling) but that BDNF alone is not sufficient for the mature thalamic
cells.
4. Summary of possible mechanisms regulating PCD in the thalamus and
some unanwered questions
This study has determined the period of perinatal thalamic PCD and has
indicated that survival of thalamic cells is regulated by neurotrophic factors, in
particular, BDNF and TrkB signaling. But there may still possibly be other factors
involved in the regulation of thalamic PCD. Moreover, the underlying cause(s)
making thalamic cells come under trophic factor regulation and undergo PCD at a
specific perinatal period is unknown. Endogenous factors such as Bcl-2 may be
involved in the timing of this event (see Chapter 4 for detailed discussion, Greenlund
et ah, 1995; Holm and Isacson, 1999). In the perinatal period, it is possible that
thalamic cells may undergo trophic switching or may narrowing their trophic
dependence to respond only to factors produced by the target (Davies, 1996; Lotto et
ah, 1997). This was tested as described in the subsequent chapter. In addition, neural
activity and connectivity during development might be essential to determine the
time of the trophic dependency in thalamic cells (Magowan and Price, 1996).
Although the period of the thalamic PCD coincides with the period of
thalamocortical innervation, the correlation between the two is difficult to prove.
However, several observations indicated that competition for trophic factor among
thalamic cells (according to the Neurotrophic Hypothesis) is likely to occur. In
Chapter 6 I have shown that thalamic cortical fibers might be essential for thalamic
cells to obtain sufficient trophic factors.
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Chapter 4: Neurotrophic effects of condition media in
dissociated thalamic cell culture
Introduction
In previous chapters, I showed that in cultures of dissociated cells, the
survival of developing thalamus is promoted by increasing their cell density (see
Chapter 2). This can be regarded as an intrinsic property of the thalamus. However,
the high cellular density of El 5 thalamic cells could not maintain the viability of
cells when they were cultured for 3-5 days (which corresponds to the period of
innervation and the time of birth in vivo). Neither could high cellular density
maintain the viability of cells taken from the perinatal age. Lotto and I also showed
that the survival of developing thalamic cells is increased when cells are supplied
with external trophic support, culture medium conditioned with El9 cortex (see
Chapter 3, in vitro experiments). Although at least one neurotrophin (BDNF) is
present in this conditioned medium and Trk signaling (TrkB) is known now to be
essential, it is not sufficient as a sole factor for thalamic survival. Some unidentified-
neurotrophic factors released from conditioned medium might also play a crucial role
in regulating thalamic survival.
In this chapter, I describe my investigations focused on the basic properties of
conditioned medium in thalamic cell cultures with less concern for any particular
neurotrophins or trophic factor families. Diffusible factors from various tissues as
well as from the cerebral cortex have been shown to promote both survival and
neurite outgrowth of thalamic neurons of different ages (Hisanaga and Sharp, 1990;
Lotto et al., 1997; Lotto and Price, 1994). For example, cortex, cerebellum, medulla,
and thalamus can promote neurite growth from El6 thalamic explants in culture
(Rennie et al., 1994). Co-culturing with different ages of cortical explants also varies
the amount of neurite outgrowth from thalamic explants. Although trophic factors
released from some of these different tissues may have similar survival or growth
promoting effects, the molecules responsible for both effects may be different. My
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interest was to test the ability and specificity of these unknown molecules from
different tissues at different ages in promoting thalamic survival.
First I confirmed the basic properties of the conditioned medium by testing
the effect the withdrawal of E19 cortical condition medium. This is to verify that the
conditioned medium has a real trophic role (i.e. that it maintains thalamic cell
viability) rather than merely aiding initial recovery from dissociation. Many trophic
substances released from conditioned medium or from nervous tissue extract which
promote neuronal populations are often temperature sensitive and are proteinaceous
(Oh, 1976). In parallel with the antibody experiment showing the likelihood of
neurotrophin involvement in the previous chapter, I confirmed that the trophic effects
in the conditioned medium are from proteinaceous or temperature sensitive
substances. This was done by heat treating the conditioned medium.
If the notion of the neurotrophic hypothesis applies to the thalamus, we may
predict that thalamic cells at the time of cortical innervation should become
dependent on their major target - the cerebral cortex. I tested if these thalamic cells
respond specifically to target (cortical)-derived factors. This was done by comparing
the trophic effects of various media preconditioned with different tissues including
the thalamus itself on dissociated young thalamic cells cultured until the age at which
they would have innervated cortex.
As reported by others, some neuronal populations also undergo a
neurotrophic switch during the target innervation period i.e. those neurons which
formerly respond to one or more trophic factor(s) become dependent on another
factor(s) released from the target (see review in Chapter 1; Birren et al., 1993;
Davies, 1988a; b; Davies, 1994a; Pinon et ah, 1996). If this switch occurs in the
thalamus, 1 predicted that maturing thalamic cells should preferentially switch their
responsiveness to depend almost exclusively on trophic factors derived from cortical
tissue and no longer respond to factors produced intrinsically in thalamus of the same
age.
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Although thalamic neurons maintain their own survival before the time of
cortical innervation, it is not known how this ability declines with time. I tested if
trophic factors released from the thalamus itself (intrinsic factors), as well as from
the cortex of different stages (using El 5, El 9, and P2 tissues) produce similar trophic
effects on later thalamic neurons. However, it is difficult to obtain trophic factors
released from the maturing thalamus (> El9) in conditioning medium as the
thalamus at this age does not survive well. Since several studies suggested that
unidentified trophic factors from neural tissue extract promote viability in various
types of nervous tissue (Oh, 1976; Yin et al., 1992; Karasek et ah, 1977), first I tried
to obtain trophic factors directly by this tissue extraction method. However, the
attempt failed but I saw some increased trophic effects of maturing thalamus by
adding K+ to maintain its survival, as it has been shown to increase neuronal
depolarisation and activity (Magowan and Price, 1996; Lipscombe et al., 1988).
Embryonic thalamic neurons in cultures are heterogeneous, as in vivo. The
thalamus contains 2 main types of neuronal population 1) interneurons and 2)
projecting neurons. The major neurons of each subpopulation are 1) GABAergic
interneurons (neurons producing gamma-aminobutyric acid as a neurotransmitter)
and 2) glutamatergic projecting neurons (neurons producing glutamate as a
neurotransmitter) (Jones, 1985). Both GABAergic neurons and glutamatergic
neurons in other brain regions have been shown to be affected by BDNF or NT-4/5
in many aspects including differentiation, maturation, electrochemical activity, and
induction of the production of neurotransmitters (Huang et al., 1999; Mizuno et al.,
1994; Widmer and Hefti, 1994a; 1994b). Moreover, some neurotrophic factors can
both induce differentiation and selectively promote survival of certain neuronal
subpopulations at the same time (Hisanaga and Sharp, 1990; Huang et al., 1999;
Mizuno et al., 1994; Widmer and Hefti, 1994). It is thus possible that the trophic
effects of different sources of conditioned medium selectively rescue different
subpopulations of thalamic neurons.
Here I tested the possibility that 1) conditioned media from thalamus and
cortex of different ages has different effects on GABAergic interneuron
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subpopulations, and 2) the cortical conditioned medium selectively promotes
survival of non-GABAergic neurons (presumably mostly projecting neurons) and




C3H mice were obtained from overnight matings. Animals at E15, E19 and
P2 were sacrificed. For dissociated cell cultures, El5 thalami were removed as
described in Chapter 2 and dissociated. For conditioning media and preparing tissue
extracts, El5, El9, and P2 thalami, El5, El9, and P2 cerebral cortices, El9 tecta,
El9 cerebella, El9 livers, and E19 hearts were removed from foetuses and placed in
an adequate volume of culture medium.
Culture methods
Detailed methods for cell dissociation, culture processes, and calculation of
plating density were described in detail in Chapter 2. In this Chapter, tissue culture
with cells plated at 1,000 cells/mm2, and 4,000 cells/mm2 were regarded as low
density and high density respectively. After 24h in culture, 80pl of culture medium
in some samples was replaced by fresh culture medium, conditioned medium, or
tissue extracts in culture medium, depending on the experiments. Withdrawal
experiments were done by removing El9 cortical conditioned medium after 72h (3
days), and 120h (5 days) and replacing by the same volume of fresh culture medium.
Conditioning medium
Explants of thalamus, cortex, cerebellum, tectum, liver, and heart aged from
El5 to P2 were sliced at 500 x 500 pm2 with a Mcllwain tissue chopper. Chunks of
the explant were put in culture medium (serum-free). 40 pieces of each type of
explants in lOOpl culture medium were put on a 24 well Transwell collagen culture
plate (Costar, Transwell-COL) which was suspended over wells filled with 400pl
culture medium. The explants were cultured for 24h and the Transwells containing
explants were removed. Only the remaining culture medium in the lower part, which
was now conditioned, was stored at -70°C. Before these frozen conditioned media
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were added to the dissociated cell culture, they were thawed in a 37°C incubator for
at least lh. El9 thalamic and El9 cortical explants were reserved, fixed with 4%
paraformaldehyde, and histological processed (sectioned at 10pm), to determine their
viability.
For control cultures that had been left for longer than 24h, most control
culture medium was not replaced. This is because replacing old culture medium with
fresh or normal culture medium, which had been preincubated with collagen
Transwell filters, did not rescue thalamic cells after 3 days in culture.
Heat treating of conditioned medium
El9 cortical conditioned medium was heated to 85°C for either 3 minutes or
30 minutes before it was added to 24h thalamic cell cultures. The viability of samples
with added preheated normal culture medium was compared with the viability of
samples with normal culture medium that had no heat pretreatment.
Tissue extracts in culture medium (homoginisation experiment)
Explants of thalamus, cortex, cerebellum, tectum, liver, and heart aged El 5 or
El9 were sliced at 500 x 500 pm2 with a Mcllwain tissue chopper. Every 200 pieces
of each type of explants were put in 2.5ml culture medium (serum-free, same
proportion as in conditioning medium; 40 pieces/0.5ml). Tissue extracts were
prepared by homogenizing the tissue in the culture medium with a glass tissue
grinder and centrifuging the homogenate in a Beckman ultracentrifuge at 100,000g
4°C for 2h according to Oh (1976). The supernatant was collected and filtered
(0.45pm). These extracts then were added to the dissociated cells that had been in
culture for 24h.
In the experiment testing the toxic effects of the extracts, these extracts were
also diluted 1:10, 1:100, and 1:1000 in culture medium before adding to the
dissociated cells that had been in culture for 24h. Cells were fixed after 2 and 5 days.
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Direct application of K+ on dissociated cell culture
In this experiment, after culturing for 24h, 80pl of culture medium was
replaced by culture medium containing 0.05mM, 0.5mM, 5mM, or 50mM KC1 to test
the effect of potassium on thalamic cell cultures. The quantitation of cell viability
was done and compared with the control.
Conditioning media with the presence of KCI
For explants that had been used for conditioning media and had had K+
added, 0.05mM, 0.5mM, 5mM, or 50mM KC1 were added to culture medium to
conditioning the media. After 24h of conditioning in a 37°C incubator, El 9 explants
of both thalamus and cortex cultured with different K+ concentration were fixed,
embedded and sectioned at 10pm to determine viability. Culture media conditioned
with thalami or with cortices in different concentration of K+ were taken and stored
at -70°C. Before used, these conditioned media were thawed and prewarmed at 37°C.
Immunohistochemistry for GABA
Dissociated thalamic cells that had been fixed in 4% paraformaldehyde at
room temperature for 15 minutes were washed with 3 times 2.0% Triton-X in PBS
for 5 minutes each. Cells were then preblocked with normal goat serum (NGS) in
TBS (1:4NGS:TBS) for 10 minutes. Cells were incubated with affinity purified
(polyclonal) rabbit anti-GABA antibody (1:1000, Sigma) in 4°C overnight. The
following day, cells were washed twice in PBS for 5 minutes each. A second
preblocking with NRS followed. The sections were next treated with a biotinylated
secondary antibody (goat anti-rabbit, 5pl/ml) at 4°C overnight. When this incubation
was complete, the cells were once again washed with TBS, then treated with avidin
and biotinylated complex kit (ABC kit, Vector) according to the manufacturer's
instructions for 30 minutes. Then cells were washed and reacted with 3,3'-
diaminobezidine (DAB, Sigma) solution (0.05% DAB, 750pl tris buffer, 20pl 0.1%
H2O2 and one flake of imidazole) for 8 minutes.
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Before proceeding with the investigation, I optimised the concentration of the
primary antibody (the anti-GABA antibody) by dilution studies. The 1:1000 was the
lowest concentration that gives the best labeling and therefore was used in this study.
The immunoreactive cells were classified into two classes; heavy and lightly labeled
cells. For secondary antibody, the 1:200 dilution was used as a routine concentration
in our lab. For negative controls, the reactions were performed with the omission of
primary antibody. Since the antibody is polyclonal, non-specific background staining
may occur (Harlow and Lane 1988). I tested if at the dilution of 1:1000 the antibody
had such non-specific staining. In one reaction (among the first run of the
experiments), the antibody was preblocked with GABA molecules (1:100, mol/mol)
(so called preadsorbed antibody) before adding to the cells. These samples were
compared with antibody-omitted negative controls and the experimental sample
without preadsorption. No non-specific staining was found in the sample with
preadsorbed antibody.
Samples of GABA reactions and the negative control are shown in Figure
4.8.
Analysis
Cell viability analysis in culture
All quantitative measurements were done with Hoechst staining as detailed in the
previous chapter. Data for all viability experiments were analysed and their
significance was determined with Student's t-test (comparing with control), and by
ANOVA if more than two experimental treatments were compared.
Cell viability analysis in explants used for conditioned medium
To assess the viability of organotypic thalamic explants that had been used
for conditioning medium, explants of each age tested (El 5 and El 9) were fixed,
embedded in wax, sectioned at lOpl, and stained with 5pg/ml Hoechst. For five to
ten randomly selected explants of each tissue, the viability was assessed by counting
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the proportion of living cells and total cell number in a grid square under a UV filter
of a flurescence microscope.
Data for all viability experiments (both dissociated cultures and explants)
were analysed and their significance was determined with Student's t-test.
Quantification for GABA immunocytochemistry
Only 'living cells' that were reactive to GABA antibody were counted as
GABA positive cells (because GABA positive dead cells were difficult to identify as
they may be confused with cell debris or artifacts). GABA positive cells were
divided into 2 groups; highly labeled cells and lightly labeled cells. Counts were
made as percentages of the heavily labeled cells and the lightly labeled cells relative
to the total living cells (Figure 4.9).
I was unable to perform GABA reactions using fluorescence
immunocytochemistry. Cell counts with Hoechst according to previous cell viability
criteria cannot be applied in light microscope. Live cells in this experiment were
determined as the phase dark healthy-looking cells producing neurites.
The quantitation of GABA positive cells was tested by analysis of variance
(ANOVA) instead of Student's t-test. This is because I compared also the difference
among different treatment groups in addition to comparing each experimental groups
with control.
92
Summary of the n-numberforthe experiment in this chapter
Experiment mice used
in conditioning/ in dissociation wells
extracts
mice used no. of culture
1. Conditioned medium withdrawal
each group
10 in all of
2. Heat treatment 2
except: cells in 5 days in vitro (DIV) with CCM,
cells in 5 DIV with 85°C 30' CCM,
3 in all groups
n = 4
n = 5
3. Low density with conditioned medium 2
4. High density with conditioned medium 5
2 DIV
5 DIV with el5thcm, el5ccm, el9thcm, el9ccm




n = 10 each
n = 15 each
n = 10 each
5. Extract experiment





n = 4 each
n = 4 each
n = 4 each
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Results
1. Withdrawal of cortical conditioned medium
Dissociated El 5 thalamic cells at high plating density progressively died over
a period of 6 days in vitro (DIV) but around 50% or more of cells survived up until 3
DIV. By the time that corresponded to the period of target innervation in vivo (from
El 8 in vivo or cells > 3 days DIV onwards), the majority of cells did not survive. For
example at 6 DIV the viability was only 1.5 + 1.95 %, unless cells were provided
with the medium preconditioned with the El9 cerebral cortex (CCM) after the first
day of culture (viability = 52.03 + 6.58 % at 6 DIV) (Figure 4.1, 4.2). This trophic
effect was abolished if the CCM was removed and replaced by normal culture
medium. When CCM was withdrawn after 3 days in culture, thalamic cells did not
survive at 6 DIV (viability = 5.05 + 0.4%). Interestingly, if CCM was maintained
until the day before the end of culture period (6 DIV), this withdrawal did not
completely abolish the viability. The thalamic viability in this case was 36.02 +
1.95% (p < 0.05 comparing with 1 DIV culture).
2. Heat inactivation of cortical conditioned medium
In this set of experiments, thalamic viability in all samples was generally
lower than other sets of experiments (viability was below 40% after 2 DIV). I do not
know the reason but it is possibly due to errors during technical-preparation
procedures. When heated at 85°C for as long as 30 minutes, normal culture medium
(CM) was still able to provide essential substances required by the dissociated
thalamic neurons at 2 DIV (Figure 4.3, Table A). The level of survival promoting
effects in the heated culture medium was not significantly different compared with
that in the non-heated control (heated: 38.23 + 5.86 %, control: 37.02 + 1.65 %).
Similarly, heat treatment had no effects in the cultures with cortical conditioned
medium (CCM) in 2 DIV cultures. 2 DIV thalamic neurons with a supply of
preheated CCM or non-heated CCM survived normally (38.86 + 5.39 %, and 39.06 +
2.32 % respectively). This suggested that heat inactivation does not degrade
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Figure 4.1
Photomicrographs of thalamic cells cultured for 5 days (high plating density), stained
with 5pg/ml Hoechst and viewed under a UV-filter on a fluorescence microscope.
(a) With normal culture medium (CM), most thalamic cells die with pyknotic
morphology (red arrows).




Graph showing the withdrawal effects of cortical conditioned medium (CCM) on the
survival in high-density thalamic cultures. Survival of thalamic cells in normal
medium dropped fairly steadily up to 5 days in culture, with the sharpest declination
at 3 days (blue). CCM rescued over 50% of thalamic cells after 5 days in culture
(pink). When CCM is withdrawn on the 3rd, most cells do not survive in 5 day-
culture (orange dotted line). When CCM is withdrawn on the 5th day, survival
percentage of thalamic cells is marginally decreased (light blue).
0 DIV (6h) 1 DIV 2 DIV 3 DIV 4 DIV 5 DIV
Days in Culture
Figure 4.3
Tables showing the trophic effects of cortical conditioned medium (CCM) and
normal culture medium (CM) with heat pretreatment (85°C) on the survival of
dissociated thalamic cells at high plating density.
(a) In 2-day cultures, survival of thalamic cells in either CM or CCM that has been
preheated for 3 or 30 minutes is not different from thalamic cells cultured with fresh
CM or CCM.
(b) In 5-day cultures, most thalamic cells in CM die while CCM promotes thalamic




2 DIV % Survival
without heat 3 minutes 30 minutes
CM 37.02 ± 1.65% 37.37 ± 2.48% 38.23 ± 5.86%
E19CCM 38.86 ± 5.4% 35.73 ± 6.02% 39.06 ± 2.32%
Table B
5 DIV % Survival
without heat 3 minutes 30 minutes
CM 0.39 ± 0.36% 0.39 + 0.39% 0.31 ± 0.27%
E19CCM 39.34 ± 1.96% 40.82 ±3.14% 20.29 ± 2.98%*
(p < 0.05)
molecules present in the normal culture medium within the designed culture period.
Thus, if heat treatment altered the trophic effect of CCM at later stages, it would be
likely that heat treatment reduces the additional trophic molecules rather than reduces
the levels of essential molecules already existing in culture medium before
conditioning.
When cultured for 5 days the cells did not survive either with the heated or
non-heated normal culture medium (Figure 4.3, Table B). Cortical conditioned
medium maintained the viability of thalamic cells at the stage. But when it was
heated for half an hour, survival of thalamic neurons decreased by half of that seen in
the non-heated CCM (20.29 + 2.98 %, compared with unheated 39.34 + 1.96 %,p <
0.05). Thus, the trophic effect of the cortical conditioned medium is heat sensitive.
However, heat treatment for 3 minutes did not reduce the trophic effect of CCM.
3. Effects of various sources of conditioned medium
3.1. Effects on E15 thalamic neurons at high plating density
At high plating density, around 50% or more thalamic cells remained viable
after 2 days in culture. The viability of these cells was not increased in the presence
of any conditioned medium of any tissue explants studied (Figure 4.4a).
At 5 DIV (equivalent to P0 in vivo), El 5 thalamic neurons, which would
nonnally die, did respond to conditioned media obtained from many tissue types
(Figure 4.4b, c). All of the effects were only found in the conditioned medium from
neuronal sources in varying degree. Conditioned media from heart and liver did not
enhance thalamic survival (Figure 4.4c). E19 cerebellar conditioned medium
(CBCM, non-target conditioned medium) promoted thalamic survival at the same
level as E19CCM (effects of E19CBCM = 50.42 ± 4.7%, E19CCM = 50.53 ±3.43
%). This was in contrast to the previous finding that cerebellum had less neurite-
promoting effects on thalamus than cerebral cortex (Lotto and Price, 1995).
95
Figure 4.4
Graphs showing thalamic survival in high-density cultures in response to different
conditioned media.
(a) After 2 days in culture, most thalamic cells at high plating density in all types of
the given medium. Conditioned media had no survival promoting effects.
(b) Survival of thalamic cells after 5 days is reduced markedly in control media.
Medium conditioned with El5 thalamus, El5 cortex, or El9 cortex restores the
viability. However, El9 thalamic conditioned medium rescues only a small number
of thalamic cells.
(c) In the presence of medium preconditioned with other tissues (non-target and non-
thalamic tissues), they only respond to medium preconditioned with neuronal tissue
but not to medium conditioned with heart or liver. El9 cerebellar conditioned
medium has a similar trophic effect to E15THCM, E15CCM and E19CCM. Tectal
conditioned medium produces only a small increase in survival.
Abbreviations: cont: control; E15THCM: El5 thalamic conditioned medium;
E15CCM: E15 cortical conditioned medium; E19THCM: E19 thalamic conditioned
medium; E19CCM: E19 thalamic conditioned medium. E19CBCM: E19 cerebellar
conditioned medium; E19TECM: El9 tectal conditioned medium; E19HEART:
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Conditioned media from other neuronal tissues also had trophic effects on the
thalamic cells. E19 tectal conditioned medium (E19TECM) and E19 thalamic
conditioned medium (E19THCM) significantly promoted thalamic survival (all p <
0.05 compared with 5 days control), although to a much lesser extent (10.69 + 3.73
% and 8.72 + 1.72 % respectively) (Figure 4.4b).
Conditioned medium of tissues of different ages had different effects on
thalamic survival. E15CCM and E19CCM had a similar trophic effect. However,
when I compared the conditioned medium of E15 thalamus (E15THCM) and E19
thalamus (E19THCM) (viability of E15THCM = 51.28 ± 4.4 %, E19THCM = 8.72 ±
1.72 %), E19THCM failed to maintain the high level of survival of the dissociated
thalamic cells. This was not surprising as this result does correspond with the
reduction in the viability of the dissociated thalamic cells at high density on their
own when were cultured for more than 3 days (> El8).
3.2. Effects on E15 thalamic neurons at low plating density
In 2 DIV cultures, thalamic cells taken from El 5 embryos survived well at
high plating density. As seen in Section 3.1, conditioned media had no trophic effects
on high-density thalamic cells. This raises two possibilities that either early thalamic
cells do not respond to trophic factors from any conditioned medium or increase in
intrinsic trophic molecules and/or cell-cell interaction present in high density is
sufficient to maintain the cell viability. To test these possibilities, I lowered the
plating density and retested the effects of the conditioned media.
In 2 DIV low-plating density cultures, only 30.88 + 5.83 % of the thalamic
cells survived. Thalamic cells at this condition were promiscuous to trophic factors
from several tissue types. All conditioned media had the same trophic effects on low-
density cells (Figure 4.5). No difference in trophic effects was found among the
effects of these media (p > 0.05). Contrary to the effects on 5 DIV at high density,
E19THCM was sufficient to promote thalamic survival of 2 DIV low-plating density
cultures at the same level as E15THCM, E15CCM, and E19CCM.
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Figure 4.5
Graph showing survival of thalamic cells in low-density cultures after 2 days in
response to different conditioned media. Survival of thalamic cells was promoted to
the same extent by all conditioned media including E19 thalamic conditioned
medium (p < 0.05 when any treatment is compared with control, p > 0.05 when any
treatment is compared with the others).
Abbreviations: as in Figure 4.4.
control E15THCM E15CCM E19THCM E19CCM
Culture Medium
The thalamic viability promoted by conditioned media at low density was
around the same level as the viability in high plating density. This suggested that at 2
DIV, cells survived at high plating density environment were due to the local release
of diffusible trophic molecules. In addition, evidence that E19THCM was able to
promote early thalamic cells at low density at the same level as other conditioned
media suggested that its low-but-significant trophic effects on 5 DIV high-density
thalamic cultures was not an artifact.
4. Testing the trophic factors productivity of the maturing thalamus
Intrinsic trophic efficacy of the thalamus is reduced as the tissue matures. In
section 3.1, E19THCM promoted thalamic survival in a much lesser extent than
E15THCM. Two possible explanations for this include:
1) A reduction in production of thalamic derived neurotrophic factors: the internal
clock of the thalamus tells it not to produce the trophic factors required by it and start
to depend on trophic factors from other sources.
2) A reduction or switch in the responsiveness to autocrine/paracrine thalamic
derived trophic factors: thalamic cells may switch or narrow their trophic
requirement and no longer respond to trophic factors produced by themselves.
However, my observations indicated that the second possibility is less likely
because thalamic cells at 5 DIV (equivalent to PO in vivo) were able to respond to the
trophic factors that they produced at E15 (E15THCM) and still responded (although
weakly) to conditioned medium from E19 thalamus. To test whether El 9 thalamus is
able to produce diffusible trophic factors or thalamic cells cultured for 5 DIV (around
PO in vivo) lose their ability to respond to the intrinsic factors, I derived two
approaches to increase the amount of the released trophic factors from several
neuronal tissues to be added to the dissociated thalamic cells: 1) by homogenisation
technique and 2) by increasing activity of the explants that had been used for
conditioning medium.
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4.1 Effects of homogenated thalamic and cortical extracts on
dissociated thalamic cells
In this experiment I used El 5 and E19 thalamic or cortical extracts in an
attempt to rescue dissociated thalamic cells that had been cultured for 5 DIV.
However, none of these tissue extracts promoted thalamic survival of 5 DIV cells.
Instead, some of them had toxic effects early on 2 DIV dissociated thalamic cells. In
these 2 DIV cultures, viability of dissociated cells with the added El 5 thalamic or
El5 cortical extracts survived with a similar degree as control cultures (without
added tissue extracts) (around 50%) while addition of El 9 thalamic and El 9 cortical
extracts killed all dissociated cells.
To test whether the toxic effects of E19 thalamic and E19 cortical extracts is
due to the high concentration of the extracts, I diluted E19 thalamic and E19 cortical
extract in 1:10, 1:100, and 1:1000 of the first concentration I tested. None of these
concentrations rescued thalamic dissociated cells.
4.2 Effects of thalamic and cortical conditioned medium of different
ages; with K+ added to the conditioned explants
When the first attempt to study the trophic effects of El 9 thalamus by direct
tissue extraction failed, I tried another approach to increase trophic production by
increasing the activity and viability of E19 explants used for conditioning medium.
KC1 has long been used for depolarising neuronal tissue and it hence
increases neuronal activity. K+ enhances production and release of trophic molecules
from several types of neuronal tissue (Ghosh et ah, 1994; Magowan and Price, 1996).
More importantly, the addition of K+ also promotes survival of certain neuronal
populations (particularly thalamus) during particular developmental periods e.g.
Magowan and Price (1996) showed that El9 thalamic explants cultured for 3 days
did not survive but addition of K+ rescued most of the thalamic cells in the explants.
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As it is probable that the low trophic effects of E19THCM is due to the
reduction in viability of the El 9 thalamic explant used for conditioning medium, I
thus added K+ at concentration of 0.05mM, 0.5mM, 5mM, and 50mM either to
medium used for conditioning explants of El 5 thalamus, El 9 thalamus, El 5 cortex,
El9 cortex, or directly to dissociated cultures. These are the concentrations used in
Magowan and Price (1996). I then measured viability of both explants used for
conditioning medium and dissociated thalamic cells in different conditioned media
with added K+.
4.2.1) Assessing the viability of explants that had been used for conditioning culture medium
with the addition of K7.
Before studying the viability of thalamic cells in conditioned media with
added K+, viability of explants cultured with different concentrations of K+ was first
assessed (Figure 4.6, Figure 4.7a). This was to test whether addition of K+ modified
explant viabilities and to see if the viabilities of dissociated cells with different
conditioned media correlate with the viability of conditioned explants treated with
K+.
El 9 and P2 thalamic explants without K+ could not survive, and all cells in
all explants with added 50mM K+ died. Survival cortical explants treated with K+ at
concentration lower than 50mM were not significantly different from the viability
El9 cortical explant without K+ (viability = 70-80%). P2 cortical explants were also
unaffected with 0.05-5mM K+, but had a slight lower viability (60-75%). Survival of
P2 thalamic explants was low and was not increased with K+ treatment. Survival of
El9 thalamic explants which is normally low in normal medium was increased with
the addition of K+ in a concentration-dependent manner.
4.2.2) Increased viability of thalamic cells in dissociation in E19THCM with added K.
Except for the 50mM K+ concentration which is the toxic dose which killed
all cells, 2 DIV dissociated cells in culture medium with direct addition of K+ in all
other concentrations survive normally. Direct application of K+ did not promote
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Figure 4.6
Photomicrographs showing explants used for conditioning medium.
(a) E19 thalamic explant without addition of KC1: viability is poor and many cells
become pyknotic.
(b) El9 thalamic explant with KC1: many cells still survive at 24h.
(c) El9 cortical explant: most cells have large nuclei and diffuse chromatin
















Graphs showing viability of (a) explants that had been used for conditioning medium
with addition of K+ and (b) dissociated thalamic cells after adding different
conditioned media from tissues that had been pretreated with K+. Addition of 50mM
K+ is toxic to both dissociated thalamic cells and cells in the explants.
(a) In El9 thalamic explants that have been used for conditioning medium, the
survival was enhanced by the addition of K+ in a dose-dependent manner after 24h in
cultures. Addition of K+ did not increase the survival P2 thalamic explants. Neither
El9 nor P2 cortical explants respond to KC1.
(b) Dissociated thalamic cells in control medium do not respond to the addition of K+
below 50mM.
Survival of dissociated thalamic cells cultured for 5 days was promoted by
E19THCM-K+ in a dose-dependent manner to the amount of K+ that has been added
in conditioning.
Addition of K+ at the concentration below 50mM to the preconditioned medium did
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survival of 2 DIV thalamic cells. None survived at 5 DIV (see control group with
added K+ in Figure 4.7b). This study excluded the possibility that the increased
viability of the dissociated cells in any media conditioned with added K+ is due to the
direct effects of K+ but is due to the trophic release from the explants used for
conditioning.
Thalamic and cortical explants at El9 and P2 were used to condition the
media with different concentrations of added K+. Conditioned media with K+ were
then added to 24h-dissociated thalamic cells. At 5 DIV, the survival of dissociated
thalamic cells in E19THCM with added a K+ (E19THCM-K) was increased {p < 0.05
control) (Figure 4.7b). This was dose-dependent (viabilities ranging from OmM,
0.05mM, 0.5mM, 5mM K+ in El9THCM-K = 19.24 ± 2.78 %, 29.48 ±2.18 %,
54.32 + 3.64 %, 51.7 + 6.6 %). None of the media conditioned with 50mM K+
promoted thalamic survival in dissociated cultures. El9 and P2 cortical conditioned
media with added < 0.5mM K+ (E19CCM-K and P2CCM-K) promoted thalamic
viability normally (around 50% survival). P2 thalamic conditioned medium showed a
slight survival promoting effect on the dissociated cells (7-12 %) but P2-THCM-K+
did not increase the dissociated cell survival.
5. Effects of thalamic and cortical conditioned medium on the population of
GABA immunoreactive cells
The vast majority of cells in 2-day culture was completely negative for
GABA (~ 83%). This suggested that the proportion of interneurons in cultures was
low (similar to in vivo, Arcelli et al., 1997). In 5-day culture, most thalamic cells died
while the surviving cells were mostly immunopositive to GABA antibody (Figure
4.8c, 4.9). It is less likely that the increase in GABAergic ratio in this culture was
due to the in vitro differentiation inducing cells to become GABAergic, because 1) I
rarely observed many dead cells that were immunopositive to GABA in this culture
(see Figure 4.8c) and 2) the numbers of GABA positive cells in each window in this
culture were always lower than the numbers of GABA positive cells in other cultures
(comparing Figure 4.8c to Figure 4.8d). This implied that GABAergic neurons




Photomicrograph showing immunohistochemistry for gamma-amino-butyric acid
(GABA) in high-density dissociated thalamic culture.
(a) Negative control, when anti-GABA antibody is omitted.
(b) Negative control with pre-adsorbed GABA antibody; anti-GABA antibody was
pre-incubated with GABA molecules (1:100) before reacting with the samples.
(c) Immunoreaction for GABA positive cells in 5-day thalamic cells cultured in
normal culture medium (CM). Most cells die in normal culture medium and most
surviving cells are GABA positive (as seen by dark brown color).
(d) Immunoreaction for GABA positive cells in 5-day thalamic cells cultured in
cortical conditioned medium (CCM). Darkly labeled cells, lightly labeled, and
negatively labeled cells are shown by red, green and white arrows accordingly.




Graphs showing distribution of GABA positive cells in thalamic cultures. When
comparing percentages of GABA positive cells in proportion to total living cells in
culture, GABA positive cells (supposedly interneurons) are present in small
proportion in 2-day with normal medium cultures and in 5-day cultures with
E15THCM, E15CCM, E19CCM, and E19THCM-K+ (around up to 10% darkly
labeled ratio or lightly labeled cells), while in 5-day cultures with normal or with
E19THCM (without K+), proportions of GABA positive cells are increase as the non-
GABAergic cells die without enough trophic support.
2DIV 5 DIV E15THCM E15CCM E19CCM E19THCM E19THCM/K+
culture medium
with other type of cells. Application of E15THCM (but not E19THCM), E15 or
E19CCM promoted overall thalamic survival and the proportions of GABAergic
cells (both darkly and lightly labeled populations) were in the same proportions with
surviving cells as in 2-day culture (without statistical differences) (Figure 4.9). These
cultures had lower percentages of GABAergic cells than 5-day cultures without
conditioned media. However, in 5-day cultures with E19THCM, where overall cell
survival was promoted slightly (< 10%), the ratio of living GABAergic positive cells
to the total of living cells was lower than in a 5-day control but significantly higher
than with other conditioned media. This was possibly because the E19THCM had
low trophic effect on promotion of non-GABAergic cell survival and the result was




Thalamic cells that have been in culture for longer than 3 days cannot survive
without external trophic support. This trophic requirement lasts until at least around
the time of birth (5-6 DIV). Removal of the diffusible trophic factors at any time
during the culture period would result in an increase in cell death. These trophic
factors, although currently unknown, likely include molecules that are sensitive to
heat inactivation such as proteins. The trophic support, however, is not only present
in the major target (cerebral cortex), but it can also be found in conditioned media
obtained from other main regions. The sources of these trophic molecules are
restricted to neuronal tissues and the molecules are not found in other non-neuronal
tissue such as heart or liver. Whether or not the trophic effects found within different
neuronal sources come from the same neurotrophic factors is still unclear. It is also
not known whether the mechanisms that promote thalamic survival are likely to
control neuronal outgrowth or vice versa. Additionally, it is important to discuss here
the role of the intrinsic property of the thalamus before and after the target
innervation period and the switch in its requirements.
Possible trophic substances to be presented in conditioned medium
Many types of conditioned media applied to El 5 low-density thalamic cells
(where there are less cell-cell interactions) can mimic the trophic effect presented in
El 5 high plating density cultures. The conditioned media must therefore contain one
or more essential trophic substance(s). Withdrawal of these substances produces
similar results to the withdrawal of neurotrophins or FGF deprivation that has been
previously demonstrated (Lotto et al., 1997). Together with the in vitro BDNF
experiments done in collaboration with Dr. Beau Lotto (see Chapter 3), this result
strongly ensured that at least one factor that thalamic cells require from the
conditioned medium is likely to be a neurotrophin (i.e. BDNF in particular), and 1
further tested whether the trophic molecule is likely to be protein by heat treatment. I
found that viability of thalamic cells was reduced if the cortical conditioned medium
is heated for 30 minutes. However, there is still a possibility that other trophic
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factors, in addition to neurotrophins, are involved. This is because heat inactivation
cannot completely abolish the neurotrophic effects of the conditioned medium, and
the molecules seem to be relatively stable as short exposure (3 minutes) of heat
cannot reduce their trophic effects.
Some extracellular matrix substances are among candidates for these trophic
substances. Several members of proteoglycans such as chondroitin sulfates, and
heparan sulfates and kerantan sulfates abundantly found in neuronal tissues may have
either growth inhibiting or growth promoting effects, depending on the types of the
molecules and the populations of cells (i.e. one type of molecules may have different
effects when present in different populations) (Emerling and Lander, 1996).
Generally, most proteoglycans are found to inhibit neurite outgrowth in many
neuronal systems (see review by Holm and Isacson 1999) but heparan sulfate was
found to have growth promoting effects on thalamic axons (Kinnunen et al., 1999).
Additionally, this molecule also helps increased bioactivity of basic-fibroblast
growth factor (bFGF) (Nissen et ah, 1999), which is also known to promote thalamic
survival and outgrowth (Fotto et ah, 1997; Lotto and Price, 1995). More importantly,
most chondroitin sulfates are relatively more stable to temperature treatment than
ordinary proteins or peptides (Volpi et ah, 1999). Moreover, Lander and colleagues
showed that cortical conditioned medium contains chondroitin sulfate proteoglycan
(Lander et ah, 1998). This might help to explain the remaining trophic effects of the
cortical conditioned medium after heat treatment.
Specificity of trophic factors in conditioned medium from other tissues
Hisanaga and Sharp (1990) first showed that in addition to target cortical
neurons, non-target cerebellar cells also produce a prominent trophic effect on
thalamic neurons. In this study, 1 investigated further whether other structures also
have a stimulatory effect on thalamic survival. I found the trophic factors required by
thalamic cells are likely to be present only in neuronal tissues. Thus, 1) cells
responsible for producing such trophic factors are specifically or preferentially either
neurons or glia and 2) the level of factors produced may be different in different CNS
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structures. Two candidates that fit both characteristics are neurotransmitters and
neurotrophins.
Although several CNS tissues tested produced trophic effects on maturing
thalamic cells, it is not know whether these are the same trophic factors that
specifically promote thalamic survival. However, the choices of possible trophic
molecules essential for survival of the late thalamus may be limited since thalamic
neurons lose trophic promiscuity and have more specific trophic requirement as they
mature. For example, the cells lost their ability to respond to several neurotrophins
but still require BDNF as they mature (Chapter 2, Lotto et ah, 1997). This suggests
that trophic molecules that are found in different CNS tissues, which promote
thalamic survival, could be the same molecules. However, to precisely answer this
question, isolation and identification these trophic molecules individually presented
in each CNS structure are required.
In vitro, thalamic cells respond to various sources of trophic factors, however,
this does not necessary mean that the cortical target is not the major/specific source
of trophic supply for thalamic cells in in vivo. Apart from autocrine responses, it is
believed that neurons obtain their trophic support via their target innervation
(Oppenheim, 1999). As the animal matures, production of trophic factors for
thalamic cells need thalamocortical activity (Ghosh, 1996). In addition, trophic
factors produced by the thalamus itself are reduced as the thalamus matures
(comparing the trophic effects of E15THCM and E19THCM), and this requirement
seems to correspond with the period of target innervation and programmed cell
death. Therefore, it is still acceptable to believe that the majority of the late
embryonic thalamic cells require and obtain trophic support from the cortical target.
Study of trophic effects of K+ and homogenated thalamic and cortical extracts
K+ increases the viability of the thalamic explants but not the viability of
thalamic cells in dissociation. A possible explanation is that the action of K+ needs an
intact and high degree of thalamic organisation (e.g. intrathalamic connections, and
axonal formation) which is preserved in the explants but not in dissociation.
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Dissociated thalamic cells have to adapt in to a new environment and may have lost
their original intrinsic activity. Thalamic cells taken from E15 embryos mostly die
after 3 days in dissociated cultures while most still survive in explant cultures.
Tissue extracts have been introduced in several studies for the isolation and
identification of neurotrophic factors (Yin et al., 1992; Sato et al., 1997). For
example, survival of chick motoneurons is promoted by chick muscle extracts (see
Sato et al., 1997) and conversely, extracts of nerve tissue can enhance the
development of chick embryonic muscle (Oh, 1976). Although many have found
trophic effects in many types of tissue extracts, the identification of the trophic
molecules is often unsuccessful. Contrary to those reports, I did not find any trophic
effects of neuronal tissue extracts on thalamic survival. In addition, El 9 cortical
extracts were even toxic to the thalamic cells. Survival of thalamic neurons might
depend on the balance between growth promoting and growth inhibiting factors. In
this case, the effects of neurotoxic substances may overcome the effects of trophic
factors.
Regulation of thalamic survival by activity-dependent mechanisms and
trophic factors signaling: A possible interaction of the two.
The interaction between activity and neurotrophins is essential for neuronal
growth and survival (McAllister et al., 1996). It is not known whether interaction
between both are in linear, ordered relationship (activity promotes
production/secretion of trophic factors; activity trophic factors survival, or
neurons may primarily need activity to survive but trophic factors may help
strengthen the synapse formation and increase the survival; trophic factors
activity survival). It is also possible that neuronal survival may need both trophic
factors and maintenance of activity in a complex mechanism (neurotrophic factors +
activity survival) (see McAllister et al., 1996). Increasing evidence suggests that
activity enhances trophic release and hence promotes survival. Depolarising agents
such as KC1 and glutamate have been shown to enhance survival of central neurons
in vitro (Ghosh et al., 1994; Cohen-Cory et al., 1991; Meyer-Franke et al., 1995).
This mechanism has been shown to involve intracellular Ca++ signaling and trophic
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factors release (Finkbeiner and Greenberg, 1996; Ghosh et al., 1994; Cohen-Cory et
al., 1991; Meyer-Franke et al., 1995; Magowan and Price, 1996). Both in vitro and in
vivo, neurotrophin production and secretion are regulated by electrical and synaptic
activity (Castren et al., 1992; Lindholm et al., 1994; Schoups et al., 1995; Blochl and
Thoenen, 1995; 1996; Goodman et al., 1996).
However, depolarisations by KC1 and by glutamate act via different Ca++
channels. Trophic effects of K+ is thought to act via voltage-sensitive calcium
channels (VSCCs) and induce release of neurotrophic factors (Ghosh et al., 1994). In
my experiment, I have also shown that K+ depolarisation can induce release of
trophic substance(s) in the El9 embryonic thalamic explants and hence promote
survival of dissociated thalamic neurons. In contrast, the mechanism of trophic
effects of glutamate in vivo is still unclear. Ghosh et al. (1994) found a small
neurotrophic effect by activation of kainate receptors but not by NMDA receptors. In
contrast, by experiment applying APV antagonist for NMDA receptor, Magowan and
Price found that glutamate likely to promote thalamic survival via NMDA receptor
(unpublished results). Whether or not glutamate increases trophic factors to promote
neuronal survival remain to be investigated.
In vivo, survival of thalamic neurons may require the release of
neurotransmitter such as glutamate (from the thalamic neurons themselves, from
their afferent inputs, or from the retrograde target-dependent activity) or electrical
depolarisation, which consequently increase the release of trophic molecules.
However, neither K+, glutamate, nor neurotrophins are sufficient to prolong the
trophic effects on thalamic neurons at the postnatal stage (Magowan and Price, 1996;
Magowan and Price, unpublised data; Lotto et al., 1997). The regulation of
programmed cell death may need additional control, the intrinsic regulation of timing
such as the control of bcl-2 expression (see below).
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Growing thalamus: Thalamic viability, age related trophic requirement and
possible role of extracellular matrix
The progressive loss of the ability of dissociated thalamic cells to survive
with time in culture may be due to several reasons. The first simplest explanation is
that cells are dying over the time in culture as a result of the consumption of nutrients
and accumulation of waste/toxic substance in culture medium. However, this is
unlikely to be the case since replacing culture medium cannot rescue thalamic cells
that have been cultured for longer than 3 days and the thalamic cells are strongly
dependent on the conditioned medium.
The peak of cell death of thalamic cells in culture (E17-E18 in vitro) preceeds
the normal period of thalamic PCD (from PI) in vivo. This can be explained by 1) the
adaptation to the new environment that may induce the maturation or susceptibility
to death of thalamic cells, 2) the lack of trophic substances which are normally found
in the thalamus at E17-P0. In vivo, it is possible that this late gestation may be the
window period that thalamic cells prepare themselves to become dependent on their
cortical target. Concomitantly, brain is increasing extracellular space and producing
extracellular matrix, which includes proteoglycans (Holm and Isacson, 1999). In
many cases, extracellular matrix is thought to be neuronal inhibitive to neurite
outgrowth although it is still controversial (Holm and Isacson, 1999; Nissen et ah,
1999). It is possible that the increase in extracellular matrix may reduce cell-cell
interaction and neuronal activity within the thalamus and reduces the intrinsic trophic
production, and thus forces the thalamic cells to become dependent on their cortical
target via thalamocortical axons.
Switching in trophic dependence of thalamic cells: Specificity in cortical target
dependency but not specificity in trophic responsiveness
At the time corresponding to in vivo E17-P0, cultured thalamic cells
progressively lose their ability to survive and grow in vitro. Many have previously
described cortex-derived growth factors may be the major influence to the regulation
of thalamic survival and growth which corresponding to time of cortical target
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innervation (Cunningham et al., 1987; Price et al., 1995). Similar findings on
regulation of neuronal survival by target were also reported in other neuronal
systems. Many types of neurons are transiently supported by other neurotrophic
factors early in their development before they switch their trophic responsiveness and
become dependent to their target derived factors (Davies, 1994a). However, I found
that thalamic cells aged at the time of target innervation did not switch off the ability
to response to the self-produced (thalamic-derived) neurotrophic factors. This
suggests that target dependency does not always correspond with selective
responsiveness to the trophic factors released from the target tissue. This finding
does not correspond to the previously described trophic switch hypothesis which
states that cells would lose both responsiveness and self production of theirs own
trophic factors before becoming dependent on target (Davies, 1994a).
Cortical conditioned media of different ages (E15-P2) promote thalamic
survival to a similar degree. However, the trophic effects of the condition medium
from the thalamus of different ages are varied. Thalamic cells responded to
E19THCM but in a much lower degree than the E15THCM. With the addition of K+
on the E19 thalamic explants, E19THCM-K had similar effects as E15THCM. This
suggests that thalamic cells did not lose ability to respond to the trophic factors
released endogenously but instead, they may lose the ability to produce sufficient
quantities of trophic supply. Intrinsic factors may set the clock for thalamus when
they have to become dependent on the target by the regulation of trophic production.
This regulation for the loss in the intrinsic property in the maturing thalamus will be
discussed below.
Intrinsic mechanism regulating thalamic survival and signaling for switching in
trophic dependence
Intrinsic mechanisms may play a key role in regulation of thalamic viability
before their axons innervate their target (Davies, 1994a). The intrinsic signaling in
addition to the extrinsic factor signaling (Holm and Isacson, 1999) may trigger the
loss in the intrinsic viability. This intrinsic regulation involves the local cellular
activities such as metabolism, electrical or biochemical activities within the cells or
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communication, and genetic internal clock (Magowan and Price, 1996; Holm and
Isacson, 1999). Certain apoptotic regulating genes may be involved in this thalamic
survival regulation. For example, bcl-2 (anti-apoptotic) and possibly bax (pro-
apoptotic) genes are thought to be in a central mechanism regulating PCD in many
neuronal systems (Pettman and Henderson 1998). bcl-2 is expressed in the CNS
during the middle to late gestational period and its expression is down regulated at
the time of birth, persisting in regions with late differentiation, such as the dentate
gyrus (Merry et al., 1994). This correlates with the period of in vivo peak of the
thalamic PCD (see Chapter 3). Bcl-2 production declines with age in most CNS
neurons (Holm and Isacson, 1999). The pattern of the bax/bcl-2 expression ratio
corresponds with the timing of neuronal death in the rat cortex and thalamus
(Mooney and Miller, 1999). Furthermore, Bcl-2 has a neuroprotective effect against
neurotrophin deprivation in many types of neurons and some think that it is the
intrinsic instructive gene controlling the time of PCD (Allsopp et al., 1993; Holm and
Isacson, 1999).
Outgrowth vs. survival promoting effects of trophic factors in conditioned
medium
Trophic derived growth factors obtained from non-target E19CBCM,
E15THCM, and K+-induced E19THCM (E19THCM-K) increased thalamic cell
survival at the same degree as the target E19CCM. However, previous report showed
that thalamus co-cultured with different CNS tissues had different degrees of
thalamic outgrowth. Cerebellum and thalamic explants enhanced less outgrowth than
cerebral cortex explants did (Lotto and Price, 1996). Despite the fact that less viable
cells produce less outgrowth (Magowan and Price, 1997), the converse is not
necessarily true: enhanced viability does not necessarily produce enhanced
outgrowth. The relationship between thalamic viability and growth may not be
simple. For example, K' promotes both survival and outgrowth of E13-E17 thalamic
explants but only promotes survival without enhancing neurite outgrowth of thalamic
explants at El9. It is thus possible that outgrowth and survival promoting effects of
K are mediated by different proteins (Graham & Burgoyne, 1993; Magowan and
Price, 1997).
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It is not known whether these trophic factors rescuing thalamic cells are the
same as that found in all conditioned mediums from several neuronal sources used in
this study. This issue remains to be further investigated.
Conditioned medium did not affect GABAergic subpopulation in the thalamus
The thalamus consists of several subpopulations of neurons. Most thalamic
neurons are projecting cells that innervate cortex (thalamocortical cells) while some
smaller proportions of thalamic cells are GABAergic intemeurons. My experiments
aimed at 1) testing whether the thalamocortical projecting neurons obtain
neurotrophic support from their cortical target, in particular, the target at the age of
thalamocortical innervation (E19CCM) and 2) testing whether GABAergic thalamic
intemeurons which axons are confined to thalamus were independent on cortical-
derived trophic factors but possibly on thalamic derived trophic factors. I first
predicted that 1) E19CCM would increase more proportion of projecting neurons
than other test conditioned media and 2) E15THCM, E19THCM, E19THCM-K
would either promote or sustain the same level of GABAergic neurons.
Thalamic cells without conditioned medium die at 5DIV, 2DIV (El7 in vitro)
were thus used as control samples. This may cause an inaccuracy in the estimation of
the proportion of GABAergic cells because the El 7 in vitro cells may be less
differentiated than El9 in vitro cells. However, neither E15CCM nor E19CCM
altered the proportions of GABAergic and non-GABAergic populations in 5 DIV
cultures. Percentages of GABAergic populations were also similar among
E15THCM, and CCMs. This suggests that all conditioned mediums may only sustain
overall viability of thalamic cells, does not selectively rescue specific subpopulations
or involve in GABAergic differentiation.
Considering the GABAergic population, the surviving thalamic cells at 5 DIV
are mostly GABAergic cells. Numbers of GABAergic cells are relatively and
similarly low throughout all treatments. This suggests that the GABAergic cells may
be independent to any conditioned medium.
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Summary
In conclusion, I found that trophic dependency in the thalamus is not only
regulated by extrinsic factors but also by the intrinsic factors. The switch in trophic
dependence to the target support may still exist but with different mechanisms i.e.
thalamic cells may not reduce the trophic responsiveness but the production of
sufficient intrinsic trophic factors. Thalamic cells also respond to trophic factors
present in other CNS tissues than the thalamus and the cortex.
There are other important questions remain to be further investigated. These
include: the identification of the intrinsic factors regulating thalamic survival, the
mechanisms underlying switching of thalamic cells to extrinsic dependence, and the
characterisation of the neurotrophic molecules in condition media obtained from
cerebral cortex as well as different neuronal sources of tissue.
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Chapter 5: In vitro studies in the thalamus of mice lacking
neurotrophin tyrosine kinase receptors
Introduction
Previous studies have shown that neurotrophin signaling is required for
survival of late embryonic and postnatal thalamic neurons that have innervated the
cortex (see Chapter 3; Alcantara et al., 1997). In mice lacking Trk receptor genes,
such as trkB-/- mice, there is a significant increase in cell death in different regions
of the thalamus around E17-P1 (see Chapter 3) and in late postnatal life (after P8,
Alcantara et al., 1997). However, the increases in these in vivo studies are subtle
(occurring at low rates), and no marked increase in cell death appeared before El 5.
Moreover, the gross morphology of the thalamus of these mutants still appeared
normal (Klein et al., 1989). Possible explanations for the subtlety of the effects
include compensation by other neurotrophins or an overlap in the functions of Trk
receptors (Ernfors et al., 1992; Merlio et al., 1992).
In a system isolated in tissue culture, any compensation mechanisms
involving neighboring or target tissue would be reduced. Organotypic slice cultures
have previously been used to study the effects of axotomy on the survival of
developing trkB-/- hippocampal neurons that have already reached their target fields
(Alcantara et al., 1997). In thalamus, the in vitro defects resulting from Trk
knockouts have not been studied. In this Chapter, I used an in vitro approach to
investigate the survival of thalamic neurons of mice with mutated trkB or trkC genes
at the ages before and after innervation of the cortex. Ideally, I would have carried
out a dissociation technique that would also reduce the chance of compensatory
effects produced intrinsically within the thalamus. However, there are difficulties
since I would have had to dissociate each embryonic thalamus individually and
genotype it before cells were plated and labeled. This approach seemed impossible.
Instead, organotypic thalamic explants were used in this study and I identified their
genotypes retrospectively by PCR.
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In the first set of experiments, I isolated El 5 thalamus of wild type, trkB-/-,
and trkC-/- embryos to compare their viability in vitro. The thalamus at this age has
begun to extend its fibers but they have not reached the cortical plate (Rennie et al.,
1994; Auladell et ah, 1999). This experiment was to investigate if the thalamus of the
mutant mice depends on Trk signaling in vitro at this early stage in the absence of
neighboring or target tissues as compared to in vivo where there are no differences in
rates of cell death among the wild types and the mutants. Next, I cultured El 9 mutant
and wild type thalamic explants to observe their survival at the period of innervation.
However, the survival of the thalamic explants of wild type, trkB-/-, and trkC-/-
embryos are low at this later age and this made it difficult to observe any differences
in the viability in mutants (see Results).
As a result of the low survival rates and difficulties in comparing the survival
of the older wild type and mutant thalamic explants, I added K+ to the El 9 explants
to increase their survival to the level at which they can be compared. K+ is widely
used to non-specifically depolarise neuronal membranes and enhance levels of neural
activity, which will be increasing in this perinatal period in the thalamus, largely due
to the onset of spontaneous activity in the peripheral sensory receptors (Shatz and
Stryker, 1988). Activity can then stimulate the embryonic thalamus to grow and
survive (Magowan and Price, 1996). However, the mechanisms by which K+
promotes thalamic survival may be complex and the K+ addition may trigger
production of several other trophic signaling molecules than neurotrophins (Ghosh et





Mice heterozygous for targeted mutations in trkB or in trkC sequences
encoding the catalytic domains of the TrkB or TrkC tyrosine kinase receptor
isoforms (Klein et al., 1993; 1994) were used. Heterozygous trkB or trkC mice were
mated to give wild type, heterozygous, and homozygous embryos. Embryos were
removed at the assigned stage of pregnancy. Parts of the embryos (either legs or tails)
were removed for PCR genotyping (see Chapter 3). Wild type and homozygous
{trkB-/- or trkC-/-) thalami were dissected from foetal brains of El 5 and El 9 mice.
Explant culture procedure & histology
The thalamic explants were sliced on a Mcllwain tissue chopper at 350
microns and placed in pre-incubated defined serum-free culture medium (Romijn et
al., 1984). After culturing for 3 days at 37°C in 5% CO2 with 95% humidity, the
tissues were fixed in 4% paraformaldehyde and embedded. Embedding processes
were done as described in Chapter 2. Sections were cut at 10pm and mounted on
poly-/.-lysine coated slides.
Addition of K+
5mM KC1 (the concentration known to promote thalamic survival, Magowan
and Price, 1996) was added to the serum-free culture medium used for wild type and
mutant El9 thalamic explants.
Counts and analysis
To assess the viability of organotypic thalamic explants that had been
cultured alone for three days, four explants of each age tested (El 5 and El 9) were
fixed, the slides of the explants were stained with lpg/ml Hoechst, and mounted with
Vectashield (Vector). For each of five equally spaced sections taken from
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approximately the middle of each explant, the number of pyknotic cells (dead or
dying cells) per total number of cells seen in the 10 x 10 pm square grid window
were counted. Viabilities of the wild type thalamic explants either versus the trkB-/-
explants or versus the trkC-/- explants were compared using Students' t-test.
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Results
1. E15 thalamic explants
Similar to the previous findings, cells of the El 5 wild type thalamic explants
cultured for 3 days maintained high levels of viability (80.62 + 5.2%, n = 4). At this
age, survival in the explants of mutant thalami (both trkB-/- and trkC-/-) was about
the same level as that in wild type explants (Figure 5.1, n = 4 each, viability = 83.37
+ 3.12 % and 82.66 + 3.5 % respectively). There was no significant difference in
survival among these explants (p > 0.05). These results suggested that TrkB and
TrkC signaling are not required for survival of thalamic cells of this age, which is
before target innervation and target dependence.
2. E19 thalamic explants, without K+
At El 9, the age around the time of cortical innervation, survival of thalamic
cells in wild type and in mutant explant cultures was poor (Figure 5.2a, 5.3a; 9.73 +
4.2% for wild type, 7.06 + 1.93 % for trkB-/-, and 7.5 + 1.22 % for trkC-/-; n = 4
each).
There was no statistical difference in survival among these thalami. However,
since the percentages of surviving cells were low, those surviving may represent only
certain subpopulations which do not require these neurotrophic signaling in vivo.
Thus it was not known if the rest of the cells at El 9 that can normally be rescued by
K require TrkB or TrkC signaling. I then used K+ at 5mM (the KC1 concentration
known to produce the highest thalamic cell viability) to increase thalamic activity to
compare the viability in wild types and mutants.
3. E19 thalamic explants, with K+
With the addition of K+ to serum-free culture medium to promote survival of
the mutant and wild type thalami, I predicted that 1) survival of all thalamic cells
116
Figure 5.1
Graph showing viability of El 5 wild type and the trk mutant thalamic explants:
survival of thalamic explants from both trkB-/- and trkC-/- embryos is as high as
of the wild type. No significant difference is found.
%sruvival
Figure 5.2
Photomicrographs of thalamic explants stained with Hoechst.
(a) El9 wild type explant without K+ treatment; most cells die. (b) El9 wild type
explant with 5mM K+. (c) El9 trkB-/- thalamic explant with 5mM K+. (d) El9 trkC-
/- thalamic explant with 5mM K+. Over 60-70% of cells in (b)-(d) survive. Red





























































Graphs showing viability of El 9 wild type and the trk mutant thalamic explants.
(a) El9 thalamic explants without K+ treatment: most thalamic cells in either wild
type or the mutants die. No significant difference in survival rate is found.
(b) El9 thalamic explants with K+ treatment: K+ promotes thalamic viability in both
wild type and mutant explants equally. No significant difference is found.
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should be increased due to the increased activity; 2) if this K+ effect is modulated by
the release of neurotrophins (such as BDNF, NT-4/5, or NT-3), the thalamic explants
from trkB-/- and trkC-/- mice should show less survival than those of wild type mice.
In this experiment, I found that the viability of thalamic cells in El 9 explants
was markedly promoted in wild type, trkB-/-, and trkC-/- explants (Figure 5.2b-d,
5.2b, n = 4 each; 63.26 + 4.85 %, 57.46 + 9.25 %, and 60.92 + 6.42% respectively).
This indicates that the survival of thalamic cells at this age is activity dependent and
that this activity dependent survival is not mediated by either TrkB or TrkC.
Moreover, I failed to show the increase in cell death of trkB-/- thalamus which I
previously demonstrated in vivo. No statistical differences in survival among the El9
thalamic explants of wild type, trkB-/-, and trkC-/- mice in the presence of K+ were
observed. Some possible explanations will be discussed below.
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Discussion
The main purpose of this study was to assess the viability of embryonic
thalamic cells from mice lacking TrkB or TrkC in vitro. Initially, I cultured the
explants with the intention of establishing an in vitro system for further studies of the
mutant tissue. Organotypic culture would normally provide an isolated system for
specific studies such as the effects of K+ depolarisation (Magowan and Price, 1996),
the thalamocortical interaction (Lotto and Price, 1996) and target removal (Alcantara
et ah, 1997), the release and survival response to trophic factors (Lotto and Price,
1996), and the addition of neurotrophins and blocking antibodies (Ghosh et ah, 1994;
Segal et ah, 1992). However, I found that there are several difficulties with carrying
out such studies on the knockout tissues. For example, 1) it is a tedious process
without knowing the genotype before putting tissue in to cultures, 2) the number of
samples of particularly the homozygous tissues obtained in each experiment are
variable and often low, 3) these variable number of samples of unknown genotype
make it difficult to perform experiments with many variables/conditions, such as
varying doses, and 4) the amounts of a test substance needed are high since the
volumes for explant cultures are large (2.5ml culture medium per 2-4 explants,
compared with lOOpl per well in dissociated cell culture).
Thus, in this chapter, I did only simple pilot studies and analysis of the TrkB
and TrkC knockout thalami in culture as follows: 1)1 analysed thalamic viability in
mutants taken before and after the period of cortical innervation in isolation and 2) I
studied the effects of K+ depolarisation (using the concentration which is known to
promote thalamic survival, Magowan and Price, 1996) to test whether this required
Trk signaling to promote cell survival.
1. Time and factors that control survival of thalamic explant
In wild type control experiments, the viability of the young El 5 thalamic
explants was high, corresponding to the low cell death rate in vivo (see Chapter 3)
and high viability of El 5 dissociated cells in culture (see Chapter 3 and 4; Lotto et
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al., 1997). Together, this suggests that the factors sufficient to support the viability of
the early embryonic thalamus are produced within the thalamus itself. In vivo, the
target may have little or no influence on thalamic viability at this early embryonic
age of El 5 (Price et al., 1995). In addition, confirming the previous report (Magowan
and Price, 1996), thalamic viability decreased in older explants at around the time of
cortical innervation and in the perinatal period.
Increasing evidence shows that thalamic neurons become more demanding as
the thalamus matures. Most of the older (> El 9) thalamic cells in dissociated culture
(Chapter 4) and in explants die as they age (see Figure 5.2b). It has been proposed
that survival of thalamic cells at this age is regulated by both intrinsic and target
dependent mechanisms (Lotto et al., 1997) and exhibit many interesting
characteristics: i.e.l) the survival of the cells is highly sensitive to and transiently
regulated by activity-dependent mechanisms (Magowan and Price, 1996). 2) El5
thalamic cells in culture up until E19-P1 (4-6 DIV) require BDNF signaling and
many neuronal tissue-derived trophic factors (including cortical- and thalamic-
derived) (Hisanaga and Sharp, 1990; Chapter 3, 4). 3) Moreover, in vivo studies
indicate that the cells at this age (in the perinatal period) seem to require target
innervation to prevent PCD (see Chapter 3). 4) Lastly, part of the survival regulation
mechanisms may involve TrkB signaling as some small increases in cell death in
certain thalamic nuclei were found in trkB knockout mice (see Chapter 3). Therefore,
the mechanism regulating thalamic survival may be complex but is likely to involve
at least neurotrophin signaling and activity regulation.
2. Thalamic explants and neurotrophin signaling
It was not known whether, and if so when, thalamic cells require Trk
signaling for their survival. In Chapter 3, Lotto and I have shown that thalamic
neurons develop a requirement for BDNF as they age. In addition, early thalamic
neurons in cultures do respond to neurotrophins as early as El 5 (Lotto et al., 1997)
and become more dependent on them at E18-E19. However, in in vivo studies, there
is no increase in cell death in the early (before El 5) thalamus of the mutants. Thus, it
is possible that 1) the Trks are not essential for thalamic survival at these early ages
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or 2) there may be a trophic compensatory mechanism, e.g. trophic redundancy, that
keeps the mutant thalamic cells surviving normally at the early stages. According to
the findings in this chapter that no increased cell death is found in El 5 thalamic
explants of the mutants compared with the wild types, it is yet more possible that
TrkB and TrkC signaling are not required for survival of the young thalamus.
As discussed earlier, the mechanisms regulating thalamic survival may be
complex and I tested if TrkB or TrkC signaling alone is crucial for the thalamus in
explants at El 9. Unfortunately, the viability of all the wild type and the mutant
thalami were low (<10%) with high values of standard error, preventing me from
observing any possible increase in cell death in the mutants. It is possible that the
surviving cells are a population of neurotrophin independent cells while the dead
cells (in both wild types and mutants) are TrkB/TrkC dependent cells. If this is the
case, a difference in thalamic survival between the wild types and the mutants cannot
be observed by this experiment. I thus attempted to rescue the dead population that
may require TrkB or TrkC signaling by adding K+, since K+ has previously been
shown to depolarise and promote survival of various types of neuronal populations
(including thalamic cells) (Ghosh et al., 1994; Magowan and Price, 1996;
Limpscombe et al., 1988). However, interpretation must be made with caution. I
predicted that if there is any difference in viability among the mutant and wild type
cells, thalamic survival may require one or more of either the independent actions of
TrkB or TrkC and K+ depolarisation as K+ itself might also enhance production of
trophic factors.
3. The role of K+ and neurotrophin signaling in the survival of thalamic
explants
When KC1 was applied to the thalamic explants of the mutants and the wild
types, the survival of all thalamic explants increased markedly. Surprisingly, the El 9
trkB-/- thalamic explants with added K+ did not show any significant increase in cell
death as found in in vivo studies (see Chapter 3). This also suggested that the survival
promoting effects of K+ on thalamic cells might not involve TrkB signaling which is
opposite to what is found in cortical neurons. Ghosh et al (1994) showed that the
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increase in cortical neuron survival after treatment with KC1 was dependent on
BDNF function. Anti-BDNF completely prevented the survival effects of KC1
(Ghosh et al., 1994). They also further suggested that the survival promoting effects
of KC1, via BDNF, involve the influx of Ca++ and intracellular Ca++ signaling. Jiang
and Guroff (1997) also confirmed that BDNF promotes cell survival by signaling
through intracellular Ca++. In fact, however, the role of intracellular Ca++ signaling in
preventing neuronal death is still unclear, because intracellular Ca++ is also thought
to be involved in the PCD process (Pettman and Henderson, 1998).
One possible explanation as to why I did not observe a change in cell survival
of the mutant thalami in the presence of K+ may because K+ depolarisation has a
more generalised effect on regulating thalamic survival and does not act solely via
neurotrophin signaling. It is also possible that K+ may promote the release of more
than one trophic factor (e.g. more than one neurotrophins and/or neurotransmitters)
(Ben-Ari et ah, 1994; Bessho et ah, 1994). Therefore, thalamic cells in vitro (of
either wild type or mutant), with the presence of K+, may bypass their exclusive
requirement for TrkB signaling in vivo. However, there is still no clear evidence to
support these possibilities and they remain to be further investigated. In addition,
although less likely, it is also possible that due to unknown congenital compensatory
mechanisms present in the knockouts, thalamic explants of these animals respond to
K+ normally.
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Chapter 6: Programmed cell death in small eye brain
Introduction
Pax-6 is a gene encoding a transcription factor with both paired- and homeo-
domain DNA binding motifs (Walther and Gruss, 1991). Both motifs are highly
conserved among species (reviewed by Callaerts et ah, 1997). The gene is believed
to play an essential role in the development of nervous system, eye, and nose. In the
forebrain, pax-6 mRNA is first detected at around E9 (Mastick et ah, 1997) and is
expressed restrictively in spatiotemporal patterns early during development in alar
plate of the diencephalon and the telencephalon (Stoykova et ah, 1996). As the
animal develops, the expression of this gene in the forebrain is found in cerebral
cortex, ventral thalamus (i.e. reticular nucleus, zona incerta and ventral lateral
geniculate nucleus) and hypothalamus (Stoykova et ah, 1996). The function of the
gene is not only important to the cells that express it but also to other pax-6 non-
expressing tissues such as the dorsal thalamus. Recent studies have shown that
proper formation and guidance of thalamocortical fibers requires pax-6 (Kawano et
ah, 1999; Edgar, 1998).
Mice and rats with a natural point mutation in the pax-6 gene, called small
eye (Sey), have severe malformations in many developing tissues (Hill et ah, 1991;
Kawano et ah, 1999). The homozygous mice (Sey/Sey) lack eyes and nasal cavities.
The brains are markedly reduced in size and show several defects in the
diencephalon (Warren and Price, 1997). In addition, Sey/Sey mutants also have
undeveloped olfactory bulbs (Hogan et ah, 1986), defects in the posterior
commissure and tract of the postoptic commissure (Mastick et ah, 1997), and an
absence of thalamocortical formation (Kawano et ah, 1999). Migratory capacity is
also altered in late-bom cortical precursors (Caric et ah, 1997). Due to these and
other severe anomalies, Sey/Sey homozygotes cannot survive after birth (Gotz et ah,
1998).
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One explanation for the defects caused by the pax-6 mutation could be that
the gene normally has a regulatory role in the expression of cell adhesion molecules.
For instance, cell migration and boundary formation defects occur as a result of
alteration in R-cadherin and tenascin-C expression in pax-6 mutant mice (Stoykova
et ah, 1997) and possible alteration of expression of TAG-1 and PSA-NCAM
molecules (Fukuda et al., 2000). Moreover, the adhesion molecule LI, which is
known to regulate axon guidance and fasciculation, can be activated by pax-6
(Meech et ah, 1999).
Aside from the possible role ofpax-6 in regulating cell adhesion molecules,
some have proposed a role for the gene in regulating cell turnover. It has been shown
previously that pax-6 regulates cell proliferation. Cell numbers and percentages of
BrdU incorporating cells (mitotic cells) were markedly reduced in both the
diencephalon and the telencephalon of the mutant brain (Warren and Price, 1997;
Gotz et ah, 1998; Warren et ah, 1999). However, it has not been clearly
demonstrated whether pax-6 has a direct or indirect role in controlling cell death.
Gotz et ah (1998) showed that, at E13.5, there is no significant change in the rate of
cell death in the mutant cortex. Neither was there a difference in cell death between
Sey/Sey and wild type in developing diencephalon from Ell to El 5 (Warren and
Price, 1997). However, in the Sey/Sey mutant there is an absence of cell death which
is normally present in lateral nasal processes at around El 1 (Grindley et ah, 1995). It
is thought that pax-6 has an indirect role in regulating cell death in nasal
development.
In the dorsal thalamus of the mutant, thalamocortical fibers are disrupted
(Figure 6.1). The Neurotrophic Hypothesis predicts that these fibers are required for
thalamic survival. It is not known whether this hypothesis is true in the
thalamocortical system, but it is possible that pax-6 might cause secondary cell death
in dorsal thalamus. In this study, I investigated the pattern of programmed cell death
in Sey/Sey thalamus in vivo and determined the viability in culture of mutant thalamic
cells in the presence or absence of diffusible trophic factors from the mutant or wild
type target tissues (cerebral cortices). This was aimed at understanding whether the
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gene and/or the establishment of thalamocortical fibers are essential to the viability
of the thalamic cells.
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Figure 6.1
A diagram showing thalamocortical formation in wild-type (left) and Sey/Sey (right)
rat. The picture is taken from Kawano et al. (1999). The malformation pattern is also
similar in mice (Edgar, 1998).
axons from dorsal thalamus
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Materials and Methods
1. In vivo study
Apoptosis Labeling
El7 and El9 Sey/Sey (n - 5, n = 4) and Swiss wild type mice (n = 5 each)
were dissected and processed histologically. Small eye homozygous mutant mice
(Sey/Sey) were easily identified by the absence of eyes and a shortened snout. The
TUNEL technique was carried out as described in Chapter 2.
Identification of thalamic boundaries was done according to Schambra et al.
(1992) and Paxinos et al. (1994) (see also Chapter 2). Dorsal thalamus was identified
as a mass of cells lying between the external medullary lamina (eml) (distinguishing
dorsal from ventral thalamus) and the fasciculus retroflexus (fr - hablenulo-
peduncular tract) (distinguishing dorsally from epi-thalamus). In Sey/Sey embryos,
the eml and fr are less clear but still identifiable as cell-sparse borders in the Sey/Sey
diencephalon.
Cell counts were made in both the cerebral cortex and the thalamus. Details
of using the grid under the 40x objective for counts were as described in Chapter 3.1
counted the normalised proportions of TUNEL positive cells per 1000 cells in
randomly selected areas. For cerebral cortex, counts were made in sections
approximately every 20% of the distance from the most anterior section where the
cortex was first seen to the most posterior section (see Figure 6.2, red lines). The
average proportion of dead cells in cerebral cortex was calculated by dividing the
total number of TUNEL positive cells in all areas (from section at 20%, 40%, 60%,
and 80%) by the total number of cells counted in those areas and normalising to the
proportion per 1000 cells.
Since the morphology of Sey/Sey dorsal thalamus is severely distorted and the
thalamic nuclei could not be identified in sections, the division of the thalamus for
cell counts was done in the same way as in the cerebral cortex. I counted in sections
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Figure 6.2
A diagram showing how the developing mouse brains are divided and counted.
Positions of the sections at 20%, 40%, 60%, and 80% of the distance through the
cerebral cortex from anterior to posterior are illustrated by red dotted lines. Positions
of the sections at 20%, 40%, 60%, and 80% of the distance through the thalamus
from anterior to posterior are illustrated by blue dotted lines. Examples of sections of
the dorsal thalamus used for cell counts in each are illustrated in Figure 6.3.
 
through the thalamus at 20%, 40%, 60%, and 80% of distance from where I first saw
thalamus to the last sections in which I could observe it in coronal sections (see
Figure 6.2, blue lines). The first section (20%) corresponded to anterior thalamic
nuclei, the section at 40% was around the region of ventral nuclei and dorsomedial
group, the section at 60% corresponded to ventral posterior and lateral geniculate
nuclei, and the section at 80% corresponded to the area of posterior thalamic nuclei.
2. In vitro study
Dissociated cells were obtained as described earlier in Chapter 2 (total n = 45
wells). Although Sey/Sey brains showed severe abnormalities in the diencephalon, it
was still possible to identify their dorsal thalamus at El 5. The thin borders of two
tracts (eml and fr) were used to distinguish the dorsal thalamus. Conditioned media
were obtained from both wild type and Sey/Sey El 9 cortices, with 40 pieces of cortex
per 500pl culture medium in each well of 24 well culture plates. Details of this are
described in Chapter 4.
3. Analysis
In both in vivo and in vitro studies, differences in cell death were tested
statistically with Students' t-test.
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Results
Coronal sections of the brain (stained with DAPI) around the region of the
thalamus of El 9 wild type and small eye brains are shown in Figure 6.3. It was clear
that the Sey/Sey brain was markedly underdeveloped and was reduced in size (Figure
6.3 b, d, f, and h). The third ventricle was prominently enlarged. Dorsal thalamus
was identified by two thin strips of cell sparse zones in the diencephalon as described
in Methods, and the lower border was around the level of the upper closure of the
third ventricle. Abnormal structure within the dorsal thalamus of the Sey/Sey mutant
was evident. It was impossible to subdivide the dorsal thalamus or identify individual
thalamic nuclei.
Dramatic increase in cell death is found in Sey/Sey thalamus at E19, but not
at E17
A previous study reported that there were no differences in cell death
between wild type and Sey/Sey mice aged from El 1 to El 5 (Warren and Price,
1997). This study effectively continues that previous study to older ages. At El7,
some increase in cell death was found in the first anterior sections (20%) of the
thalamus (area corresponding to paraventricular or anterior nuclei) with an average
of 7.44 cells/1000 cells in Sey/Sey mice. However, the standard deviation is high (+
4.45 cells/1000 cells) and the cell death rate was not significantly different to wild-
types (1.44 + 0.69 cells/1000 cells). Cell death in other regions in Sey/Sey mutants
was as follows: 1.15, 0.84 and 1.64 cells/1000 cells (corresponding to areas 40%,
60%, and 80% from anterior to posterior through the thalamus). The cell death rates
in sections in the wild types were 0.8, 1.2, and 2.9 cells/1000 cells. The average cell
death rate throughout all sections was not different in the mutant (1.45 + 0.53
cells/1000 cells in wild type, and 2.54 + 0.96 cells/1000 cells in Sey/Sey). A
summary of these cell counts is shown in Figure 6.4a.
At El 9, the proportion of apoptotic cells rose sharply in Sey/Sey thalamus,
























Photomicrographs showing TUNEL positive cells in representative areas of E19
dorsal thalamus in coronal sections. An increase in the numbers of TUNEL positive
cells can be found in the section of the anterior (20%) Sey/Sey thalamus (b),
compared with the wild type thalamus (a). In a posterior section (section at 60%) of
the dorsal thalamus, a marked increase in cell death was found in the mutant (d),
compared to the wild type thalamus (c). Red arrowheads depict TUNEL positive
cells. White arrows = false-positive cells.
 
Figure 6.4
Graph showing the number of TUNEL positive cells per 1000 cells in El7 (a) and
El 9 (b) thalamus of the Sey/Sey (red bars) and wild type (blue bars). Note: in (a), the
increase in average cell death in the rostral section (20%) is not significant. In (b), a
marked increase in cell death is found in every section of the mutant thalamus,
particularly at the posterior ends of the sections.
Figure 6.3
Morphological defects in the Sey/Sey dorsal thalamus stained with DAPI. (a), (c), (e)
and (g) are El9 wild type thalamus, (b), (d), (f) and (h) are Sey/Sey thalamus.
Pictures are in anterior-posterior order (sections at 20% are (a) and (b), 40% are (c)
and (d), 60% are (e) and (f), and 80% are g) and h)). Two thin strips of cell-sparse
areas (dotted lines) determine the upper and lower borders of the dorsal thalamus in
wild type and Sey/Sey brains. Note: the mutant thalamus is smaller and distorted in
shape. Thalamic nuclei are indistinguishable. (Pictures of El 9 wild type brains are
the same as shown in Figure 2.1, Chapter 2).
while the average cell death in wild type thalamus was only 2.0 + 0.4 cells/1000 cells
(p < 10*4) (Figure 6.4b, Figure 6.5). The anterior half of the Sey/Sey thalamus had
much lower death rates than the other half. Cell death rates in sections at 20% and
40% (anterior) were 21.71 + 9.2 and 24.8 + 5.0 cells/1000 cells, compared with
sections at 60% and 80% (posterior) which gave rates of 118.5 + 22.68 and 68.91 +
35.93 cells/1000 cells (p<10"3), while cell death rates in wild types at E19 were low
with the values ranging from 0.86 to 5.48 cells/1000 cells (from section 20% to 80%)
(Figure 6.4b, Figure 6.5).
It should be noted here that 1) the increase in cell death in Sey/Sey thalamus
at El9 (approximately 21-118 cells/1000 cells) was even higher than the peak cell
death which occurs in normal thalamus at PI (4-50 cells/1000 cells, see Chapter 3).
2) Although the thalamic nuclei were unidentifiable, the area that showed the highest
cell death in the mutant (-60% posterior), was around the same level as ventral
posterior nuclei in wild type thalamus, which showed the highest death rates
compared to other thalamic nuclei at P1.
Cortical cell death in the pax-6 mutants is not affected
To further confirm that an increased cell death in the mutant thalamus at El 9
was not a reflection of generally increased non-specific cell death, I also investigated
cell death in the cortex of these mice. The cerebral cortex of the mutant was thinner
and the cells were more densely packed than in the wild types (as previously shown
by Caric et al., 1997; Mastick, et al., 1997; Warren and Price, 1997; Warren et ah,
1999). A TUNEL study in E17 and E19 cortices revealed no significant difference in
death rates in the mutants (Figure 6.6a, b). The total cell death count per 1,000 cells
in E17 Sey/Sey cortices remained low (0.84 + 0.12 cells/1000 cells) which was
similar to that in wild types (0.84 + 0.06 cells/1000 cells). There was no difference in
cell death in any particular area from anterior to posterior in wild types (0.66, 0.71,
0.70, 1.46 cells/1000 cells) compared to Sey/Sey embryos (0.82, 0.93, 0.74, 0.86
cells/1 OOOcells). Likewise, El9 Sey/Sey cortices had an average cell death of 1 + 0.22
cells/1000 cells, around the same rate as wild-types (0.91 + 0.21 cells/1000 cells).
The distributions of cell death at both ages in both Sey/Sey and wild type were
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Figure 6.6
Graphs show cell death ratio in El7 (a) and E19 (b) mutant (red bars) and wild type
(blue bars) cerebral cortex. No significant difference in cell death was found in any
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A summary graph comparing averages of total cell death in both thalamus and cortex
of the E17 and E19 Sey/Sey and wild type mice. Note: only Sey/Sey E19 thalamus
has a marked increase in cell death.
 
scattered. Anterior-posterior distributions of cell death were similar (see summary in
Figure 6.4a, b).
A summary of the in vivo TUNEL studies in the whole thalamus and cortex is
also shown in Figure 6.7.
In vitro experiments
Cell culture experiments were done to investigate the viability of Sey/Sey
thalamic cells, their response to trophic factors obtained by conditioning their
medium with cerebral cortex, and the production of target derived trophic factors by
the Sey/Sey cortex. These were aimed at identifying the possible mechanisms by
which the mutated pax-6 gene causes increased thalamic cell death in vivo. Possible
mechanisms include the following: 1) A direct effect of the pax-6 mutation, causing
thalamic cell death before and/or after the period of target innervation. Although this
possibility is the least likely (see discussion), cell culture studies would help to
exclude it. 2) Reduction in the trophic supply by the target cerebral cortex. This was
tested by observing the ability of Sey CCM to promote thalamic survival in vitro. 3)
Thalamocortical disruption inhibiting thalamic cells from obtaining sufficient trophic
factors. This could be inferred if Sey/Sey thalamic cells survive normally with wild-
type CCM and if Sey CCM produces the trophic effect of wild-type CCM.
In a first set of culture experiments, I cultured wild type and Sey/Sey thalamic
cells for 5 days. Comparing the viability of Sey/Sey and wild type thalamic neurons
showed similar patterns (Figure 6.8a). Up to 50% of both Sey/Sey mutant and wild
type thalamic cells survived for two days. This indicated that the ability of thalamic
neurons to survive is not directly affected by the pax-6 mutation. It is interesting that
survival of Sey/Sey thalamus seemed better than that of wild type thalamus after 3
days of culture (28% in 3-day and 14% in 4-day culture, compared to 18% at 3 days
and only 2% at 4 days for wild-type cells). I cannot fully explain this result but it is
possible that the mutation in pax-6 makes thalamic cells less susceptible to death at
this age in vitro. At 5 DIV (~P0 in vivo), on the other hand, very few cells survived
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Figure 6.8
Graphs showing thalamic viability in cultures
(a) Survival percentages of Sey/Sey thalamic cells comparing to the wild-type cells
when cultured for 5 days. Sey/Sey thalamic viability (blue) is similar to the wild type
(light blue). With the supply of either Sey/Sey CCM or wild-type CCM, Sey/Sey
thalamic cells at 5th day respond and survive normally (pink and yellow lines,
comparing to the wild type viability - purple and brown lines).
(b) A more clear demonstration of the thalamic viability at the 5th day of culture:
Survival of both mutant and wild type thalamic cells is very poor without the supply
of CCM. Sey CCM promotes wild type thalamic cell survival to the same extent as
wild-type CCM. Survival of Sey/Sey thalamic cells is equal to the wild type viability
with or without CCM.
(CCM = El9 cortical conditioned medium, "-CCM" = without CCM, Sey = Sey/Sey
tissue, Th = thalamic cells, WT = Wild-type)
♦ Sey ■ Sey-Th with normal CCM Sey-Th with Sey CCM
-M WT - - X- - WT-Th with normal CCM • WT-Th with Sey CCM
1 DIV 2 DIV 3 DIV 4 DIV 5 DIV
















in both mutants and wild types. This suggested that the cells in both wild types and
the mutants require external trophic support as shown previously in Chapters 3 and 4.
Next, I tested two hypotheses: 1) whether Sey/Sey thalamic cells were able to
respond normally to target derived factors from the cortical conditioned medium and
2) whether the increased cell death in Sey/Sey thalamus might be due to the reduction
in the production of trophic factors in the cortex. These were done by culturing wild
type or Sey/Sey thalamic cells for five days in the presence of conditioned medium
obtained from either Sey/Sey or wild type E19 cortex (E19 Sey CCM or E19 Wt
CCM) (Figure 6.8a, b). The results showed that: 1) Sey/Sey thalamic cells responded
to trophic substance(s) from E19 Sey CCM (48 + 1.5%) and normal El 9 CCM (49 +
1.7 %) as normally as wild type cells did and 2) El9 Sey CCM had the same level of
survival promoting effects as normal El9 CCM on 5 DIV wild type thalamic cells
(the cells had nearly 50% survival).
From these in vitro results, it is likely that the pax-6 gene does not have a
direct role in either regulation of thalamic cell death or the production of trophic
factors released from the cortex.
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Discussion
Several striking anomalies including a reduction in tissue size in many CNS
regions are found in the pax-6 mutant brain. It is possible that the pax-6 mutation
affects either cell proliferation, cell interaction and guidance, cell migration, cell
survival, or a combination of these processes. Reductions in proliferation and cell
number revealed by BrdU studies are found in many CNS regions such as
diencephalon and cerebral cortex (Caric et al., 1997; Warren and Price, 1997).
Several axonal pathways are disrupted. These include posterior commissural fibers,
the postoptic commissural tract, olfactory fibers and thalamocortical fibers (Mastick
et al., 1997; Grindley et al., 1995; Kawano et al., 1999). There are also migratory
defects during neocortical development, i.e. some cortical cells of the mutant which
would normally disperse and migrate form clusters in the subventricular zone. The
possible downstream targets ofPax-6 which regulate cell migration include cell
adhesion molecules such as LI, PSA-NCAM and others (Caric et al., 1997; Schmahl
et al., 1993). However, to date, there is not enough evidence to suggest whether
defects in pax-6 directly control cell survival.
In fact, when I studied the possible abnormality in cell death in the mutant, I
first looked at the cell death in cortical tissue before examining the thalamus. The
rate of cell death in the cortex was relatively normal at both ages studied (El 7 and
E19). This agrees with the cell death studies done at E13-E14 in cortex by Gotz et
al., (1994), where they also found no significant difference in the rate of cell death in
mutants. Recent studies also confirmed that there was no change in cell death in the
later stages of developing mutant cortex (Fukuda et al., 2000). Altogether, these
findings suggested that cell death is not directly controlled by Pax-6 itself or by
immediate downstream mechanisms controlled by Pax-6 (i.e. the pax-6 mutation is
not directly lethal to developing cells). However, as will be discussed below, it is still
possible that Pax-6 alters some environmental factors that older (but not younger)
thalamic cells require to survive and thus results in an increased thalamic PCD only
at the later stages of development (my speculation is that such environmental factors
include the disruption of thalamocortical fibers).
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Similar to events in cortex, early embryonic Sey/Sey thalamic cells (E10-E15)
do not show any striking abnormality of cell death (Warren & Price, 1997). My
results also showed no obvious difference in PCD in El 7 Sey/Sey thalamus.
However, surprisingly, the change in the cell death rate in El9 Sey/Sey thalamus was
dramatic. Several possible explanations arise following this finding.
Possible direct survival role of pax-6?
Since Sey/Sey mice die soon after birth, it is possible that the increased cell
death found in the late stages of thalamic development is due to nonspecific cell
death and/or Sey/Sey mice might have already died before they were actually born.
However, the Sey/Sey embryos I obtained had no apparent signs of this (embryos
seemed to be still viable at the time of removal). The increase in PCD found in the
Sey/Sey E19 brain was regional even within the dorsal thalamus itself (i.e. with a
posterio-anterior gradient). I concluded that this rise in cell death in the mutant
thalamus is a specific process.
Several findings do not favor the hypothesis that pax-6 has a direct role in
regulating cell survival. First of all, there was no increase in cell death in the mutant
cerebral cortex, where pax-6 mRNA is normally expressed. No other areas of El 7 or
El9 brains had as high number of TUNEL labeled cells as the dorsal thalamus of
El9 mutants (no quantitative data, but I observed the appearance in the distribution
of TUNEL positive cells compared with other adjacent brain areas). Secondly, Pax-6
is an early developmental transcription factor, and overall morphological defects
observed in the mutant appear as early as E9 (Walther and Gruss, 1991; Puelles and
Rubenstein, 1993, Mastick et al., 1997) while the increased thalamic cell death was
observed at the perinatal period. Moreover, in vitro 5-day culture of dissociated El 5
mutant thalamic cells showed the same survival pattern as wild type El 5 cells (i.e.
young Sey/Sey thalamic cells survive normally).
Since pax-6 expression shows spatio-temporal changes in pattern and alters
with time, it is possible that Pax-6 affects particular gene(s) at specific ages, e.g.
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genes that express in the thalamus only at E19, which is(are) required for thalamic
survival. This possibility is unlikely because when Sey/Sey thalamic cells in 5-day
culture (around PO in vivo) were supplied with medium conditioned by either wild
type or Sey/Sey cortex, their survival rate appeared normal. This means that intrinsic
thalamic viability is not altered by pax-6 mutation as the cells mature.
Cell death in E19 Sey/Sey thalamus is an indirect consequence of the pax-6
mutation?
According to the Neurotrophic Hypothesis, target derived trophic support and
the ability of neurons to establish proper connections are thought to be essential for
survival. Previous studies have also shown the importance of target derived factors in
the maintenance of thalamic survival particularly during the period of target
innervation - El7 to early postnatal days (Price et al., 1995; see also in Chapter 3, 4).
At El9, thalamic cells undergo many changes in their biological activity and their
physiological properties. Unlike the El7 cells, they are more vulnerable and subject
to death in vitro. They become more dependent on the supply of trophic factors from
cortical conditioned medium and are highly sensitive to exogenous K+ stimulation,
most likely via an activity dependent mechanism (Magowan and Price, 1997). I
tested if in these Sey/Sey animals, the cerebral cortex produced less trophic support to
the thalamus, which could explain the striking PCD phenomenon at this age in vivo.
However, Sey/Sey cortical conditioned medium had equivalent effects to the wild
type cortical conditioned medium when tested on both wild type and Sey/Sey
thalamic cells in cultures. Furthermore, Sey/Sey thalamic cells responded to cortical
trophic factors normally. This implied that trophic factors released from the cortex
are not deprived in the mutant. Then, the question remains, why do more Sey/Sey
thalamic cells die at El9?
The answer seems to be that the path by which thalamic cells obtain trophic
factors is absent. Coinciding with the time at which an increased PCD is found in the
mutant thalamus, El9 thalamic cells become dependent on their target as shown in
both in vitro and in vivo. The thalamocortical system in the Sey/Sey embryo is
malformed (Kawano et al., 1999; Edgar, 1998). Mastick et al. (1997) showed that
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Pax-6 is essential for navigation of axons of many CNS populations. The
thalamocortical fibers which are normally guided by the expression ofpax-6 are
misdirected at the ventral thalamus and terminate at the wrong target, the amygdala
(Kawano et ah, 1999). They never reach the cortex. Dil labeling in the thalamus also
indicated the absence of thalamocortical axons from the telecephalon (Edgar, 1998).
Unfortunately, the pax-6 mutants did not survive after birth. This prevented
me from carrying out further studies on the consequences of thalamocortical
disruption and thus I could not observe the effect of the mutation on the peak period
of thalamic PCD, which normally occurs at PI. In addition, the culture of the older
thalamic cells is much more difficult to manipulate so that the study of this mutant
was focused only on the period before birth.
In summary, my results and the information from previous axonal formation
studies strongly implicate thalamocortical fibers, rather than pax-6 itself, in the
survival of thalamic cells during the critical period of development.
Interestingly, it should be noted from the studies in trkB knockouts and pax-6
mutants that the increase in thalamic cell death in both cases occurs prenatally,
during the time when the thalamocortical axons have already started to navigate, but
before the natural peak of PCD at PI. Combined with the observations on the time of
the trophic requirement of the in vitro E17-E18 cells, this suggests that the process
that makes thalamic cells become dependent on trophic factors occurs before the
period of naturally occurring cell death. The time of thalamocortical innervation does
not precisely coincide with the peak period of PCD but is an earlier event that may
induce cells to commit to the trophic competition process.
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Chapter 7: Study of cell proliferation in mice defective in TrkC
receptor gene in thalamus and cortex
Introduction
Neurotrophin-3 (NT-3) is known to be important for neuronal and glial
development (Kahn et al., 1999). Through TrkC, NT-3 signals a number of trophic
effects, ranging from mitogenesis, through differentiation to promotion of survival,
depending on the developmental stage of the target cells (see review by Chalazonitis,
1996). Both NT-3 and trkC mRNA are expressed from around midgestation in
several CNS regions including thalamus and cortex (Barbacid et al., 1994). Via a Ras
dependent pathway, they can induce cell proliferation, while via a SNT pathway (see
Chapter 1), they induce cells to stop mitosis and promote cell differentiation (Ockel
et al., 1996; Lewin and Barde, 1996; Segal and Greenberg, 1996). The regulation of
NT-3 action is still unclear. In oligodendrocytes, NT-3 and TrkC are thought to play
a major role in cell proliferation (Kahn et al., 1999). For neural crest cells, they
promote both proliferation and differentiation (Hapner et al., 1998; Pinco et al.,
1993; Kalcheim, 1992), but for cortical neurons, they reduce proliferation and
increase cell differentiation (Ghosh and Greenberg, 1995; Pappas and Parnavelas,
1997). Findings in the sympathetic neuroblast population are controversial. Lu et al.
(1996) reported that NT-3 had no effects on sympathetic neuroblast mitosis and
Verdi and Anderson (1994) showed that it produced a mitogenic stop signal, while
DiCicco-Bloom et al. (1993) showed that NT-3 promoted mitosis and induced both
mitotic and non-mitotic cells to differentiate at the same time. In cortex and
thalamus, there is no clear evidence as to whether NT-3 or TrkC signaling are
essential to neuronal or glial proliferation/differentiation.
Concerning the development of the cerebral cortex, cortical cells are derived
from neuroepithelial precursors that lie in a layer called the ventricular zone (VZ).
Axons grow over this zone to form the intermediate zone (IZ). The first set of
postmitotic neurons migrates through the IZ to form the preplate (PP). Cells in the
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VZ also give rise to cells in the subventricular zone (SV). Later, the second
generation postmitotic neurons migrates out of the VZ to form the cortical plate (CP)
which splits the PP into the outer part - the marginal zone (MZ, which later become
the cortical layer I in adult) and the inner part - the subplate (SP). The CP neurons
then migrate along radial glial processes and form cortical layers II-VI in an 'inside-
out' sequence (where layer VI cells are born first) (reviewed by Hatten, 1999;
Parnavelas, 2000). Early bom cells give rise mostly to neurons. Glial cells in the
cerebral cortex were thought to be generated from the subventricular zone and appear
after neurogenesis (Smart, 1972; Halliday and Cepko, 1992). In mice, extensive
cortical gliogenesis can be found around E18-P0 and is thought to increase
postnatally (Edgar, 1998; Levers, 1999). In adult, only cortical layers I-VI and white
matter (which is derived from the IZ) are evident.
Like the cerebral cortex, the dorsal thalamus develops from germinal cells
dividing in the ventricular zone. It emerges from the prosomere 2 (p2) region of the
diencephalon at around El3 (Altman and Bayer, 1988). Unlike the CP, postmitotic
thalamic cells do not form in an 'inside out' sequence. Instead, the early bom
thalamic neurons give rise to the most lateral thalamic nuclei and the late born cells
give rise to the most medial nuclei (Altman and Bayer, 1979a; b; c; Angevine, 1970).
In the mouse, the cells that will give rise to the thalamic nuclei are bom between El 1
and E15 (Angevine, 1970). Most cells generated around this period are neurons.
From El 5 to postnatal life the differentiation of functional thalamic nuclei becomes
evident. However, the evidence for the period of gliogenesis in the thalamus is still
obscure. If we accept the general hypothesis that gliogenesis often occurs after
neurogenesis is complete (Smart, 1972; Halliday and Cepko, 1992), we might
assume that it may occur any time after E15-E16.
Based on the evidence in Chapter 3, that there is a small reduction in cell
death in young TrkC knockout thalamus (El3), I hypothesised that TrkC signaling
may be required for homeostasis of cells during the period of cell proliferation in the
developing brain. Since this is likely to directly affect the proliferating cells, we may
be able to observe defects in knockout mice. In this study, therefore, 1 examined the
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proliferation rate in the mutant brain from very early in neurogenesis at El 1 to the
time before birth by using BrdU immunocytochemistry.
5-bromo-2-deoxyuridine (BrdU) is a molecule that can be employed to study
proliferation, migration and time of origin of cells in the developing central nervous
system (Miller and Nowakowski, 1988). It is an alternative to traditional [3H]
thymidine labeling. Like [3H] thymidine, BrdU is incorporated into the DNA of
proliferating cells during S-phase of the cell cycle. These proliferating cells can be
detected by immunohistochemistry (Miller and Nowakowski, 1988).
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Materials and Methods
Animals and BrdU injections
Mice heterozygous for a targeted mutation in the trkC sequence encoding the
catalytic domain of the TrkC tyrosine kinase receptor isoforms (Klein et al., 1994)
were used. Heterozygous trkC were mated to give wild type, heterozygous, and
homozygous mice. The pregnant mice were injected with a single dose (0.2mls of a
2mg/ml solution, i.p.) of BrdU dissolved in sterile saline on El 1, E13, E15, E17, and
El9. One hour later, the animals were sacrificed by cervical dislocation. Embryos
were removed at the assigned stage of pregnancy. Parts of the embryos (either legs or
tails) were removed for PCR genotyping (see Chapter 3). Brains were removed and
processed histologically as described in Chapter 2.
Immunohistochemistry
Sections were treated with 0.1% trypsin in 0.1% CaCl2 at 37°C, to
permeabilise the cell membranes for 20 minutes. The sections were then washed with
tris-buffered saline (TBS pH 7.6) for 5 minutes before being treated with 1 N HC1 at
60°C for 8 minutes, to denature the double-stranded DNA molecules and expose the
incorporated BrdU molecules. Sections were washed with TBS, preblocked with
normal rabbit serum (NRS) in TBS (1:4 NRS:TBS) for 10 minutes. The sections
were incubated with anti-BrdU (5pl/ml) for 30 minutes and then washed twice in
TBS for 5 minutes each. A second preblocking with NRS followed. The sections
were next treated with a biotinylated secondary antibody (5pl/ml) for 30 minutes).
When this incubation was complete, the sections were once again washed with TBS,
then treated with avidin and biotinylated complex kit (ABC kit, Vector) according to
the manufacturer's instructions for 30 minutes. Then sections were washed and
reacted with 3,3'-diaminobezidine (DAB, Sigma) solution (0.05% DAB, 750pl tris
buffer, 20pl 0.1% H2O2 and one flake of imidazole) for 8 minutes, conterstained with
cresyl violet and differentiated in graded concentrations of alcohol in water. Once
dry, the sections were coverslipped with DPX mountant.
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Cell counts and Analysis
I analysed two areas of the brain in this study: cerebral cortex and thalamus.
In the cerebral cortex, four selected coronal sections (approximately equidistant,
every 20% of the way through the brain) from the anterior to posterior were chosen
for cell counts. Detail was as described in methods in Chapter 6 and Figure 6.1. For
the thalamus, samples of major thalamic nuclei were chosen for cell counts in the
same way as in Chapter 3.
A ratio of BrdU labeled cells over total cells in a selected area (under 40x
magnification in a 10 x 10 grid-square bin, see detail in Chapter 3) is called
'Labeling Index' (Takahashi et al., 1991). I expressed this value as a percentage of
BrdU labeled cells. Since a single BrdU dose labels nuclei in S-phase of the cell
cycle only (Takahashi et ah, 1991), the labeling indices (in percentages) obtained in
this study represent the proportion of S-phase cells.
Both cortical and thalamic Lis in the mutant and the wild type brains were




At El 1 and El3, dorsal thalamus has not fully developed and so the analysis
was made in the region of diencephalon which is likely to develop into the dorsal
thalamus. Cell proliferation in mice at these ages is high. The rates of BrdU positive
cells per total cells are 37.1 + 3.17% in El 1 and 19.09 + 3.27% in E13 (Figure 7.1a,
e, 7.2b, d). Most of the immunoreactive cells are localised nearer to the ventricular
edge of the brain.
At El 5, the dorsal thalamus and some of its nuclei can be identified. The
percentages of BrdU labeled cells at this age were reduced markedly to 2.11 + 1.49
% (see Figure 7.7b). However, in some brains, I still saw some highly proliferative
regions particularly in the paraventricular area. This varied from one brain to
another. This resulted in the high standard error in the counts in many nuclei and in
the average for the thalamus (Figure 7.3b). From El7 to El9, the percentages of
BrdU labeled cells were very low (less than 1%, 0.62 + 0.13 % and 0.52 + 0.3 %
respectively). The distribution of the labeled cells was dispersed, and was no longer
restricted to the ventricular/paraventricular area.
As in wild types, the trkC-/- thalamus decreased its proliferative rate
markedly at around El5. I found no statistical difference between the Lis in the
mutant thalamus and those in the wild type thalamus at any age, and in none of the
thalamic nuclei studied (Figure 7.2b, 7.2d, 7.3b, 7.5b, 7.6b, and 7.7b for El 1, E13,
El5, El7, and E19). In more detail, the total average proliferative rates of trkC-/-
thalamus were 33.85 + 3.34% at El 1, 21.24 ± 2.09% at El3, 2.13 ± 1.55% at El 5,
0.44 + 0.2 % at El 7 and 0.49 + 0.3 % at El9 (the proliferative rates for individual
nuclei are summarised in the Figures).
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Figure 7.1
Photomicrographs of El 3 wild type and trkC mutant brains in coronal plane: low
magnification picture of BrdU labeled cells (brown cells) in whole brain of (a) wild
type, and in (b) trkC-/- embryos. Higher magnification of BrdU labeled cells in the
cerebral cortex in wild type and mutant are shown in (c) and (d). Higher
magnification of BrdU labeled cells in the wild type and the mutant thalamus are




Graphs showing labeling index (percentage of BrdU labeled cells) in El 1 and El3
cortex and thalamus of wild type and trkC knockout brains, (a) Shows BrdU labeling
index in the El 1 wild type and trkC-/- cerebral cortex, (b) Shows BrdU labeling
index in the El 1 wild type and trkC-/- thalamus, (c) Shows BrdU labeling index in
the El3 wild type and trkC-/- cerebral cortex. Since the cortex has started to enlarge,
cell counts are made in different areas anterior-posteriorly. (d) Shows BrdU labeling
index in the El3 wild type and trkC-/- thalamus.
No significant difference in the labeling index is found at these ages.
 
Figure 7.3
Graphs showing labeling index (percentage of BrdU labeled cells) in El5 cortex and
thalamus ofwild type and trkC knockout brains, (a) Shows BrdU labeling index in
the El5 wild type and trkC-/- cerebral cortex, (b) Shows BrdU labeling index in the
El5 wild type and trkC-/- thalamus. No significant difference in the labeling index is
found in the mutants at this age.
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Figure 7.4
Photomicrographs of El 7 wild type and trkC knockout brains in anterior sections
(section at 20% in anterior-posterior axis) in coronal plane, (a, b) Low magnification
pictures of BrdU labeled cells (brown cells) of wild type and trkC-/- embryos, (c, d)
Higher magnification of BrdU labeled cells in the cerebral cortex in wild type and
mutant, (e, f) Higher magnification of BrdU labeled cells in the wild type and the
mutant thalamus. Numbers of BrdU labeled cells in the thalamus at this age is very
low.
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Photomicrographs of El 7 wild type and trkC knockout brains in posterior sections
(section at 80% in anterior-posterior axis) in coronal plane, (g, h) Low magnification
pictures of BrdU labeled cells (brown cells) of wild type and trkC-/- embryos, (i, j)
Higher magnification of BrdU labeled cells in the cerebral cortex in wild type and
mutant, (k, 1) Higher magnification of BrdU labeled cells in the wild type and the
mutant thalamus. Note: Fewer labeled cells are found in El7 trkC-/- posterior cortex
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Graphs showing labeling index (percentage of BrdU labeled cells) in El7 cortex and
thalamus of wild type and trkC knockout brains, (a) Shows BrdU labeling index in
the El 7 wild type and trkC-/- cerebral cortex, (b) Shows BrdU labeling index in the
El7 wild type and trkC-/- thalamus. A small but significant decrease in the
percentage of BrdU labeled cells is found at the posterior (80%) section of the
mutant cortex. No significant difference in the labeling index is found in any of the
nuclei of the thalamus.
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Figure 7.7
Graphs showing labeling index (percentage of BrdU labeled cells) in El9 cortex and
thalamus of wild type and trkC knockout brains, (a) Shows BrdU labeling index in
the El9 wild type and trkC-/- cerebral cortex, (b) Shows BrdU labeling index in the
El 9 wild type and trkC-/- thalamus. A significant decrease in percentage of BrdU
labeled cells is found at the posterior (80%) section of the mutant cortex. No





Summary graphs showing average labeling index (LI - percentage of BrdU labeled
cells) in the cortex and thalamus of wild type and trkC knockout brains plotted
against embryonic age. (a) BrdU labeling index in the wild type and trkC-/- cerebral
cortex. Percentage of the labeled cells drops gradually and is lower than 10% after
El 5. Significant changes in LI of the mutant posterior cortex (Figure 7.5a and 7.6a)
are insufficient to alter the overall LI. (b) BrdU labeling index in the wild type and
trkC-/- thalamus is reduced earlier than in the cortex (below 5% after El5).
 
Cerebral Cortex
At El 1 and El3, when the cortex is thin and there is a fast proliferative rate,
the BrdU positive cells were found throughout the thickness of the cortex, and the
dense areas of immunopositive cells were often found in the middle of the cortex due
to interkinetic movement of the cells and the occurrence of the S-phase cells at this
central position (Figure 7.1a, c). This pattern of cell proliferation was the same as
that found in the previous BrdU studies by Takahashi et al. (1991). As the cortical
cells continue to proliferate, the El5 cortex becomes much thicker and many more
cortical zones develop. The labeling index at this age was 8.89 + 1.01 %. Highly
immunopositivc regions were found in subventricular zone and ventricular zone
respectively (Figure 7.3). This continued to E19. But from E17, more BrdU positive
cells were also found in the cortical plate. The Lis at E17 and E19 were 6.72 +
0.85% and 1.81 ± 0.28 % (Figure 7.4 -7.6).
In the mutant cortex, the proliferative rates remained the same as those in the
wild type until El 7 (Figure 7.2, Figure 7.3). The average percentages of labeled
cells from Ell, E13, and E15 were 34.79 ± 3.23 %, 19.2 ± 3.12 %, and 9.58 ± 0.32
% respectively. Interestingly, I found a reduction in cell proliferation with some
statistical differences {p < 0.05) in the sections 80% of the distance through the
cortex at both El 7 and E19. At El 7, percentages of cells proliferating in this area
(80% of the distance from the anterior section of the cortex) were 6.28 + 0.41 % in
wild type, and 4.66 + 0.39% in trkC-/-. At E19, they were 1.58 + 0.17 % in wild
type, and 1.01 + 0.1 % in the mutant. The area which was found to have a reduction
in immunopositive cells corresponded to the occipital cortex, although the
percentages of immunopositive cells for the cortex as a whole were the same.
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Discussion
The motivation to carry out a study of cell proliferation in trkC-/- CNS
followed the results in Chapter 3.1 previously observed an unexpected, slight
decrease in the percentage of cell death in early trkC mutant thalamus (El 3), but this
was not found in any other age studied. It was of particular interest because cells are
highly proliferative at this age. I argued that if reduced cell death is found in this
early stage without altered morphology or cell density in later ages of development,
there might be other regulation to counterbalance the effects of the reduction in cell
death. This regulation is likely to be cell proliferation. Both cell death and cell
proliferation are essential parameters in regulating cell turnover and homeostasis
(Kerr et al., 1980; 1994). Moreover, it has been suggested that cell death can occur
not only in the postmitotic but also in the proliferating cells during embryogenesis
(Blaschke et al., 1996; 1998). I thus postulated that TrkC signaling may be essential
to homeostasis, in particular in the proliferation of early embryonic CNS cells, not
only restricted to thalamic cells but also cells in other CNS regions such as cerebral
cortex.
In this study, however, BrdU incorporation by most of the early thalamic and
cortical cells aged between El 1 -El5 appeared to be normal. An effect was found in
the later stage of development. Proliferative rates in a cortical area corresponding to
occipital cortex (this area includes visual cortex) showed a significant reduction in
the proportion BrdU labeled cells in the mutant. This reduction was found not only in
one age but two (El7 and El9) indicating that TrkC signaling is required
continuously for a certain period of time. In brief, TrkC may play a key role in cell
proliferation and perhaps also in the decision to exit the cell cycle and differentiate at
a specific period of development in specific brain areas (regional and age specificity)
(Lewin and Barde, 1996; Segal and Greenberg, 1996; Kahn et al., 1999).
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TrkC signaling plays a role in regulating proliferative rates in a restricted
region in the brain
The roles of TrkC in brain development are still unclear although trkC
mRNA is widely expressed and can be detected in the CNS early, before
midgestation (Tessarollo et al., 1993). In their survival role, NT-3 and TrkC
signaling can regulate cell death, often in early developmental stages, of many
neuronal populations particularly in the PNS and among ganglionic neurons, but the
effects in certain brain regions such as thalamus and cortex are subtle (see Chapter 3;
Lotto et al., 1997; de la Rosa et al., 1994; ElShamy and Ernfors, 1996). Silos-
Santiago et al. (1997) suggested that TrkC signaling might not play a major role in
promoting survival in CNS development.
The role of TrkC in cell differentiation is also still controversial. Ghosh and
Greenberg (1995) reported that NT-3 and TrkC signaling promote cortical neuronal
differentiation while another study done by Silos-Santiago et al. (1998) reported that
it does not play a major role in the differentiation of CNS neurons during embryonic
development (Silos-Santiago et al., 1998).
Increasing evidence suggests that TrkC may play a role in the proliferation
and differentiation of CNS cells (de la Rosa et al., 1994; Kumar et al., 1998; Engel
and Wolswijk, 1996). But the effects are found at a relatively later stage of
development and are thought to regulate gliogenesis rather than neurogenesis (see
discussion below). In spinal cord, the lack of NT-3 or TrkC affected cell proliferation
throughout the entire subventricular zone (Kahn et al., 1999). However, here I found
that in trkC-/- mice, the proportions of proliferative cells were decreased only in a
restricted region of the brain which corresponds to the occipital cortex, while there
was no any other significant difference observed in the thalamus or other cortical
areas. Within the cortical areas studied, the occipital cortex appeared to express the
most trkC mRNA (see ISH result in Chapter 3). These findings indicated that TrkC
signaling is regulates cell proliferation in a regional specific pattern in the CNS.
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Although gross morphology appeared to be normal during embryonic
development, both body size and brain size in the trkC-/- homozygous mice were
reduced markedly in postnatal life. Thus it is possible that the reduction in
proliferation at the later stage of development (peri- and post- natal) may contribute
to this abnormality. Since most homozygous mutant die in early postnatal life, it is
also possible that this late stage of cell proliferation may have essential physiological
functions for foetal development (Klein et ah, 1994).
Possible role of NT-3 and TrkC signaling in visual cortex
The neurotrophins have been implicated in shaping and remodeling the
connectivity of neural circuits (Okuno et ah, 1999). Both neurotrophins and their
receptors are localised in numerous visual centers from the retina to the visual cortex
(see review by Von Bartheld, 1998). BDNF and TrkB receptors are the most studied
molecules in the development of retina and visual pathways. For example, BDNF
can prevent the death of cultured retinal ganglion cells in many animal species (see
Lewin and Barde, 1996). BDNF (and also NT-3) can prevent naturally occurring cell
death in the isthmo-optic nucleus (Von Bartheld et ah, 1994). In visual cortex, BDNF
and NT-4/5 can influence the patterning of projections and the formation of ocular
dominance columns (Cabelli et ah, 1995). Moreover BDNF regulates dendritic
growth and modulates plasticity in developing visual cortex (McAllister et ah, 1995;
Ghosh, 1996). In contrast, much fewer studies have been earned out to investigate
the role of NT-3 in the development of this area. Yet McAllister et al. (1997)
demonstrated that NT-3 opposes BDNF action on dendritic growth in visual cortex.
In addition, NT-3 is known to regulate proliferation and survival of glial cells in the
optic pathways (von Bartheld, 1998).
In the in situ hybridisation studies, NT-3 mRNA is found to be transiently
expressed in the neonatal cortex and thalamus and declines during the first two
postnatal weeks, while levels of BDNF and VGFmRNAs expression increase during
postnatal development and reach mature levels around 3 weeks of age (Schoups et
ah, 1995; Ringstedt et ah, 1993). As for the family of trk receptors, trkA is expressed
at very low levels in most CNS areas while trkB and trkC are expressed both in the
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developing LGN and the occipital cortex, mostly in overlapping patterns (see
Chapter 3; Ringstedt et al., 1993). In addition, trkC is widely expressed in other brain
regions and in non-neuronal tissues where trkA or trkB are excluded (Tessarollo et
al., 1993). In the occipital cortex, trkC is found to be relatively more highly
expressed than in other rostral neocortical areas (i.e. there is a rostro-caudal gradient
of trkC expression, see Chapter 3).
In summary, the findings of strong trkC expression in visual cortex and
the proliferative defects found in trkC mutants indicated that TrkC and NT-3 are as
important as TrkB and BDNF in playing a role in the development and maturation of
the visual cortex.
Possible role of NT-3 and TrkC signaling in gliogenesis
The reduction in the number of BrdU labeled cells in the trkC mutant brain
could be because the lack in TrkC signaling 1) shortens S-phase and increases cells
exiting the cell cycle and differentiating (and thus make us see fewer labeled cells) or
2) reduces overall proliferative rates. So far, there is still no clear evidence
supporting the first possibility while many have reported that impaired NT-3 and
TrkC signaling results in a reduction of cell proliferation in many populations (Das et
al., 2000; Kahn et al., 1999; Kumar and de Vellis, 1996).
It is not known whether the mutant cells that exhibit the proliferative defect
are undifferentiated cells, neurons or glia. This requires further investigation but
there is a strong implication that proper development of glial populations
(gliogenesis) requires TrkC signaling. I found that the reduction in the percentages of
BrdU labeled cells in occipital cortex occurred late, around the time of extensive
gliogenesis in the cortex, when neurogenesis is almost complete (Levers, 1999;
Edgar, 1998). Moreover, TrkC receptor protein is found in several types of glioma
cells (oligodendroglia - OL, CG-4, and C6) (Kumar and de Vellis, 1996). In P2 mice
lacking NT-3 or TrkC, the numbers of glial cells of each type, namely 0-2A
progenitor cells, oligodendrocytes (OL), astrocytes, and microglial cells in the spinal
cord are markedly reduced (Kumar et al., 1998; Kahn et al., 1999). Previous studies
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also showed in vitro that NT-3 (along with platelet-derived growth factor type AA,
PDGF-AA) promoted proliferation of 0-2A progenitor cells in both perinatal optic
nerve and adult spinal cord (Barres et al., 1994; Engel and Wolswijk, 1996). Kumar
et al. (1998) also suggested that the most likely mechanism ofproliferative action of
TrkC signaling in these glial population is via the Ras and MAPK pathway.
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Chapter 8: General Conclusion
8.1 Summary of main points
In this thesis, my main interest was to investigate the process of programmed
cell death (PCD) and the mechanisms and factors regulating it in the developing
thalamus at the tissue level. I have used both in vivo and in vitro approaches to look
at this process in the embryonic and early postnatal mice.
Measuring thalamic PCD
At the beginning of the thesis, I successfully identified one of the most
common and prominent modes of PCD in the thalamus, apoptosis, both in vitro and
in vivo. I found that both nuclear morphology revealed by DNA fluorochromes and
TUNEL staining confirmed the characteristics of apoptotic cells. In vitro, dying
embryonic thalamic cells are mostly apoptotic. I also confirmed that PCD actually
occurred in this tissue in vivo by observing PCD with TUNEL studies.
Occurrence of thalamic PCD
I conducted a study identifying the time course of PCD in vivo. Cell death is
found throughout the late gestation and early postnatal stages of thalamic
development, and the results correspond with previous reports in other developing
tissues. The work done by Glucksmann (1951) and Hensey and Gautier (1998)
showed that cell death occurs as early as the blastocyst stage, during gastrulation and
extended to the period of neurogenesis. However, the PCD occurring at these stages
is rare and random. Similar results were found in my studies of PCD in the early
thalamus at El 3. It is thought that cell death at this stage does not involve trophic
support as a survival-determining factor (Hensey and Gautier, 1998), but is likely to
be regulated by other as yet poorly understood mechanisms. On the other hand,
thalamic PCD was found extensively in later stages of the development (i.e. during
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the perinatal period, postnatal day 1). In addition, cell death at this later stage is
patterned and distributed differently in different thalamic nuclei (with the highest
PCD found in VPM). This uneven PCD distribution emphasizes the heterogeneity
among thalamic nuclei e.g. the time or extent in establishment of synaptic
organisation and axonal pathways of each thalamic nucleus might be different and
result in different PCD distributions.
In tissue culture, the increase in cell death in thalamic cells is found earlier
than in vivo (in vitro day El 8), although this is still around the period of early
cortical innervation. Survival of these cultured thalamic neurons is increasingly
dependent on several more factors as the cells mature. For example, the cells require
a high cell density environment (Chapter 2), trophic supply from medium
conditioned with neuronal tissues (Chapter 3 and 4) and perhaps thalamic activity
involving K+ depolarisation to maintain survival (Chapter 4 and 5). However, the last
possibility is controversial since K+ depolarisation can only promote thalamic
survival in explants but not in dissociated cells.
The different period at which there is increased cell death in vitro (El8) and
in vivo (PI) suggests that there might be a window (E18-P1) during which thalamic
cells need to adapt or switch from the stage of intrinsic self-sufficient viability to the
stage of dependency on extrinsic factors (i.e. the target). This transition period is
interestingly matched with the time thalamic cells extend their axons to innervate the
target (Rennie, 1994; Lotto et al., 1997). Similarly, in Xenopus embryonic cells, there
is also such a transition period before the period of normal in vivo PCD. During this
period, cells are sensitive to external apoptotic stimuli but give a partial and delayed
apoptotic response (Hensey and Gautier, 1997).
Matching the Neurotrophic hypothesis with PCD in thalamus
A very plausible mechanism to explain PCD in the thalamus is the
Neurotrophic Hypothesis. This was originally proposed in the peripheral nervous
system but the application in the CNS is poorly understood (see review by
Oppenheim, 1999). The concept of the hypothesis is that neurons are initially
148
overproduced and PCD occurs to neurons that fail to compete for limiting amounts of
target-derived trophic molecules during the innervation period. In my study, I tested
two major possibilities, which could fit with this hypothesis. Firstly, I showed the
importance of neurotrophic factors (neurotrophins and unidentified trophic factors
from medium conditioned with neuronal tissues) on thalamic survival both in vivo
and in vitro (Chapter 3 and 4). And later, the experiments in Pax-6 mutant cells also
indirectly indicated the significance of the thalamocortical innervation (Chapter 6).
Although there is no definite method to prove this hypothesis, the findings in my
investigation strongly support this applicability of the hypothesis in the CNS.
Regulation of thalamic PCD
1. Possible roles of neurotrophins in the thalamus
Prime candidates for molecules that are likely to control thalamic cell
survival are neurotrophins. In the periphery, the survival and differentiation of
particular neurons generally depends on individual neurotrophins (reviewed by
Snider, 1994; Lindsay et al., 1994). The roles of neurotrophins in central nervous
system development are likely to be more complex, as central neurons commonly
respond to several neurotrophic factors, and their survival and differentiation in vitro
requires multiple neurotrophic factors (Snider, 1994; Meyer-Franke et al., 1995).
Multiple neurotrophins provide redundant growth and differentiation signals, but a
more interesting possibility is that developing neurons use multiple neurotrophin
signals to direct distinct aspects of neuronal growth and differentiation (McAllister et
al., 1997).
In the collaborative studies with Dr R Beau Lotto in Chapter 3, we examined
the survival-promoting role of neurotrophins and their receptors in the developing
thalamus. We found that BDNF and its receptor, TrkB, but not other neurotrophins
or their companion receptors, are essential for the survival of some thalamic
populations. The effects from the manipulation of BDNF or TrkB are prominent
around the period of target innervation (from around El 7 both in vitro and in vivo)
and before the time of the PCD peak. However, we cannot conclude that BDNF is
149
the only factor essential for thalamic survival in that study since BDNF alone is not
sufficient for thalamic survival in vitro. This leads to the interpretation that the
regulation of PCD in the CNS is likely to be more complex and may involve several
trophic factors or mechanisms.
Another possible role of neurotrophins in thalamic and cortical development
was also investigated in this thesis. In Chapter 7,1 studied the proliferative defect in
TrkC knockout mice and found that TrkC might be involved in cell proliferation
particularly in the later stage of cortical development, which possibly involves
gliogenesis. Thus neurotrophins may also have other roles than controlling survival
in the developing forebrain.
2. Dynamic roles of intrinsic- and target-derived trophic factors
My work and other previous investigations suggested that there are likely to
be more than one trophic factor supporting thalamic viability and that conditioned
medium can promote survival of the majority of thalamic cells in vitro. However, the
purification of trophic factors from this medium has been unsuccessful. In order to
gain a better understanding of the nature of this medium while the factors within it
are unknown, I tested the specificity of media pre-conditioned with various sources
of tissue including thalamus and cortex to promote thalamic survival. Surprisingly,
not only cortical conditioned medium but also conditioned medium of other neuronal
tissues could promote thalamic survival. This means that trophic factors required by
thalamus are present in many neuronal tissues including the thalamus itself.
Dissociated thalamic neurons are able to survive in El9 thalamic conditioned
medium providing that the activity of the conditioned tissue is maintained by K+.
This suggests that thalamic cells do not completely switch their trophic
responsiveness from the intrinsically produced trophic factors to target-derived
factors during cortical innervation period, while such a switch has been reported to
occur in several other neuronal systems (Davies, 1996). In the case of the thalamus, it
is thus possible that the reduction in the level of intrinsic trophic production (rather
than the switch in trophic responsiveness) crucially regulates the viability of thalamic
150
neurons during the innervation period and later forces the thalamic cells to change
their source of trophic supply and become dependent on the target cerebral cortex.
It is not clear what mechanisms make the thalamus reduce its own production
of the growth factors at El9. In my opinion, it may be due to both an intrinsic clock
and the remodelling for establishment of thalamocortical circuits. The intrinsic
mechanism signaling thalamic cells to become less viable is one of the aspects that is
worth further investigation.
3. Possible roles of neuronal activity in regulating thalamic survival and
possible interaction of K+ and neurotrophin signaling
As discussed above, there may be more than one factor that regulates
thalamic survival. One possibility is the activity-mediated regulation of neuronal
survival (Ghosh et al., 1996). Magowan and Price (1996) have shown that K+
depolarisation promotes growth and survival of thalamic neurons during the period
of innervation before birth (the peak of in vivo PCD). I found a similar effect in this
study. I also further investigated whether thalamic trophic effects of K+ would be
compromised in the mice lacking one of the neurotrophin receptors (either TrkB or
TrkC). No significant difference in cell death was found among the wild type and the
mutants in response to treatment with K+. Thus, 1 found no direct correlation between
the effect of K+ activity and neurotrophin receptor signaling. Therefore, it leaves the
possibility that activity-dependent survival promoting effects mediated by K+ may
use other neurotrophin-independent mechanisms to regulate thalamic PCD.
4. Regulation of PCD during the innervation period: possible essential
role of the innervating axons
I investigated the possible role of a developmental transcription factor, Pax-6,
in thalamic survival. Although expressed in both diencephalon and telencephalon,
this gene is not detectable in the developing dorsal thalamus at later stages of
development. Striking observations were found in this study: 1) an increased cell
death was found only in the thalamus (but not in the cortex) at the time before birth
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(corresponding to the innervation period), while 2) thalamic cells cultured up to this
age in vivo (E19-P0 DIV) survive normally when supplied with sufficient trophic
support, and 3) the cortex-derived factors were not absent in the mutant. This
suggests that the death of thalamic cells is not due to an intrinsic defect or a
reduction in trophic production from the target but is likely a result of the disruption
of thalamocortical axons found in the mutant during the innervation period. This
finding supports the concept of the significance of innervating axons in controlling
cell survival.
In final summary, there are several components controlling survival and PCD
in developing thalamus particularly during the critical innervation period (El7 to the
early postnatal period in mice). First is the intrinsic properties of the thalamus i.e. a)
internal clock, b) thalamic activity, and c) regulation of intrinsic trophic production.
Secondly, survival in the developing thalamus could be regulated by external
support: a) neurotrophic factors supplied by the target, and b) proper axonal growth,
guidance and establishment of connection.
8.2 Future works
There are three main areas where I would like to extend my research in the
future to gain a better understanding of thalamic PCD related with thalamic cell
growth.
1) An investigation of the intrinsic properties of the developing thalamus: the
in vitro investigation of Bcl-2
I would like to investigate cellular and molecular mechanisms regulating
thalamic PCD e.g. to study whether regulation of the thalamic PCD involves
metabolic activity, protein synthesis, transcription regulation, and/or is controlled by
apoptotic proteins. Bcl-2, as well as other cell death regulating elements (both
proteins and genes), plays a key role in the intrinsic (intracellular) signaling of
apoptosis. Recent studies have shown that it also regulates neuronal growth and
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regeneration in CNS and PNS. Moreover, exogenous Bcl-2 has been successfully
introduced to the cells in vitro by using Cre/Lox-P system (Sato et ah, 1998). With
this technique, I can investigate the possible role of this protein during the critical
period by introducing and expressing the gene in thalamic cells cultured at different
ages. Studies of the distribution of this protein in the brain and investigations of the
defects in the thalamus of mice lacking or overexpressing Bcl-2 could also be
meaningful.
2) An investigation of other possible trophic factors and guidance molecules:
a possible role of extracellular matrix molecules
It is interesting that there is no collagen but there is a high proportion of other
glycosaminoglycans in the extracellular matrix of neuronal tissue. Many of these
molecules are known to promote the growth of thalamic neurons as well as other
neuronal populations (Emerling and Lander, 1996; Nissen et al., 1999). But the
function of these molecules in survival has not been established. I wish also to study
the role of molecules such as the family of chondroitin sulfates in thalamic
development, using both in vivo and in vitro approaches.
3) An investigation of the interaction between thalamic neurons and cortical
neurons in vitro
Embryonic stem (ES) cells and transgenic mice ubiquitously expressing a
tau-GFP (green/luorescent /?rotein) fusion protein have recently been generated in
our laboratory (Pratt et ah, 1999). This is a useful animal model to provide a
universal source of labeled cells for cell mixing experiment in vitro. For example,
with a labeling of one type of cell, I hope to be able to study cell interaction and
behavior between thalamic neurons and other cell types including the target cortical
neurons. I may observe the formation of synapses or neuronal connections, which
may strengthen the ability of thalamic neurons to survive in culture.
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** Transferrin is a beta glycoprotein (iron transport protein in the blood). It
transports iron to (and possibly within the cell) in culture. It may also have a
detoxifying role).
*** Antibiotics: Gentamycin sulphate (lOOmg)
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Make up to 20ml with double distilled water (sterile), then filter sterilise.
Store in 1ml aliquots at -20°C.
**** Supplements:
1) lOOpM putrescene (161.1mg/100ml in sterile double distilled water, filter
sterilise. Store in 4ml aliqouts at -70°C.
Putrecene is the decarboxylated product of the amino acid ornithine. It is
needed as a precursor for the synthesis of polyamines which are involved in cell
growth and proliferation.
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z.-glutamine is a non-essential amino acid which is an important precursor for
nucleotide and structural protein synthesis. It is required of /.-glutamate and GABA
synthesis. At high concentrations is may have neurotoxic side effects.
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